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Engineering osteochondral tissues with human adipose tissue derived stem 
cells under precise biomechanical and biochemical in vitro environments 
Abstract 
With the continuous increase in life expectancy, health problems tend to arise, whereas joint 
ailments are among the most prevalent. The knee joint, in particular, is subjected to serious 
illnesses that range from articular cartilage injuries, osteochondral lesions and osteoarthritis. 
Joint pathologies globally affect population of all ages and gender, resulting in reduced quality 
of life due to limited activity and increased expenditures, either directly (treatment, private 
expenditure), or indirectly (lost productivity, lost earnings). In this context, the need for new 
therapies and products that could satisfy the growing clinical requirements will rise in the future. 
Tissue engineering and regenerative medicine, as a rapidly emerging field, is expected to 
provide valuable solutions.  
Osteochondral lesions are articular cartilage lesions where the underlying bone is also 
damaged. A tissue engineering approach needs to address the cartilage component, 
composed by a hydrated soft tissue layer, and the bone compartment, composed by a stiff, 
complex and vascularized tissue.  
In this thesis we propose complementary approaches to evolve current state of the art, and 
move a step further in the development of functional solutions for cartilage, bone and/or 
osteochondral regeneration. Our rationale was based on the use of human adipose stem cells 
(hASC) as a single cell source to engineer all tissue compartments, by taking advantage of its 
characteristics: 1) hASC have intrinsic capacity to differentiate into the chondrogenic, 
osteogenic and endothelial lineages; 2) hASC can be obtained from adipose tissue collected by 
dedicated or non-dedicated liposuction procedures, repeatedly and abundantly; 3) hASC are 
isolated by enzymatic digestion, yielding high cell number, which may avoid or minimize cell 
expansion. Furthermore, we explored the use of precise biomechanical and biochemical 
environments specific for each engineered tissue, in order to improve cell differentiation and 
matrix deposition. Specifically, hydrostatic pressure stimulation was employed for cartilage 
engineering, while flow perfusion and inherent shear stress were investigated in bone 
development context. In order to vascularize engineered bone, a specific spatio-temporal 
regulation of growth factors and cells were thoroughly explored. 
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To this end, five experimental studies were performed. The first studied focused on the 
development of two bioreactor devices aimed at generating hydrostatic pressure (HP) for 
dynamic culturing of cartilage tissue. We hypothesized that the formation of engineered 
cartilage could be augmented by applying such physiologic stimuli to chondrogenic cells 
(human nasal chondrocytes - HNC) or stem cells (human adipose stem cells - hASC), cultured 
in gellan gum hydrogels, by varying both frequency and magnitude of loading. In the HNC 
study, the best tissue development was achieved for pulsatile HP regimen, while in the hASC 
study, the best cartilage outcomes were obtained for physiologic loading (5 MPa), as 
evidenced by gene expression of aggrecan, collagen type II and sox-9, metachromatic staining 
of cartilage matrix and immunolocalization of collagens. 
The next step aimed to evaluate the effects of scaffold architecture and biomechanics, in order 
to optimize silk scaffolds for bone tissue engineering. Silk scaffolds were fabricated using 
different solvents (aqueous vs. hexafluoro-2-propanol - HFIP), pore sizes (250-500µm vs. 500-
1000µm) and structures (lamellar vs. spherical pores). Given the great potential of hASC for 
cell-based therapies and tissue engineering, in particular bone tissue, silk scaffold and hASCs 
are two promising components, which have not been previously investigated in combination. 
The porous HFIP silk scaffold with 400-600 µm pores performed better than any other scaffold, 
while the lamellar scaffolds performed better than spherical-pore scaffolds. 
We further used this HFIP-silk scaffold as cell support for dynamic culturing studies, where the 
effects of pulsatile perfusion on in vitro bone expression by human adipose stem cells (hASCs) 
was assessed. We hypothesized that the formation of engineered bone could be augmented by 
replicating physiologic stimuli – pulsatile interstitial flow - to cells cultured in porous scaffolds 
using bioreactors with medium perfusion. This was confirmed, once the best tissue 
development was achieved for the sequence of 2 weeks of steady flow and 3 weeks of 
pulsatile flow, as evidenced by gene expression, construct compositions, histomorphologies 
and biomechanical properties. 
Further challenge was to vascularize the engineered bone grafts. Even more demanding was 
to use the same cell source – hASC. From a clinical perspective, it would be ideal to engineer 
vascularized bone grafts starting from one single cell harvest obtained from the patient. We 
hypothesized that a sequential application of osteogenic and endothelial growth factors to 
hASC cultured on biomaterial scaffolds (HFIP-silk scaffold), with different timing of addition of 
fresh cells could support the development of bone-like tissue containing an integrated vascular 
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network. Three strategies were evaluated by changing spatio-temporal cues, but only one of 
the combinations, in particular the osteo-induction of hASC seeded to silk scaffold for 3 weeks, 
followed by addition of fibrin-encapsulated hASC to which vasculogenic cues were provided for 
2 weeks, resulted in the most promising outcomes towards vascularized bone grafts.  
The final experimental design focused on the development of an in vitro model for studies of 
heterotypic cellular interactions that couple blood vessel formation with osteogenesis by using 
human umbilical vein endothelial cells (HUVECs) and human bone marrow mesenchymal stem 
cells (hMSCs). In this study, we hypothesized that the sequential application of growth factors, 
to firstly induce the formation of stable vasculature and subsequently initiate osteogenic 
differentiation, could provide a biologically-inspired in vitro model of bone vascularization. Two 
important findings resulted from these studies: (i) vascular development needs to be induced 
prior to osteogenesis, and (ii) the addition of additional hMSCs at the osteogenic induction 
stage improves both tissue outcomes, and anastomosis of vascular networks with the host 
(SCID mice) vasculature. 
Taken altogether, the results obtained during the accomplishment and completion of this thesis 
prove the successful use of human adipose stem cells for osteochondral tissue engineering, as 
mechanically responsive cell source, which, in combination with appropriate growth factors, 
generate both cartilage and bone compartments. Besides the success obtained with dynamic 
culturing, it was proven that hASC have great potential to be used as single cell source for the 
development of vascularized bone grafts.  
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Desenvolvimento de tecidos osteocondrais com células estaminais do tecido 
adiposo sob condições precisas de estimulação biomecânica e bioquímica  
Resumo 
Com o aumento contínuo da esperança média de vida, tem ocorrido um aumento progressivo 
de problemas de saúde, estando as doenças articulares entre as mais prevalentes. A 
articulação do joelho, em particular, está sujeita a doenças graves, que vão desde lesões 
focais da cartilagem articular, lesões osteocondrais e osteoartrite. As patologias do joelho 
afetam globalmente a população de todas as idades e género, resultando numa redução 
significativa da qualidade de vida devido às limitações de atividade, assim como devido a 
despesas acrescidas, seja direta (tratamento, despesas privadas), ou indiretamente (perda de 
produtividade, perda de lucros). Neste contexto, a necessidade de novas terapias e produtos 
que possam satisfazer as crescentes exigências clínicas tende a aumentar. A engenharia de 
tecidos e medicina regenerativa, como área em rápida expansão, é estimada que possa 
fornecer soluções valiosas. 
As lesões osteocondrais são lesões da cartilagem articular onde o osso subjacente é também 
danificado. Numa abordagem de engenharia de tecidos seria necessário abordar tanto a 
componente da cartilagem, composto por uma camada de tecido mole altamente hidratado, 
como o compartimento ósseo, composto por um tecido rígido, complexo e vascularizado. 
Nesta tese, propomos algumas abordagens para evoluir o estado da arte atual, assim como 
avançar um passo no desenvolvimento de soluções funcionais para o osso, cartilagem e / ou 
regeneração osteocondral. Para tal, usamos células estaminais humanas derivadas do tecido 
adiposo (TA) (hASC), como fonte celular única para a engenharia de todos os compartimentos 
do tecido, tirando partido das suas características: 1) as hASC têm capacidade intrínseca para 
se diferenciar nas linhagens condrogénica, osteogénica e endotelial, 2) as hASC podem ser 
obtidas de TA recolhido em cirurgia de lipoaspiração, em abundância e repetidamente; 3) as 
hASC são isoladas através de uma digestão enzimática fácil e rápida, resultando num elevado 
número de células, evitando ou minimizando a expansão celular. Adicionalmente, exploramos 
o uso de ambientes biomecânicos e bioquimicamente precisos e específicos para cada tecido 
a ser desenvolvido, de modo a melhorar a diferenciação celular e deposição de matriz. De 
forma específica, a estimulação através de pressão hidrostática foi utilizada para o 
desenvolvimento de cartilagem, enquanto a perfusão de fluxo e inerente tensão de corte foram 
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investigados no contexto do desenvolvimento ósseo. A fim de vascularizar o enxerto ósseo 
desenvolvido, foram exploradas condições específicas de regulação espaço-temporal de 
células e fatores de crescimento. 
Para este propósito, cinco estudos experimentais foram realizados. O primeiro estudo focado 
no desenvolvimento de dois bioreatores visou gerar pressão hidrostática (HP) para a cultura 
dinâmica do tecido cartilaginoso. Consideramos como hipótese que a formação de cartilagem 
poderia ser aumentada através da aplicação de tais estímulos fisiológicos, tanto em células 
primárias (condrócitos) (septo nasal humano - HNC) ou células-estaminais (células estaminais 
do tecido adiposo humano - hASC), cultivadas em hidrogéis de goma gelana, variando a 
frequência e magnitude de carga. No estudo HNC, o melhor desenvolvimento de tecido foi 
conseguido para o regime de HP pulsátil, enquanto que no estudo hASC, os melhores 
resultados foram obtidos através da aplicação de níveis fisiológicos de HP (5 MPa), como 
evidenciado pela expressão genética de agrecano, colagénio tipo II e sox-9, assim como 
através da coloração metacromática da matriz da cartilagem e imunolocalização de 
colagénios. 
O próximo passo pretendia avaliar os efeitos da arquitectura e propriedades biomecânicas de 
suportes, a fim de otimizar suportes de seda para a engenharia de tecido ósseo. Suportes de 
seda foram fabricados usando diferentes solventes (aquoso vs hexafluoro-2-propanol - HFIP), 
tamanhos de poros (250-500µm versus 500-1000µm) e estruturas (poros lamelar versus 
esférica). Dado o grande potencial de hASC para terapias celulares e engenharia de tecidos, 
em especial do tecido ósseo, os suportes de seda e hASC constituem dois componentes 
promissores, que ainda não foram previamente investigados em combinação. O suporte 
composto por seda-HFIP, com poros esféricos de 400-600 µm, demonstrou melhor 
desempenho do que qualquer outro suporte, enquanto os suportes com estrutura lamelar 
demonstraram melhor desempenho do que os suportes com poros esféricos. 
Este suportes de seda-HFIP foram posteriormente utilizados para os estudos de cultura 
dinâmica, onde foram avaliados os efeitos da perfusão pulsátil sobre a expressão óssea por 
hASC. Consideramos como hipótese que a formação de osso poderia ser aumentada através 
da replicação de estímulos fisiológicos - fluxo intersticial pulsátil - para as células cultivadas 
em suportes porosos utilizando bioreatores com perfusão do meio de cultura. Esta hipótese foi 
confirmada, uma vez que o melhor desenvolvimento de tecido foi obtido para a sequência de 2 
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semanas de fluxo constante e 3 semanas de fluxo pulsátil, como evidenciado pela expressão 
genética, composição do enxerto, histomorfologias e propriedades biomecânicas. 
O desafio seguinte consistia em vascularizar os enxertos ósseos desenvolvidos. Mais exigente 
foi o uso da mesma fonte celular - hASC. Numa perspectiva clínica, o ideal seria desenvolver 
enxertos ósseos vascularizados a partir de uma colheita celular única obtida do paciente. 
Consideramos como hipótese que uma aplicação sequencial de fatores de crescimento 
endoteliais e osteogénicos em hASC cultivadas em biomateriais (suportes de seda-HFIP), com 
diferentes períodos de adição de células frescas, poderia beneficiar o desenvolvimento de 
osso contendo uma rede vascular integrada. Três estratégias foram avaliadas mas apenas 
uma das combinações forneceu resultados promissores para o desenvolvimento de enxerto 
ósseo vascularizado, em particular a osteo-indução das hASC aderidas ao suporte de seda 
durante 3 semanas, seguido pela adição de hASC encapsuladas em fibrina, às quais foram 
fornecidas fatores vasculogénicos durante 2 semanas. 
O desenho experimental final concentrou-se no desenvolvimento de um modelo in vitro para 
estudo de interações celulares heterotípicas que combinem formação de vasos sanguíneos 
com osteogénese, usando células endoteliais do cordão umbilical humano (HUVECs) e 
células-estaminais mesenquimatosas da medula óssea humana (hMSCs). Neste estudo, 
testamos a hipótese da aplicação sequencial de fatores de crescimento, em primeiro lugar, 
induzir a formação de vasos estáveis e, posteriormente, iniciar a diferenciação osteogénica, 
poder fornecer um modelo in vitro de vascularização óssea, biologicamente inspirado. Duas 
conclusões importantes resultaram deste estudo: (i) o desenvolvimento vascular necessita de 
ser induzida antes da osteogénese, e (ii) a adição de hMSCs adicionais na fase de indução 
osteogénica melhora os resultados do tecido, assim como a anastomose das redes vasculares 
com a vasculatura do animal recetor (ratinhos SCID). 
Analisados em conjunto, os resultados obtidos durante a realização e conclusão desta tese 
provam o sucesso do uso de células estaminais do tecido adiposo humano para engenharia 
de tecidos osteocondrais, como fonte de células mecanicamente sensíveis às distintas forças 
de estimulação biomecânica, que, em combinação com os fatores de crescimento adequados, 
desenvolveram os compartimentos cartilagíneo e ósseo. Além do sucesso obtido com a 
cultura dinâmica, foi comprovado que as hASC apresentam grande potencial para serem 
utilizadas como fonte celular única para o crescimento de enxertos ósseos vascularizados. 
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#p<0.001 to all other groups, *p<0.01, **p<0.001.  
Figure 7. Model of in vitro coordination of bone and vascular tissue development. hASC 
(beige spindle-shape) adhered to silk scaffold wall, sense the hard surface and osteogenic 
factors provided, stimulate osteogenic differentiation (green cells) and deposition of mineralized 
matrix (grey). At a second stage, hASC encapsulated in fibrin hydrogel (light blue) are triggered 
by smooth vasculogenic surface growth factors provided, to undergo endothelial differentiation 
(red cells). 
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Scale bar = 50 µm. Rows 3 and 4: In vivo bone development. Goldner’s Masson trichrome 
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Figure 6. Model of in vitro coordination of vascular and bone tissue development. In a co-
culture of ECs and hMSCs (beige, spindle-shaped cells), angiogenic supplements provide cues 
to stimulate the formation of primitive vascular networks (red) by the ECs (dispersed ECs are not 
shown in the model). These, in turn, recruit hMSCs into a pericyte-like role (green) that enables 
the vascular network to remain stable when osteogenic cues are provided. These cues induce 
osteoblast formation (blue cells) and deposition of mineralized matrix (beige).  
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Figure S1: Gel cultivation. A: HUVECs only at 3 weeks in EGM-2. Co-culture of HUVECs with 
MSCs (1:1) enables formation of stable micro-vasculature networks at 3 weeks in EGM-2 (B) that 
last up to 12 weeks (C) during in vitro culture. D: von Willebrand Factor (vWF) staining of lumen. 
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Figure S2: Gel screening studies.  HUVECs (pre-stained with Di-I) and MSCs were 
encapsulated in fibrin hydrogels (1:1 ratio) and cultured in small wells for 4 weeks to determine 
cellular responses to different medium conditions. Confocal images were used to evaluate 
vascular network formation and provide a read-out on HUVEC viability (cellular debris). Scale 
bar= 50 µm. Bottom row: von Kossa staining of mineral deposition within the gel regions.  
Mineral is shown as black/dark brown stains within the gels. 
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Figure S3: H&E staining of constructs at day 1. Cells are uniformly distributed throughout the 
scaffold upon seeding. Cells are located predominantly on the wall surfaces of scaffolds but grow 
into pore spaces subsequently. 
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Figure S4: EGM|cocktail+MSC group stained with anti-human CD31 mAb. Human origin lumen, 
with red blood cells inside (stained with hematoxylin) are pointed with yellow arrows.  
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Introduction to thesis format 
The present thesis is divided in six sections and nine chapters. The first section is composed of 
two review papers, gathering relevant bibliographic references and significant research done in 
osteochondral tissue engineering while positioning the work developed in this thesis among 
current state-of-the-art. The second section explains the materials and methods used for 
experimental work described in further sections three, four and five. Finally, the major 
conclusions achieved within this thesis are addressed in section six. A brief description of each 
section is summarized below: 
Section 1. 
 Chapter I is composed by a comprehensive review paper where dynamic culturing is 
thoroughly explored in the context of cartilage tissue engineering. Besides focusing on the 
improvement of cartilage tissue outcomes by dynamic culturing, this review also explores the 
mechanisms by which stem cells and primary cells respond to distinct biomechanical forces, 
and how these forces are applied to tissue engineered constructs through appropriate 
bioreactor devices. Shear stress, direct or indirect compression, flow perfusion and the 
generation of hydrostatic pressure are the forces of biomechanical interest for the development 
of cartilage tissues with adequate properties, and therefore explored in this review. 
 Chapter II contains a concise review of the most recent achievements on tissue 
engineering of bone, with specific highlights on major outcomes attained by dynamic culturing 
with flow perfusion, as major force governing osteocyte mechanotransduction. Mechanisms of 
mechanotransduction and mechanobiology of bone are also addressed. Furthermore, insights 
on latest findings regarding vascularization of bone are discussed. 
Section 2. 
 Chapter III explains in great detail all materials and methods used in the experimental 
work described in further sections of this thesis.  
Section 3. 
 Chapter IV presents the design and validation of two bioreactor devices for dynamic 
culturing of cartilage tissue, by generation of hydrostatic pressure (HP). The response of 
human nasal chondrocytes (HNC) and human adipose stem cells (hASC) to such physiologic 
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stimuli was addressed. Cells were encapsulated in gellan gum hydrogels, and cultured in 
distinct regimens of loading frequency and magnitude. 
Section 4. 
 Chapter V describes the performance of silk scaffolds for bone tissue engineering by 
human adipose stem cells. Different pore sizes and pore structure, as well as two types of 
solvents were tested, resulting in distinct scaffold architecture and biomechanics. hASC 
osteogenic differentiation and bone-tissue outcomes were evaluated. 
 Chapter VI reports major findings regarding the effects of pulsatile perfusion on bone 
development by human adipose stem cells (hASCs) cultivated on the HFIP-silk scaffold 
selected from previous study. Sequence application of steady and pulsatile flows were tested in 
order to understand the importance of osteogenic pre-differentiation of hASC to respond to the 
proposed mechanical stimulation. 
Section 5. 
 Chapter VII demonstrates the potential of hASC as single cell source for the 
development of vascularized bone grafts. Three major strategies, and seven experimental 
groups were evaluated by changing location and timing of construct nourishment with cells and 
growth factors.  
 Chapter VIII describes a co-culture study using human umbilical vein endothelial cells 
(HUVECs) and human bone marrow mesenchymal stem cells (hMSCs) for growth of 
vascularized bone in vitro, and further validation by anastomosis of engineered networks with 
SCID mice vasculature.   
Section 6. 
 Chapter IX highlights major conclusions and future perspectives regarding the set of 
studies presented in this thesis. More than addressing a complete analysis of the progress 
beyond state-of-the-art, future perspectives are provided regarding osteochondral tissue 
engineering and the exploitation of adipose stem cells in this context. 
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CHAPTER I 
Dynamic culturing for cartilage tissue engineering: a retrospective analysis 
 
 
This chapter is based on the following publication: Correia C, Sousa RA and Reis RL, 2011, Dynamic 
culturing for cartilage tissue engineering: a retrospective analysis - submitted. 
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Abstract   
Clinical experience has demonstrated with clear evidence that excessive loading may 
significantly contribute to joint wear, while controlled loading is a requirement for healthy 
cartilage growth and maintenance. The high incidence of joint injuries in addition with the very 
low capacity of cartilage self-repair, leads to major potential applications for cartilage tissue 
engineering. Through the past decades, tissue engineering research has advanced from 
standard static culturing towards the development of new tools aiming to mimic the dynamic 
biomechanical processes that occur at articular cartilage in vivo. 
Tensile and shear forces, direct or indirect compression, flow perfusion or the generation of 
hydrostatic pressure are forces of biomechanical interest to be generated in bioreactor devices, 
for the development of cartilage tissues with adequate properties. In this regard, high quality 
research has been made to understand how cells respond to mechanical stimulation, and in 
which manner can these forces be used to enhance cell proliferation, increase extracellular 
matrix deposition, or even to tune mesenchymal stem cell differentiation towards the 
chondrogenic lineage. This review intends to provide a retrospective critical analysis of the 
overall output obtained through the triangle relationship between cells, scaffolds and bioreactor 
devices.  
 
1. INTRODUCTION  
It has been extensively stated that joint ailments are a major health drawback affecting 
population worldwide that are age-wide and lifetime enduring. Traumatic injuries, degenerative 
or rheumatic diseases are the main causes of these ailments. Analyzing United States 
statistics at 2005, we can see that between the age of 18 and 64, fractures or joint injury are 
responsible for 10-20‰ of activity limitation, and arthritis or other musculoskeletal disease are 
responsible for 20, 58 and 98‰ of limitation among 18-44, 45-54 and 55-64 years old, 
respectively [1]. Most articular cartilage defects are caused by trauma, which can occur by a 
single impact or repeated micro trauma [2]. On the other hand, degenerative or rheumatic 
diseases are the main causes of joints cartilage degradation. Arthritis is a complex disorder 
that comprises more than 100 different disease patterns [3]  and can affect people at any stage 
of life. It is characterized by inflammation of one or more joints [4], which consequently results 
in stiffness, swelling and persistent joint pain, including hip, knee, ankle, shoulder, elbow, hand 
or wrist joint pain. In addition to the patients’ reduced quality of life, the socio-economic 
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consequences of arthritic diseases (incapacity to work and early retirement), together with 
health care costs, are noticeably high [5].  
However, currently no therapeutic approach have experienced wide clinical acceptance. The 
successful outcome of the treatment, which ideally should be the formation of a durable repair 
tissue that provides symptomatic relief and allows for normal physical activity, depends highly 
on the exact nature of the cartilage defect, such as size, location and associated pathologies. 
On what concerns knee articular cartilage, there are currently several surgical treatment 
approaches, namely arthroscopic lavage and debridement [6, 7]; microfracture [7-10] and 
mosaicplasty [11-14]. However, in a best-case scenario these approaches render only a 
temporary effect, being their long time therapeutic effect still questionable. Autologous 
chondrocyte transplantation (ACT) represented the first generation cell based therapy for 
cartilage repair [15-17]. However, even this therapy presents several performance drawbacks 
[18-21], and is not available for osteoarthritic patients. New and better solutions are clearly 
needed to repair cartilage tissue defects. 
Among the three major types of cartilage present in the human body, articular cartilage (AC) is 
the one found in most synarthroidal and diarthroidal joints. Due to the specific cartilage 
composition and structure, firstly characterized as a hypocellular connective tissue with 
complete lack of blood vessels, lymphatic vessels, and neurons, which normally nourish other 
parts of the body, cartilage is not able to regenerate when injured [22, 23]. Focusing on this 
minimal healing capacity, cartilage repair is undoubtedly a potentially significant application 
field for Tissue Engineering.  
It is well known that articular cartilage is affected in vivo as well as in vitro by several, very 
distinct, biomechanical forces that are responsible to maintain its structure and function. These 
include tensile or shear forces [24-26], fluid perfusion, compression [27-29] or hydrostatic 
pressurization, which is known to be the predominant mechanical signal governing normal 
articular cartilage [30-33] The application of mechanical stimuli to foster tissue development 
during culturing, as a complement to the use of growth factors solely, is a scientific and 
experimental challenge. In this regard, bioreactor devices have been developed in order to 
construct functional cartilage tissues. In this domain, extensive research has been performed in 
order to overcome the research-scale product designs and to dynamically engineer 
reproducible, safe and economically competitive ex vivo biologically functional tissues. In a 
cartilage tissue engineering approach, bioreactors, yet, form only one of the vertices of a very 
strict triangle relationship, of which cells and scaffolds constitute the remaining two.  
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Fundamental studies have predominantly evaluated bovine articular explants or isolated 
chondrocytes, while more recent studies have evaluated normal or osteoarthritic human 
chondrocytes’ response to load under distinct protocols of load amplitude, frequency and 
duration. Biomechanical stimuli have also been applied to adult stem cells, namely bone 
marrow mesenchymal stem cells, with the aim of tailoring these multipotent cells into the 
chondrogenic lineage.  
This review addresses the use of bioreactors in the context of cartilage tissue engineering, with 
special emphasis to dynamic culturing of cells using three-dimensional (3D) scaffolds under 
different biomechanical contexts. 
 
2. CARTILAGE BIOLOGY 
Three major types of cartilage are found in the human body [34]: elastic cartilage, fibrocartilage 
and hyaline cartilage. Their differences reside essentially in the structure and biochemical 
composition of their extracellular matrix (ECM). These characteristics result in diverse 
mechanical properties and physical occurrences within the body [22, 34].  
Hyaline cartilage is the most widespread cartilage in the human body. Macroscopically it 
appears as a white and slightly bluish tissue with a smooth surface, which can be found in the 
nose, the trachea, bronchi and most joints (synarthrodial and diarthrodial joints) [23, 35, 36]. In 
synchondroidal joints, it builds up a continuous connection between bones, e.g., between the 
ribs and sternum, in the intervertebral discs, or in the epiphyseal junction of the femur. In 
diarthrodial joints, hyaline cartilage covers the contact zones of two interlocked bones, where it 
functions to transmit high stresses generated in these joints and is so-called articular cartilage 
[22]. Articular cartilage (AC) is the most common and well-studied hyaline cartilage. It appears 
as a hydrated soft tissue layer with a thickness of 0.5 to 5 mm covering the ends of all synovial 
joints (ankle, knee, hip, shoulder, elbow, wrist, and finger) [37]. It has four important roles: 1) to 
transmit compressive forces across the joint; 2) to allow motion in the joint with minimal friction 
and wear; 3) to redistribute contact stresses over a larger area and 4) to protect the underlying 
bone. AC is constituted by a well organized biphasic system. The liquid phase is comprised by 
water and electrolytes, and ranges 80% of wet weight, while the solid phase is constituted both 
by cellular and acellular components that give rise to a porous-permeable composite material. 
This solid phase is organized at a well-defined multi-scale, hierarchical level [37]: 
Chapter I – Dynamic culturing for cartilage tissue engineering: a retrospective analysis 
	  50	  
Micro-scale 10-7-10-4 m: at this level, chondrocytes occupy 2% of the total volume. These 
singular cells synthesize and secrete extracellular matrix (ECM) which by itself occupies 20% 
wet weight of the acellular fraction;  
Ultra-scale 10-8-10-6 m: Collagen molecules are the major participants at this scale, accounting 
for 50–80% of the dry weight of articular cartilage [37]. Among all types of collagen, type II 
accounts for 90-95% of total collagen found in AC. It is displaced in a three-dimensional 
arrangement, forming fibrils, which non-covalently immobilizes the highly hydrated, negatively 
charged, proteoglycans (PGs) aggrecan and versican [36].  
Nano-scale 10-10-10-9 m: Glycosaminoglycans (GAGs) chains participate at this level. 
Chondroitin sulfate and keratan sulfate are covalently attached to the aggrecan protein 
backbone. Additionally at this nano-scale, ions such as Na+, Ca2+, SO3-, COO- are responsible 
for AC swelling, for governing osmotic pressure of cartilage, and consequently contribute for its 
compressive stiffness [37]. 
 
3. MECHANOBIOLOGY OF ARTICULAR CARTILAGE (AC) 
AC comprises a specific structure which outcomes in unique functional and mechanical 
properties (table I) [37-39]. Movement between two bones occurs with minimal friction and 
wear. The joint surfaces have remarkably low coefficients of friction - it has been reported to 
range from 0.005 to 0.04 in some joints, which allow the surfaces to glide over each other 
smoothly [37]. Cartilage is capable of distributing load over its surface, halving contact 
stresses, therefore assuring stability and functioning of the joint. Furthermore, cartilage is an 
anisotropic tissue [31, 40] and well suited to withstand demanding loads, responding to load in 
a viscoelastic manner [41, 42], by varying its stiffness according to the imposed strain rate [37]. 
This outstanding load-bearing capacity of articular cartilage is mainly assured by its 
extracellular structure, making it possible to withstand loads up to 10 times the body weight [31, 
37]. Collagen type II is an important protein on what concerns stiffness and strength of AC [43]. 
Collagen fibers, composed by three α-helix chains, include intermolecular crosslinks which 
contribute for the tensile strength of collagen fibrils [44]. On the other hand, collagen type IX 
mediates the inter-fibrillar connections by covalent linkages to the surface of collagen type II 
fibril [45]. Collagen type IX is, in addition to collagen type II, a marker for differentiated 
chondrocytes, and, a requirement for a mechanically functional extracellular network [46]. 
Proteoglycans provide compressive stiffness to the tissue while their highly negatively charged 
glycosaminoglycans chains afford ACs’ swelling capacity [37]. 
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Table I – Mechanical performance of articular cartilage extracellular matrix. Compiled from references 
[37-39] 
MECHANICAL FEATURES RANGE VALUE 
Compressive modulus < 1.5 MPa 
Shear modulus < 0.5 MPa 
Tensile equilibrium modulus 1- 18 MPa 
Permeability coefficient 1014 - 1015 m4/N.s 
Poisson’s ratio  0 - 0.42 
 
At joints, such as the hip or the knee, AC is subjected to intermittent cyclic stress that can 
either be compressive or shear (Figure 1). Compressive stress is supported by the 
incompressible fluid component, where water is driven out on loading. On the opposite, shear 
load is supported by the matrix network and results deformation. An excessive shear stress 
can result in cartilage degradation through the disruption of the cartilage fiber network, which 
results in wear and fibrillation. Intermittent hydrostatic pressure is so essential for cartilage 
homeostasis that joint immobilization or decreased loading results in cartilage thinning. Since 
95% of total applied joint load is supported by interstitial fluid pressurization, hydrostatic 
pressure is a fundamental mechanical stimulus governing the normal functioning articular 
cartilage (Figure 1) [37].  
 
 
Figure 1 – Basic forces acting on articular cartilage during loading. Adapted from [37]  
 
4. CELL MECHANOTRANSDUCTION 
State of the art knowledge makes obvious the influence of mechanical forces on cartilage and 
chondrocyte metabolism. However, the underlying machinery by which cells sense and 
respond under the influence of mechanical signal is, to a certain extent, still concealed. 
Nevertheless, within this process, five players have been identified [27, 47-52]: 
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a) Physicochemical Effects – Under load, cartilage suffers deformation to some extent, 
which activate a host of changes in extracellular matrix. Some effects created during 
cartilage loading include increased interstitial fluid flow, electrical potential variation, 
increased osmotic pressure, and decreased pH [27, 47]. 
b) Ion Pumps and Channels - Signal transduction occurs by the flow of ions into and out 
of the cell. Intracellular Ca2+ waves and stretch-activated Ca2+ channels in the plasma 
membrane have been implicated in several studies of chondrocyte 
mechanotransduction [48, 49]. 
c) Integrins - Cell-matrix interactions are strictly mediated by integrins. They are 
exceptionally positioned to act as cellular mechanosensors, performing as the primary 
bridge between the ECM and the actin cytoskeleton [50].  
d) Cytoskeleton - When subjected to load, the cytoskeleton, a potential force transducer 
in cells, can undergo numerous changes due to its structural role. These changes 
include deformation, reorganization, assembly, and disassembly. Additionally, it has 
been reported that the levels of actin, vimentin, and tubulin vary along separate 
regions in cartilage, which may somehow be correlated to the distinct load distribution 
across the tissue [51, 52]. 
e) Nuclear Deformation - Deformation of nuclei may be a pathway for transducing 
mechanical signalling into changes in gene expression. Upon deformation of the 
nucleus, the nuclear pore complex may be physically modified, or change the 
accessibility of genomic DNA for transcription [50].  
Understanding these complex mechanotransduction pathways by which chondrocytes interpret 
and respond to load is of critical importance for cartilage tissue engineers who are currently 
attempting to develop mechanically functional tissues through dynamic cell culturing. 
 
5. ENGINEERING CARTILAGE TISSUE BY DYNAMIC CULTURING 
In tissue engineering, different bioreactors [53-56] have been developed in order to provide 
control over the physicochemical culturing parameters during cell or tissue culture. These 
devices are intended to standardize and automate the major processes of cell culturing, and to 
provide a solid basis for subsequent scaling-up into clinical applications. In the scope of 
cartilage tissue engineering, two important features are important during the development of a 
bioreactor:  
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1- To assure high nutrient transport and to provide an adequate hydrodynamic 
environment in order to accelerate and improve the in vitro growth of the tissue;  
2- To mimic the biomechanical environment experienced by cartilage in vivo that results 
from the motion of joints and the forces resulting from surrounding muscles and 
tendons, in order to promote chondrocyte differentiation and tissue maturation. 
By recognizing the importance of these parameters in cartilage tissue engineering, the so-
called dynamic culturing has been developed leading to a significant advantage when 
compared with static culturing. In the last years, a great number of studies have explored the 
effects of different types of forces exerted over articular cartilage during joint movement, 
including shear stress, direct and indirect compression, flow perfusion or hydrostatic pressure. 
The experimental design of these studies vary extensively regarding the force parameters 
applied (duration, magnitude and frequency), the type of specimen employed such as the use 
of explants or isolated cells, the anatomic provenience of such cells and lately the use of three-
dimensional supports for cell attachment and growth, i.e., scaffolds.  
 
This review attempts to cover the advances in dynamic cell culturing in the context of cartilage 
tissue engineering during the last years. For this, a dynamic bibliographic search was 
performed using ISI Web of KnowledgeSM (Thomson Reuters, USA) and Scopus (Elsevier, The 
Netherlands) databases. Taking into account the tissue engineering perspective given to this 
review, emphasis was given to studies based on the combined use of bioreactors with tissue 
engineering scaffolds, in detriment of experimental studies focusing solely on the effects of 
mechanical stimuli over tissue explants or cell monolayers.  
When analyzing the different types of mechanical stimuli investigated, it is possible to detect a 
trend in terms of experimental investigation. Figure 2 displays the research data published 
since 1993 by type of mechanical stimuli investigated (shear, perfusion, compression and 
hydrostatic pressure). The noticeable trend in the figure is the progressive importance of 
studies aimed at understanding the effect of stimuli such as compression, flow perfusion and 
shear stress in chondrocyte mechanotransduction and mechanosensation, as opposed to 
studies focusing on hydrostatic pressure. 
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Figure 2 – Time distribution of research studies published between 1993 and 2011 on the effect of 
mechanical stimulation of cells in the context of cartilage tissue engineering. From ISI Web of 
KnowledgeSM (Thomson Reuters, USA) and Scopus (Elsevier, The Netherlands) databases. 
 
5.1. SHEAR STRESS STIMULI 
Shear stress is a stress state where the stress is parallel or tangential to a face of the material, 
as opposed to normal stress, where the stress is perpendicular to the face (Figure 1). When 
joint movements occur, cartilage has to resist shear force generated by the synovial fluid 
pressurization alongside its surface. The shear modulus for articular cartilage ranges from 0.20 
to 0.40 MPa, indicating a low rigidity, which facilitates adaptation of the tissue to different 
shapes in an equivoluminal manner [37] . Cartilage responds by deforming without changes in 
volume neither in pressure gradient nor fluid flow. The deeper and calcified zones of cartilage 
are not able to react flexibly to the shear stress; therefore, it is the upper zone of cartilage that 
reacts flexibly to this force, being able to shift vertically up to 15° [57]. The collagen 
macromolecules are responsible for the resistance against shear stress, in a magnitude that is 
directly proportional to its concentration [57]. Research work has been developed in the context 
of cartilage tissue engineering to assess the effect of shear force over chondrocyte 
metabolism. Table II highlights the experimental setup used for these studies and summarizes 
the respective outcomes. On what concerns the type of cells investigated in this context, 
chondrocyte primary cultures have been those mostly used, namely human chondrocytes 
(nasal or articular), bovine and murine articular chondrocytes. Stem cells have scarcely been 
investigated in this context, whereas only Ohyabu et al (2009) [58] evaluated the effects of 
shear stress on the chondrogenic differentiation of Japanese White Rabbits’ bone marrow stem 
cells. 
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Regarding type of scaffolds employed, microcarriers have been extensively used in these 
studies. Frondoza et al (1996) [59] tested four types of microcarriers: Cytodex™ 1 and 2: 
180 µm and 155 µm size beads of dextran; Cytodex™ 3, 175 µm size beads of denatured pig 
skin type I collagen-coated dextran [59], and Cellagen™, 100-400~µm size beads of collagen 
type I [59, 60]. Poly(glycolic acid) (PGA) scaffolds and other poly(α-hydroxy esters) such as 
poly(L-lactic acid) (PLLA) and the co-polymer poly(lactic-co-glycolic acid) (PLGA) were also 
employed to develop cartilage constructs under shear stress conditions. Poly(α-hydroxy 
esters) have been widely adopted in this research context due to their biodegradability and 
clinical approval by FDA (Food and Drug Administration) [61-64]. Chitosan, a natural 
polysaccharide, was studied for cartilage TE due to its structural similarity with 
glycosaminoglycans [65] 
It is evident that the combination of different experimental approaches and cell models reduces 
comparability of reported data and contributes to variability of findings. Frondoza stated that 
CellagenTM microcarriers showed to be the most suitable for chondrocyte culturing, obtaining a 
20-fold cell multiplication after 2 weeks of culture, with production of extracellular matrix 
components, namely collagen type II [59]. Experiments using nasal chondrocytes, in culture 
medium for 8 days, resulted in the expression of high levels of collagen type II mRNA, together 
with low levels of collagen type I mRNA. Aggrecan mRNA was detectable, and levels of de 
novo 35SO4 incorporation were high [60]. These results were accompanied by a change in cell 
morphology, once chondrocytes at the surface of microcarriers appeared spherical. Levels of 
messenger RNA transcripts of the ß-1 integrin gene (possibly responsible for 
mechanotransduction) were high and its protein product was detectable by immunostaining. 
Based on these results, Bouchet and co-workers [60] stated that the ability to respond to a 
mechanical stimulus may be a characteristic of chondrocytes, irrespective of their source. 
 
Table II – Experimental studies developed in order to evaluate the effect of shear stress over cartilage 
biosynthesis. Compiled from references [58-63, 65, 66]  
Specie Cell 
type 
Scaffold Bioreactor Conditions* Major results / Key findings Ref. 
Human OC Cytodex™ 
and 
Cellagen™ 
microcarriers 
Spinner 
Flask (SF) 
2x102 cells/cm2 
 
60 rpm 
 
2 weeks 
Best results for Cellagen™: 20-fold 
cell multiplication;  
 
Collagen type II production  
[59] 
Human NC Cellagen™ Spinner 4x103 cells/cm2 High levels of β-1 integrin, collagen [60] 
Chapter I – Dynamic culturing for cartilage tissue engineering: a retrospective analysis 
	  56	  
microcarrier Flask (SF)  
60 rpm 
 
8 days 
type II and aggrecan mRNA 
expression 
Human DF Gelatine 
microcarrier 
Spinner 
Flask (SF) 
18x106 cells/g 
 
20 rpm 
 
12 weeks 
Increased aggrecan production [66] 
Bovine AC CPBS  
(5 mm cube) 
Rotator 6.5x105 cells/ 
scaffold 
 
60 rpm 
 
4 weeks 
Enhancement of GAG production [65] 
Bovine AC  PGA fibrous 
mesh 
(10x5mm) 
Spinner 
Flask (SF) 
7x106 cells/ 
scaffold 
 
80, 120, 160 
rpm  
 
42 days 
Presence of mixing rather than its 
intensity is more determinant in 
GAG and collagen synthesis  
[63] 
Bovine AC PGA disc 
(5x2mm) 
Wavy-
walled 
bioreactor 
(WWB) 
5x106 cells/ 
scaffold  
 
50 rpm  
 
4 weeks 
30% higher cell population 
 
60% higher production of 
extracellular matrix  
 
(as compared to spinner flask) 
[61] 
Bovine AC  PLLA disc 
(10x1.9mm) 
Concentric 
cylinder 
bioreactor 
(CCB) 
3.75, 5.0, 6.25 
x106 cells/ 
scaffold  
 
19, 38, 76 rpm  
 
4 weeks  
Robust collagen and GAG 
deposition at higher cell density  
 
GAG decrease for high rotations 
[64] 
JWR BM-
SC 
Collagen I 
sponge 
Rotating 
Wall 
Vessel 
(RWV) 
3x106 cells/cm3 
 
3 weeks 
Increase in GAG content 
 
Increase in compression strength of 
the construct 
[58] 
Murine AC PLGA disc 
(7.5x3.5mm) 
Rotating 
shaft 
bioreactor 
(RSB) 
3x106 cells/ 
scaffold  
 
2, 5,10 rpm  
 
4 weeks 
Small variations in cell number for 
different velocities  
 
Culture at 10 rpm showed aerobic 
cell metabolism, higher collagen 
synthesis but lower GAG content  
[62] 
Murine AC PLGA disc 
(7.5x3.5mm) 
Rotating 
shaft 
bioreactor 
(RSB) 
6x106 cells/ 
scaffold 
 
10 rpm 
 
3 weeks 
Increased cell number to 1.1x107 
cells/ scaffold 
 
Increase of ECM components: 
3.1 mg GAG/construct 
7.0 mg collagen/construct 
[62] 
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* Conditions: cell density, rotation conditions, culturing period 
AC – Articular chondrocytes; BM-SC – Bone Marrow Stem Cells; CPBS - chitosan-poly(butylene succinate); DF – 
Dermal Fibroblasts; GAG – Glycosaminoglycan; mRNA – messenger Ribonucleic Acid; JWR – Japanese White 
Rabbits; NC – Nasal chondrocytes; OC – Osteoarthritic chondrocytes; PGA – Poly(glycolic acid); PLGA – 
Poly(lactic-co-glycolic acid); PLLA – poly(L-lactic acid); rpm – rotations per minute 
 
On what concerns studies using spinner flasks (SF), Gooch et al (2001) [63] studied the effects 
of shear stress at different intensities over calf articular chondrocytes on PGA scaffolds. On the 
third day of culture, the mixing intensity was set to nine different levels, by varying the length 
and rotation of the stirrer. Constructs exposed to mixing contained higher fractions of collagen, 
synthesized and released more glycosaminoglycans (GAG), but exhibited lower GAG content. 
The presence or absence of mixing was the primary determinant of the GAG and collagen 
content in the constructs, while the intensity of the mixing was not so important [63]. Bovine 
chondrocytes were dynamically seeded into PLLA scaffolds and cultured for 4 weeks at 
different cell seeding densities (up to 6.25 x 106 cells / construct) and different shear stresses 
(between 19, 38, and 76 rpm). Dynamically cultured constructs with the highest cell density 
contained up to 15 x 106 cells, 2 mg GAG, and 3.5 mg collagen per construct and exhibited 
morphology similar to that of native cartilage. Cartilage constructs exhibited robust matrix 
collagen and GAG deposition [64]. The concentric cylinder bioreactor produced constructs with 
low variance in terms of chondrocyte number and collagen content, but larger variance in terms 
of GAG content upon 28 days of culture. Although higher rotations increased collagen content, 
significantly decrease in GAG composition was observed for longer culture periods [64].  
A parallel study performed using the rotating shaft bioreactor (RSB) [62] reports the culture of 
chondrocyte based constructs under medium and gas perfusion under different rotating speeds 
(up to 10 rpm). The chondrocyte density after 4 weeks exhibited small variations within the 
distinct groups, but in contrast, the average values of the molar ratio of lactate production to 
glucose consumption were lowered to ~1.26 under the highest rotating speed, which reveals 
an aerobic metabolism. This culture condition additionally resulted in higher collagen synthesis 
and GAG release, but lower GAG content [62]. Modification of the culture method by cultivating 
initially the constructs at 10 rpm during 3 weeks followed by one additional week of culture at 2 
rpm, led to a 100% increase in GAG content relatively to the control. The doubling in cell 
seeding density resulted in 40% maximum increase in cell number attained after the first week 
of culture, but resulted in the best culture conditions in terms of GAG and collagen contents per 
construct: 3.1 and 7.0 mg/construct, respectively [62].  
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The wavy-walled bioreactor (WWB) provided efficient attachment of bovine articular 
chondrocytes to PGA scaffolds, and these chondrocytes proliferated and remained 
metabolically active, synthesizing extracellular matrix over a period of 4 weeks [61]. In 
comparison with SF, WWB supported increased cell proliferation and deposition of 
glycosaminoglycans and collagen in a range of 1.3 to 1.6 fold higher. Upon 4 weeks of culture, 
the wet weight of constructs cultivated in WWB was similar to that of SF. However, the former 
were 60% heavier due to equally higher incorporation of extracellular matrix and 30% higher 
cell population [61]. 
Shear stress states have proven to be used successfully to culture cartilage constructs that 
resemble native tissue and exhibit improved matrix deposition relative to conventional static 
cultures. However, the ideal parameters to be applied to specific cultures are yet to be 
elucidated. 
 
5.2. PERFUSION OF CULTURING MEDIA 
Perfusion systems have been designed to mimic forces experienced by chondrocytes during 
joint motion, and used to investigate in vitro maturation of cartilage constructs [67]. In vivo, 
chondrocytes encounter internal stress in the form of osmotic pressure, and external stress, as 
hydrostatic pressure, during joint motion [67]. In perfusion bioreactors, medium flow through 
the pores of scaffolds benefits cell proliferation and differentiation by two ways: by enhancing 
nutrient transport to the bulk of the scaffold and by providing cell mechanical stimulation via 
fluid shear. Perfusion can be additionally used for seeding cells into scaffolds, by promoting cell 
transport throughout the porous interior of scaffolds. Hydrodynamic stress imposed on cells 
within scaffolds upon perfusion is intrinsically dependent on scaffold microstructure and on 
bioreactor configuration [68]. Several groups have gathered efforts to study the effect of fluid 
perfusion over cell / scaffold constructs using flow perfusion systems. Such efforts are shortly 
summarized in Table III. The effect of flow perfusion on cell-based constructs has been 
investigated in combination with a large variety of scaffolds. In this context, very high levels of 
porosity are mostly desirable to minimize pressure drop upon media perfusion. PGA scaffolds 
have been investigated due to its intrinsic characteristics and processability into very high 
porous structures (up to 97%) [69-72]. Other commercially available scaffolds, such as 
Degrapol® [68, 73], Polyactive™ foams [74] and Calcibon® carriers [75] have been used in this 
context, due to their particular characteristics, off-the-shelf availability and standardization. 
Collagen sponges [67, 76], alginate and agarose gels [77, 78] were also investigated as a 
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physical support during medium perfusion despite their low porosity and interconnectivity. As 
previously mentioned, chitosan has been proven a great scaffold for cartilage TE and was also 
used for perfusion studies [53, 79]. Silk fibroin, protein obtained from Bombix mori silkworm, 
when prepared into a sponge, provides a great structure for cartilage tissue development, and 
adequate for perfusion bioreactor studies [80]. 
 
Table III – Experimental studies developed in order to evaluate the effect of fluid perfusion over 
cartilage biosynthesis. Compiled from references [67-81] 
Specie Cell 
type 
Scaffold Bioreactor Conditions* Major results /Key findings Ref. 
Human ESC Silk sponge 
(8x3mm) 
Custom-
made 
perfusion 
bioreactor 
1x106cells/mL 
 
1mL/min 
 
4 weeks 
Dynamically cultured constructs 
showed higher amounts of GAGs, 
DNA, total collagen and collagen 
type II as well as 3.7-fold higher 
mechanical stiffness  
[80] 
Human ASC PGA disc 
(5x15mm) 
Re-
circulation 
bioreactor 
2 or 4x107cells/ 
scaffold 
 
0.2 mL/min  
 
5 weeks 
Highest levels of collagen II and 
GAG measured in bioreactor 
culture with initial seeding density 
of 4x107cells/ scaffold  
[81] 
Human AC Copolymer 
vicryl+ PDS  
Minucells 
and 
Minutissue 
1 mL/h,  
on/off  30’  
 
2 weeks 
Abundant proteoglycans and 
collagen fibrils formation  
[82] 
Human AC DegraPol® 
(16x2mm) 
Closed-
loop re-
circulation 
system 
1.5x106cells/ 
scaffold 
 
0.5 mL/min  
 
4 weeks 
2-fold increase of cell viability 
 
Biosynthetic activity demonstrated 
only in the bioreactor-cultured 
constructs 
[73] 
Human 
 
AC Collagen 
sponge 
(10x4mm) 
Direct 
perfusion 
bioreactor 
1x106 cells/ 
sponge  
 
0.1, 0.3, 1 mL/ 
min  
 
1 week 
No high levels of proliferation or 
synthesis of new matrix was 
measured when perfusion rates 
increased 
[67] 
Human FEC PGA disc 
(4.75x2.15 
mm) 
Glass tube 
perfusion 
bioreactor 
4.4x106 or 
8x106 cells/mL 
 
0.2 mL/min 
 
5 weeks 
Constructs contained GAG 
concentrations similar to those 
measured in ex vivo AC 
Total collagen and collagen type II 
levels were substantially lower than 
those in adult tissue 
[71] 
Bovine AC  PLLA/PGA Custom- 2.5x106 cells/ Increased content of DNA (118%) [72] 
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(12.7x1mm) made 
perfusion 
bioreactor 
scaffold 
 
400 µm/s 
  
4 weeks 
 
Increased content of GAG (184%) 
and hydroxyproline (155%) 
Bovine AC Collagen 
sponges 
(7x1.5mm) 
Custom-
made 
perfusion 
bioreactor 
3x106 cells/ 
scaffold 
 
0.33 mL/min 
  
15 days 
sGAG accumulation, 35S-sulfate 
incorporation, and aggrecan plus 
collagen type II gene expression 
were all down-regulated when 
compared to non-perfused culture  
[76] 
Bovine AC Collagen 
sponge 
(10x4mm) 
Direct 
perfusion 
bioreactor  
1x107 cells/ 
sponge 
 
 0.1, 0.3, 1 mL/ 
min 
 
1 week 
Reduction in cell number and GAG 
content was measured when 
perfusion rates increased 
[67] 
Bovine AC Collagen 
sponge 
(10x4mm) 
Direct 
perfusion & 
Free flow  
1x107 cells/ 
sponge  
 
0.1 mL/min 
  
1 week 
Non-significant change in the 
number of cells in the free flow 
system and direct perfusion  
 
GAG content was elevated by 25% 
only under free flow  
[67] 
Bovine AC Agarose gel 
(1µl) 
Perfusion 
Micro-
bioreactor 
4x106 cells/ mL 
 
1 µL /h 
  
6 days 
Increase in lactate production rate 
 
GAG production rate unaltered 
[77] 
Bovine AC Degrapol® 
(3,4,5,8x 
1mm) 
Direct 
perfusion 
bioreactor 
8x104 cell/ mm3 
 
0.5 mL/min 
  
2 weeks 
1.7-fold increase in DNA content 
 
2.9-fold increase in the mean 
content in sGAG 
[68] 
Bovine AC Agarose & 
alginate 
hydrogel 
(6x1.1mm) 
Custom-
made 
perfusion 
bioreactor 
4x106 cells/ mL 
 
0.025 mL/h 
 
7 days 
No difference in cell viability was 
observed  
Only alginate constructs under 
perfusion culture accumulated 
more GAG and collagen 
[78] 
Bovine AC Polyactive™ 
foam 
(4x8mm) 
T-CUP 1x106 cells/ 
scaffold 
 
0.4mm/s 
 
14 days 
Abundant extracellular matrix 
rather uniformly distributed and 
positively stained for GAG  
[74] 
Ovine AC PGA 
(10x2mm) 
Poly-
carbonate 
vessel 
connected 
to media 
bag 
4x106 cells/ 
scaffold 
 
0.05 or 0.8 
mL/min 
  
Higher DNA content;  
 
40% increase of sGAG synthesis 
and deposition 
[70] 
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9 days 
Porcine AC Calcibon® 
(4.55x2mm) 
Flow 
chamber 
with 
integrated 
aeration 
1x105 cells/ mL 
 
0.5 mL/min 
3 weeks 
Lower ratio of GAG/DNA 
Constructs of both culture methods 
contained high amount of collagen 
II 
[75] 
Murine ATD
C5 
cell 
line 
Chitosan 
(BMP-
loaded) 
(10x2mm) 
RCMWTM 4x104 cells/ mL 
 
2.25 mL/min 
4 weeks 
Chondrogenic phenotype 
preserved without hypertrophic 
morphology  
 
Neo-formed tissue matrix was built 
[79] 
Rabbit AC PGA 
(20x10mm) 
Poly-
carbonate 
vessel 
connected 
to a media 
bag 
4x106 cells/ 
scaffold 
 
 50 µL/min 
  
28 days 
Immunostaining positive reactivity 
for type II collagen and chondroitin 
sulfate;  
 
Collagen and GAG values showed 
to be 15% and 25% dry weight 
[69] 
* Conditions: cell density, perfusion conditions, culturing period 
AC - Articular chondrocytes; ASC – Adipose stem cells; DNA – Desoxiribonucleic acid; ESC – Embryonic stem 
cells; FEC - Fetal epiphyseal cartilage; sGAG – sulphated Glycosaminoglycan; PDS- polydioxanon; PGA – 
poly(glycolic acid); PLLA - poly(L-lactic acid); T-CUP - Tissue-Culture Under Perfusion  
 
The latest studies investigating perfusion for cartilage TE have looked into differentiation of 
human stem cells. Both embryonic (ESCs) [80] and adult stem cells [81] (obtained from 
adipose tissue – Adipose stem cells (ASC)) were explored, and promising outcomes were 
achieved: Tigli and colleagues (2011) [80] observed greater cartilage-like tissue development 
when ESCs were dynamically cultured, and Mahmoudifar et al (2010) [81] also verified that 
perfusion culturing improved ASCs chondrogenic differentiation and cartilage matrix deposition.  
The many research studies on the effect of perfusion on cell response led to some 
discrepancies. Proteoglycan and collagen formation together with an increase in cell number 
seem to be prevalent in most of dynamic culturing studies. Nevertheless, the magnitude of 
these variations varies to a large extent. Dunkelman et al (1995) [69] stated that 4 weeks of 
culture under perfusion yielded a significant production of glycosaminoglycans (GAGs), but no 
significant collagen type II deposition was detected. Secretion of chondroitin sulfate and 
hydroxyproline has been shown to be highly promoted under perfusion, as demonstrated by 
several studies [69, 70, 72, 74]. However, the influence of perfusion on chondrogenesis is not 
obvious. The culture of bovine articular chondrocytes in collagen sponges inhibited 
chondrogenesis as demonstrated by Mizuno et al (2001) [76]. Concordant with these results, 
Freyria et al (2005) [67] reported a reduction in bovine cell number and GAG content when 
perfusion rates were increased. Additionally, the experiments performed by Nagel-Heyer et al 
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(2005) [75] with articular chondrocytes from adult mini-pigs demonstrated that the constructs 
cultured in 12-well-plates had a higher amount of extracellular matrix, as quantified by the 
content of GAG and total proline, when compared to those from the bioreactor. The work 
developed by Raimondi et al (2004) [73] did not assess cartilage biosynthesis, but has shown 
that full thickness-perfused constructs, maintained a higher degree of cell viability (human 
articular chondrocytes), when compared both to surface-perfused constructs and to static 
controls. However, human articular chondrocytes cultured by Freyria et al (2005) [67] under 
perfusion for 1 week resulted in a decline in cell number and GAG content. The application of 
miniaturization to 3D cell culturing for reducing chemical gradients in both the culture 
environment and the construct proved to be successful by increasing lactate production rate of 
bovine articular chondrocytes encapsulated in agarose. Nevertheless, no improvement was 
observed in GAG production rate [77].  
When analyzing cell viability of bovine articular chondrocytes encapsulated in alginate or 
agarose and cultured under perfused or static conditions, Xu and co-workers (2006) [78] found 
no significant difference. Upon 12 days of culture, alginate based constructs cultured under 
perfusion released and accumulated more GAG and collagen as compared to the remaining 
conditions. Other study evaluated the bovine articular chondrocytes response to increasing 
values of shear flow (up to 12-fold increase in the level of applied shear) and observed that the 
total increase for DNA and sGAG content was about 1.7-fold and 2.9-fold. In contrast, the 
sGAG/DNA ratio showed a tendency to decrease for increasing shear levels [68]. At last, 
Mahmoudifar et al (2005) [71] operated the bioreactor with periodic medium flow reversal 
instead of unidirectional flow. This improvement in perfusion culturing resulted in increases in 
GAG and collagen levels when composite scaffolds were employed.  
Taken altogether, the reported data suggests that the protocol defined for perfusion culture 
requires a high level of optimization in order to achieve an appropriate balance between cell 
viability, cell proliferation, extracellular matrix production and deposition. From the reported 
literature, a certain level of culturing prior perfusion appears to be required, as the efficacy of 
physical stimulation has been demonstrated to depend on presence and amount of 
extracellular matrix at the construct. The many discrepancies among the reported data may 
result from the large number of experimental combinations that result from the vast number of 
bioreactor configurations, dynamic conditions applied, scaffolds used and cells investigated.   
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5.3. COMPRESSION FORCES 
In vivo, when articular cartilage is subjected to a uniaxial compression force the internal 
hydrostatic pressure increases within the joint. Daily activities cause intermittent loading that 
introduces very high cyclic hydrostatic pressure at the joint and the cartilage itself. Cartilage 
can be regarded as a combination of two phases: a fluid phase and a solid one. Compressive 
loading is counteracted by the stressing of the solid phase and by the pressurization of the 
interstitial fluid that behaves itself as an incompressible solid. Although pressurization tends to 
push out the fluid from the solid phase, the squeezing out is limited by the low hydraulic 
permeability of the matrix. In this regard, proteoglycans (PGs) have an important role resisting 
compression, as the hydraulic permeability is inversely correlated with the respective charge 
density. In addition, physical restraining of adjacent tissues also opposes fluid flow from the 
matrix. Upon increasing deformation, the fluid phase is further squeezed out from the tissue, 
causing the progressive loading of the cartilage matrix and a concomitant decrease in porosity, 
which further decreases fluid permeability [42, 83-86]. The removal of the compressive force 
originates hydrostatic tension in the cartilage matrix that promotes fluid migration back to the 
solid phase and restoration of the matrix volume.  
Table IV summarizes the reported results from several experimental studies aimed at 
investigating the effect of static and dynamic compressive cycling over tissue engineered 
constructs.  
In terms of the type of cell investigated, bovine articular chondrocytes remain the preferable 
type of cell studied. Cells from human origin are less represented. Human nasal chondrocytes 
have been successfully compared with healthy articular chondrocytes, which may suggest the 
potential heterologous use of these cells for articular regeneration [87]. Just like previous 
studies adopting perfusion or shear forces, stem cells of both animal and human origin have 
been investigated. 
 
Table IV – Experimental studies developed in order to evaluate the effect of compression over cartilage 
biosynthesis. Compiled from references [29, 87-107]  
Specie Cell 
type 
Scaffold Bioreactor Conditions* Major results /Key findings Ref. 
Human MSC Fibrin+ 
Poly-
urethane 
scaffold 
(8x4mm) 
Ceramic hip 
ball 
5x106 cells/scaffold 
 
25º ball oscillation,  
1 Hz. 
Dynamic 
Chondrogenesis of hMSCs 
promoted by mechanical 
load through TGF-ß pathway 
by up-regulating TGF-ß gene 
expression and protein 
[102] 
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compression of 10-
20% strain 
amplitude  
1 h/day, 7 days 
 
2 weeks 
synthesis 
Human AC PEGT/ 
PBT foam 
Poli 
ActiveTM 
(8x1mm) 
Poly-sulfone  
chamber 
with 
compression 
platen 
5x106 cells/scaffold 
  
6 cycles of 2h,  
5% amplitude,  
5% offset,  
0.1 Hz, + 10h 
without 
deformation 
 
3 days 
Response of AC does not 
depend directly upon the 
stage of cell differentiation, 
but rather on the ECM 
surrounding the cells 
[89] 
Human AC + 
NC 
Hyaff®-11 
(6x2mm) 
Chamber 
with 
compression 
platen 
3.7x106 
cells/scaffold 
 
30 minutes;  
7.5% or 15% strain 
offset; 0.1 Hz;  
every 2nd day 
 
10 days 
Increased synthesis of GAG, 
PG and collagen type II at 
NC constructs 
AC constructs were less 
responsive than NC to all 
loading regimens  
[87] 
Human AC + 
NC 
Poly-
urethane 
foam 
(8x4mm) 
Ceramic hip 
ball 
10x106 
cells/scaffold 
 
30 minutes;  
60ºamplitude 
rotation;10% 
offset; 0.1 Hz; 
every 2nd day  
 
10 days 
32.9-fold increase in the 
mRNA expression of SZP 
but not HAS-1 and HAS-2 on 
NC constructs, in 
comparison with AC 
constructs 
[87] 
Bovine AC  PGA disc 
(10x2mm) 
Stainless 
steel porous 
platens 
2x104 cells/scaffold 
 
Unconfined 10, 30, 
50%static 
deformation  
 
24h 
Synthesis of both sGAG and 
total protein were 
suppressed by 35% and 
57%, respectively, by static 
compression at an amplitude 
of 50% 
[29] 
Bovine AC  PGA disc 
(10x2mm) 
Stainless 
steel porous 
platens 
2x104 cells/scaffold 
 
Unconfined 5% 
amplitude;  
10 & 50% offset;  
0.001 & 0.1 Hz 
 
24h 
Most dramatic effects 
observed at 0.1 Hz and 50% 
compression amplitude: 
99% and 179% synthesis 
increase of total protein and 
sGAG, respectively 
 
[29] 
Bovine AC PGA disc 
(5x2mm) 
Poly-sulfone  
chamber 
with 
5x106 cells/scaffold  
 
1 h/day;  
Round cell morphology 
 
GAG and type II collagen 
[92] 
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compression 
platen 
Unconfined 10% 
compressive strain 
or dynamic 7% 
strain at 0.3 Hz  
 
37 days 
accumulated in the face 
side, as compared to the 
lateral side of the scaffold 
 
 
Bovine AC Poly-
urethane 
disc 
(8x4mm) 
Biaxial Pin-
on-Ball 
25x106 
cells/scaffold  
 
2x 1h/day;  
Unconfined 5, 10, 
20% compressive 
strain; 60º 
amplitude rotation; 
0.1 Hz 
 
3 days 
COMP gene clearly 
promoted by relative surface 
motion  
 
Stimulation of ECM 
production was reduced 
and/or inhibited  
[101] 
Bovine AC PEG 
hydrogel 
(10x4mm) 
Chamber 
with 
compression 
piston 
30x106 cells/mL  
 
1.5 h/day,  
15% deformation,  
1 Hz 
 
2 weeks 
37% increase in sGAG 
levels  
 
No differences between PEG 
and PEG-fibrinogen culturing 
[96] 
Bovine AC Poly-
urethane 
disc 
(8x4mm) 
Ceramic hip 
ball 
1x107 cells/scaffold  
 
2x/day; 
Unconfined 10-
20% strain 
amplitude; 7.5º 
scaffold oscillation; 
25º ball oscillation;   
0.1 Hz  
 
5 days 
PRG4, collagen type II and 
COMP mRNA expression 
levels increased by ball 
oscillation  
 
Aggrecan and TIMP-3 
mRNA expression levels 
upregulated by multi-
directional articular motion 
[98] 
Bovine AC Poly-
urethane 
disc 
(8x4mm) 
Ceramic hip 
ball 
10x106 
cells/scaffold  
 
2x 1h/day;  
Unconfined 10-
20% strain 
amplitude  
 
3 days 
Most pronounced mRNA up-
regulations observed for 
PRG4 expression in deep 
zone and HAS2 expression 
in superficial zone cells  
 
Full thickness chondrocytes 
experienced the greatest 
effect on HAS1 mRNA 
expression and HA release  
[99] 
Bovine AC  Agarose 
hydrogel 
(4x1.5mm) 
Chamber 
with 
compression 
platen 
20x106 cells/mL 
 
Unconfined 10% 
deformation:  
1 or 2h at 1 Hz; or  
1h at 0.33, 1 or 3 
Hz 
 
72h 
Increase in aggrecan 
promoter activity and 
decrease in collagen II 
promoter activity with 
increasing duration of 
loading 
[93] 
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Bovine BMSC Agarose 
hydrogel 
(4x1.5mm) 
Chamber 
with 
compression 
platen 
20x106 cells/mL 
 
3h/day; 
Unconfined 10% 
deformation; 
1 Hz  
 
5 days + 23 days 
free swelling 
Increase in short-term 
aggrecan transcriptional 
activity 
 
Increase in GAG deposition 
in long-term culture 
[93] 
Bovine AC Poly-
urethane 
disc 
(8x4mm) 
Ceramic hip 
ball 
10x106 
cells/scaffold 
 
1h/day; 
Confined 10-20% 
amplitude strain;  
0.5 Hz 
 
28 days 
Increase of type II collagen 
gene expression;  
No influence on aggrecan 
mRNA levels  
 
Low O2 and mechanical 
stimuli may synergistically 
act towards cell phenotype 
stabilization  
[100] 
Porcine AC Chitosan  
(6x4mm) 
Chamber 
with 
compression 
piston 
2x106 cells/scaffold 
 
4x/day;  
Unconfined 5-15% 
strain amplitude; 
0.1 Hz, 45 / 315’ 
on/off,   
  
3 weeks 
Enhanced mRNA levels for 
aggrecan 
 
5-fold and 2-fold increased  
deposition of proteoglycan  
and collagen type II, 
respectively 
[97] 
Canine AC PLLA 
(4x2.6mm) 
Commercial 
bioreactor 
(Enduratec, 
Bose, 
Minnesota, 
USA) 
1x106 cells/scaffold 
 
10% strain 
amplitude; 
1 Hz; 1h / 7h 
on/off,   
  
2 weeks 
Higher chondrocyte viability 
was obtained in the scaffolds 
cultured under dynamic 
loading 
[103] 
Canine AC Agarose 
gel 
(Ø4mm) 
Chamber 
with 
compression 
platen 
30x106 cells/mL 
 
3h/day,  
5 days/week; 
Deformational 
loading: 
Unconfined 
compression, 10% 
strain amplitude;  
1 Hz 
Sliding contact 
loading: 0.5 Hz, 
10% deformation  
  
56 days 
Loaded constructs exhibited 
increased mechanical 
properties relatively to free-
swelling control 
 
No differences were 
observed among groups 
regarding DNA, GAG and 
collagen content 
[104] 
Rabbit BMSC Agarose 
gel 
(8x1.5mm) 
Chamber 
with 
compression 
platen 
10x106 cells/mL  
 
5% compressive 
sinusoidal strain; 
Cyclic compressive loading 
alone promotes 
chondrogenic differentiation 
of BMSC 
[95] 
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1Hz 
 
14 days 
Rabbit BMSC PLCL 
(Ø9mm) 
with or 
without 
fibrin 
Compressio
n bioreactor 
2x106 cells/scaffold  
 
Continuous 
compressive 
deformation, 5% 
strain; 0.1 Hz 
 
10 days 
Dynamic culture and 3D 
environment created by 
PLCL+fibrin gel encouraged 
BMSCs to differentiate into 
chondrocytes, maintain their 
phenotypes and enhance 
GAGs production 
 
[105] 
Rabbit AC PLCL 
sponge 
(9x3mm) 
Chamber 
with 
compression 
piston 
1x106 cells/scaffold  
 
Unconfined 10% 
compressive 
strain; 0.1 Hz 
 
24h 
Proximal region of the 
COL2A1 gene promoter 
mediates the dynamic 
compression-induced 
transcriptional activation of 
the human COL2A1 gene in 
chondrocytes 
[90] 
Rabbit AC PLCL 
sponge 
(9x3mm) 
Chamber 
with 
compression 
platen 
1-5x106 
cells/scaffold  
 
Unconfined 10% 
strain amplitude; 
0.01, 0.05, 0.1, 0.5 
Hz  
 
6 days 
Improved production and 
release of sGAG at 
continuous dynamic 
compression  
High mRNA expression of 
type II collagen at 0.1 Hz 
[91] 
Rabbit AC PLCL  
(5x3mm) 
Chamber 
with 
compression 
platen 
2x106 cells/scaffold 
 
5% strain;  
0.1 Hz 
 
24 days 
Unhealthy lacunae shapes 
and hypertrophy forms were 
observed in implants 
[94] 
Rabbit AC Chitosan/ 
gelatin 
scaffolds 
(Ø6mm) 
PMMA plate 
with 
compressive 
pins 
8x106 cells/mL  
 
40% compressive 
strain; 0.1 Hz 
6h/day 
 
3 weeks 
Increased cell proliferation 
and deposition of GAG  
 
[106] 
Murine AC Collagen 
type I gel 
Cell 
Stretcher 
System NS 
500 
1x106 cells/mL  
 
0, 10, 60, 120 
min/day  
Cyclic 
compression: 5% 
strain amplitude, 
0.33Hz, 2.35 kPa 
peak stress;  
1 loading session / 
day  
 
1 week 
Dynamic compression 
reactivated the 
dedifferentiated 
chondrocytes  
 
Growth factors did not play a 
synergistic role when applied 
with loading 
[107] 
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Murine ESC Collagen 
gel 
(Ø96well-
plate) 
Weight over 
culture plate 
lid 
2.25x106 cells/mL  
 
Unconfined 20-
30% deformation  
 
10 days 
2- to 3-fold increase in 
collagen type II & aggrecan 
expression; 
Sox9 was up-regulated while 
IL-1β, was down-regulated 
[88] 
* Conditions: cell density, compression conditions, culturing period 
AC - Articular chondrocytes; BMSC – Bone marrow stromal cells; COMP – Cartilage oligomeric matrix protein; 
ECM – Extracellular matrix; ESC – Embrionic Stem Cells; sGAG – sulphated Glycosaminoglycan; HA – 
Hyaluronan; HAS (1 and 2) – Hyaluronan synthase (1 and 2); IL-1β - Interleukin-1 beta; NC- Nasal chondrocytes; 
PBT - poly(butylene terephthalate); PEG - poly(ethylene glycol); PEGT - poly(ethylene glycol terephthalate); PGA 
– Poly(glycolic acid); PLCL - poly(lactide-co- -caprolactone); PLLA – Polylactic acid; PMMA - Poly(methyl 
methacrylate); PRG4 – Proteoglycan 4;  SZP – Superficial zone protein; TIMP-3 – Tissue inhibitor 
metalloproteinase-3  
 
In the reported studies, several bioreactor configurations were adopted to exert compressive 
load over cell/scaffold constructs. For instance, static compressive forces were applied by 
exerting a constant force on the top of the construct through the use of a fixed weight [88] or 
through constant mechanical constringent of the construct by fixating it between two platens 
and a radial ring. Using this last configuration, static and dynamic compression were possible 
to be applied depending on the relative positioning of the bottom platen [29, 87, 89-91]. Other 
studies adopted similar bioreactor configurations by means of applying compression force of a 
mechanical spectrometer, separated from the culture chamber by a membrane, through an 
indenter positioned over the constructs [92-95]. The work developed by Fehrenbacher et al 
(2006) [97] and Schmidt et al (2006) [96] used the lid of the bioreactor as a manifold for 
stainless steel pistons positioned above six growth chambers. During the loading experiments, 
the lid was attached to a pneumatic actuator which induced cyclic, linear displacement of the lid 
causing the compression of the culture chambers [96, 97]. An alternative device is 
commercially available, consisting of a ceramic hip ball (32 mm in diameter) that is pressed 
against the construct. The motion generated at the interface could be (a) rotation of the sample 
holder around the main axis of the construct; (b) oscillation of the ball around an axis 
perpendicular to the main axis of the construct, and (c) oscillation in both axes in phase 
difference [87, 98-101]. This device has provided interesting results. Grad and colleagues 
exposed resorbable porous polyurethane scaffolds seeded with bovine articular chondrocytes 
to dynamic compression using this system [98], and reported increased proteoglycan 4 
(PRG4), collagen type II and cartilage oligomeric matrix protein (COMP) mRNA expression 
levels for ball oscillation, and upregulation of aggrecan and tissue inhibitor of 
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metalloproteinase-3 (TIMP-3) mRNA expression levels for multidirectional articular motion. Ball 
oscillation also increased the release of PRG4, COMP, and hyaluronan (HA) into the culture 
media [98]. Li et al (2007) [99] went further to investigate the effect of surface motion on gene 
expression of proteoglycan 4 (PRG4), hyaluronan synthases (HAS1, HAS2), as well as on 
release of hyaluronan (HA) and proteoglycan 4 (PRG4) by chondrocytes from different zones 
of bovine articular cartilage (superficial zone, deep zone, full thickness, and 1:1 
superficial/deep ratio mix chondrocytes) seeded into polyurethane scaffolds. Mechanical 
loading enhanced mRNA levels for all cell types, with most pronounced upregulation observed 
for the PRG4 expression for deep zone cells and HAS2 expression for superficial zone cells. 
The effect of the biochemical and biomechanical environment appeared to be additive, 
resulting in highest mRNA levels for the top sections of the constructs. Bioreactor stimulation 
also enhanced the HA release for all cell populations. Full thickness chondrocytes experienced 
the greatest effect on HAS1 mRNA expression and HA release, indicating that the interaction 
between cell populations influences HA synthesis as compared to subpopulations alone [99]. 
The combination of low oxygen and mechanical stimuli using this bioreactor, may act 
synergistically with respect to the stabilization of the chondrogenic phenotype [100]. Demarteau 
and his group [89] achieved outstanding results. They concluded that GAG synthesis, 
accumulation, and release induced by dynamic compression were not correlated with the 
expression of collagen type II mRNA, suggesting that the response of human articular 
chondrocytes to dynamic compression does not depend directly on the stage of cell 
differentiation but, instead, on the quantity and composition of the matrix surrounding the cells 
at the time of stimulus [89].  
In order to understand if a scaffold containing biological motifs, such as fibrinogen, would 
enhance mechanotransduction, Schmidt and colleagues [96] incorporated these motifs in PEG 
hydrogels scaffolds, but concluded that this approach did not enhance chondrocyte metabolism 
more than mechanical stimulation. The effect of strain stimulation on the total GAG (normalized 
per construct) was significant both for PEG-fibrinogen and PEG constructs [96].  
Rabbit articular chondrocyte-seeded PLCL sponges, subjected to 24 h of continuous dynamic 
compression, showed that type II collagen mRNA expression level was significantly increased 
as compared with static controls [90], while loaded at 0.1 Hz, 5% strain for 24 days resulted in 
unhealthy lacunae shapes and hypertrophy forms were observed [94]. Porcine articular 
chondrocytes loaded in chitosan-biocomposites displayed enhanced mRNA levels for COL2A1 
and aggrecan and accumulated significantly more proteoglycan and collagen type II per cell as 
compared to unloaded controls [97]. Continuous dynamic compression improved the 
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production of sGAG of rabbit articular chondrocytes cultured in SPCL scaffolds, most of which 
was released into the culture medium upon loading. At the frequency of 0.1 Hz was observed 
the highest mRNA expression for type II collagen. Small dependency on frequency was 
observed for aggrecan expression. Conversely, an intermittent loading (24-h cycle of loading 
and unloading) or short loading and unloading duration per cycle-compression regime 
maintained high levels of mRNA expression [91].  
On what concerns stem cells, Takahashi et al (1998) [88] demonstrated that static compressive 
load promotes chondrogenesis during embryonic limb bud mesenchymal cell differentiation  
and Huang and colleagues [95] showed that rabbit bone marrow mesenchymal stem cells 
exhibited chondrogenic gene expression when subjected to cyclic compressive loading. Mauk 
et al (2007) [93] cultured both bovine bone marrow stem cells and articular chondrocytes, and 
observed that, in chondrocyte culture, aggrecan promoter activity increased with increasing 
duration of loading, particularly in the outer annulus region, while type II collagen promoter 
activity decreased. The role of mechanical compression in directing chondrogenic 
differentiation of MSCs was traduced by an increase in short-term aggrecan transcriptional 
activity and by GAG deposition in the long-term [93]. Human MSCs subjected to dynamic 
compression increased TGF-ß gene expression and protein synthesis, which led Li and 
colleagues (2010) [102] to postulate that mechanical load promotes chondrogenesis of hMSCs 
through TGF-ß pathway. 
 
Compression is not always favorable for cartilage biosynthesis. 50% static compression has 
been reported to suppress the total synthesis of protein and sGAG [29]. However, the simple 
variation from static to dynamic compression has resulted in an increase of these cartilage 
components [29]. Seidel et al (2004) [92] also noticed that mechanical compression contributed 
to a decrease of GAG content for prolonged culture time, and had little effect on the 
composition, morphology and mechanical properties at the core of construct discs  but resulted 
in variation of properties at the periphery and face sides of the same on what concerns GAG 
and collagen type II retention [92]. The conditions defined by Wimmer et al (2004)[101] using 
elliptical displacement trajectories similar to the motion paths occurring in vivo resulted in the 
promotion of COMP gene, (an early marker in chondrogenesis), but resulted in a reduction or 
inhibition of extracellular matrix production .  
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5.4. HYDROSTATIC PRESSURE ENVIRONMENT 
Pressures on normal human acetabular cartilage have been collected from two implanted 
instrumented femoral head hemiprostheses [108]. Despite significant differences in subjects’ 
gender, morphology, mobility, and coordination, in vivo pressure measurements from both 
subjects covered similar ranges, with maximums of 5–6 MPa for gait, and as high as 18 MPa 
for other movements. This unique in vivo data is consistent with corresponding cadaver 
experiments and model analyses. The collective results, in vitro data, model studies, and now 
corroborating in vivo data, support the self-pressurizing ‘‘weeping’’ theory of synovial joint 
lubrication [108]. The last biomechanical force described in the context of cartilage tissue 
engineering is hydrostatic pressure. Table V summarizes scientific research performed on the 
effect of hydrostatic pressure in cartilage biosynthesis. 
Animal articular chondrocytes are usually the preferred cell source in these studies (equine 
[109], bovine [110-112], porcine [113], caprine [114], etc). Human osteoarthritic chondrocytes 
have also been investigated, but its relevance is doubtful as hydrostatic pressure within the 
normal physiological range appears to have an apoptotic effect over these cells [115], while low 
pressure loadings seem to provide increased collagen type II and aggrecan gene expression 
[116]. Human bone marrow derived stem cells cultured at 1 MPa loading and 1 Hz frequency 
enhanced in vitro differentiation in the presence of differentiation factors. This loading regime 
has been suggested to play a critical role during cartilage development and regeneration in 
vivo [117].  
 
Table V – Experimental studies developed in order to evaluate the effect of hydrostatic pressure over 
cartilage biosynthesis. Compiled from references [109-120]  
Specie Cell 
type 
Scaffold Bioreactor Conditions* Major results /Key findings Ref. 
Human OC HYAFF®‐11 
(7x3mm) 
Vessel  
connected to 
a MTS 
1x106 cells/ 
scaffold 
 
5 MPa;1 Hz 
 
4h 
Increased proportion of 
apoptotic cells in cartilage 
constructs 
[115] 
Human OC Collagen-I 
gel 
(1.5 mL) 
Polymethyl 
methacrylate 
tube 
2x105 
cells/mL 
 
40 kPa;  
0.0125 Hz 
  
14 days 
Increased collagen-II and 
aggrecan gene expression 
 
Enhancement of proteoglycan 
content in media 
[116] 
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Human BMSC Helistat®  
(12.5x12.5x5
mm) 
SS pressure 
vessel  
connected to 
a MTS 
5x105 cells/ 
scaffold 
 
1 MPa; 1 Hz; 
4h/day 
  
10 days 
Increase in mRNA expression of 
aggrecan, collagen-II and sox9  
 
No change in mRNA expression 
of Runx2 or TGF-b1 
[117] 
Bovine AC Collagen 
sponge 
(7x1.5mm) 
Pressure/ 
perfusion 
culture 
system 
3x106 cells/ 
scaffold  
 
2.8 MPa;  
0.015 Hz  
 
15 days 
3.1-fold and 2.7-fold increase in 
accumulation of sGAG with 0 
and 0.015 Hz, respectively 
[110] 
Bovine AC Agarose gel 
(0.44 mL) 
Piston+ 
pressure 
chamber 
2x106 
cells/mL 
 
5 MPa;1 Hz  
 
4h 
11% increase in GAG synthesis 
  
4-fold increase in aggrecan 
mRNA 
[111] 
Bovine AC Agarose gel 
(0.44 mL) 
Piston+ 
pressure 
chamber 
2x106 
cells/mL 
 
5 MPa  
 
4h 
ERK pathway inhibited: may be 
a negative regulator of sox9 
mRNA expression 
[111] 
Equine AC PGA fibrous 
mesh 
(1x1x5mm) 
Semi-
continuous 
perfusion/ 
compression 
system 
5x106 cells/ 
scaffold 
 
6,87MPa,  
5s on/15s 
off, 20 
min/4h 
  
5 weeks 
Concentration of sGAG in 
constructs from juvenile 
cells was found to be 10x 
greater than concentrations in 
control 
[109] 
Ovine AC Alginate 
beads 
Cyclic 
hydrostatic 
load 
generating 
machine 
2.5x104 
cells/ bead 
 
1.2 & 2.4 
MPa, 0 & 
0.66 Hz 
 
4h 
Increase in GAG content  
 
Improved cells ultrastructure and 
cell–matrix interactions 
[113] 
Porcine AC Alginate 
beads 
Compressed 
air loading 
device 
0.3 MPa, 
1’ on/off 
 
7days 
25% increase in GAG/DNA ratio; 
 
65% increase in collagen-II/ 
collagen-I ratio  
[113] 
Rabbit MC PLLA 
(1.5x3mm) 
Water-filled 
SS chamber 
connected to 
an Instron 
via a water-
0.7x106 
cells/ 
scaffold  
 
10 MPa for 1 
10 MPa, 0 Hz stimulus 
enhanced: 
total collagen/scaffold, total 
GAG/scaffold, instantaneous 
modulus and relaxation modulus  
[119] 
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driven SS 
piston 
h every 3 
days; 
0, 0.1 or 1 
Hz 
 
4 weeks 
Rabbit AC Alginate 
beads 
Oil pressure 
apparatus 
4x106 
cells/mL  
 
10 or 50 
MPa 
 
12 or 24h 
Duration and magnitude of 
loading increased apoptotic cells 
in non-pre-cultured group 
[118] 
Rabbit AC 
SPC 
BMPC 
SF 
Alginate 
beads 
SS pressure 
vessel with 
pump and 
cylinder 
valve 
4x106 
cells/mL 
 
1, 5 MPa,  
0.5 Hz 
 
1h 
SPCs under 5 MPa : 
 
enhanced mRNA expression of 
proteoglycan, collagen type II 
and sox9; 
 
enhanced production of sox9 
protein and GAG  
[119] 
* Conditions: cell density, hydrostatic pressure conditions, culturing period 
AC - Articular chondrocytes; BMPC – Bone marrow-derived progenitor cells; BMSC – Bone marrow stem cells; 
ERK- Extra-cellular signal-regulated kinase; sGAG – sulphated Glycosaminoglycan; MC – Meniscus cells; MTS – 
Mechanical Testing System; OC – Osteoarthritic chondrocytes; PGA - PoliGlycolic Acid; PLLA – Polylactic acid; 
SF – Skin fibroblasts; SPC – Synovium –derived progenitor cells; SS – Stainless Steel; TGF-ß1 – Transforming 
growth factor beta1 
 
In general, customized loading reactors are used to apply hydrostatic pressure to cell/scaffold 
constructs. These reactors have in common the possibility of applying physiological relevant 
pressures and frequencies that range between 3 to 10 MPa, and 0 to 1 Hz, respectively [37]. In 
many bioreactors, a computer controlled mechanical testing system or actuator is generally 
used to apply the desired load into a culture chamber [109-111, 114, 116]. Other devices use 
compressed air to generate load [108, 112] or oil pressurized apparatus [118]. Additionally, 
pressure can also be imposed through the fluid medium via the axial movement of a piston 
[113]. It is interesting to notice that, although hydrostatic pressurization of a cell/scaffold 
construct is especially suitable to use with any kind of scaffold structure, the majority of studies 
have used gels and beads based constructs.  
A global analysis of Table V demonstrates that hydrostatic pressure has a beneficial effect over 
cartilage extracellular matrix biosynthesis. Sulfated glycosaminoglycan (sGAG) concentration 
in pressurized constructs from juvenile bovine cells have been reported to be 10 times greater 
[109] than concentrations in non-pressurized and adult cell derived constructs. Toyoda et al 
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(2003) [110] also observed that constant pressurization yielded better outputs. Bovine articular 
chondrocytes loaded with 5 MPa constantly for 4 hours caused an 11% increase in GAG 
synthesis, which was associated with large proteoglycans, and a 4-fold increase in levels of 
aggrecan mRNA comparatively to unloaded ACs. The intermittence and magnitude of the 
hydrostatic pressure appears to be an important parameter. Intermittent pressurization at near 
7 MPa enhanced the production of collagen, suggesting that there may be a minimum level of 
pressure necessary to stimulate collagen formation [109]. In comparison with the control group, 
the incorporation of [35S]-sulfate into glycosaminoglycans (GAGs) was 3.1-fold and 2.7-fold 
greater when constant and cyclic HP, respectively, were applied for 15 days at 2.8 MPa [109].  
A significant increase in the ratio of glycosaminoglycan (GAG) to DNA was found to be 25% 
higher for intermittent 0.3 MPa loading as compared to the corresponding static control. A 65% 
higher ratio of collagen type II to I compared to the static control was also observed [113].  
Controversial results were observed by Sharma and colleagues (2007) [114]. Compared with 
unloaded cells, cyclic loading increased the glycosaminoglycan content of cells at 1.2 and 2.4 
MPa in cellular matrix and further removed matrix whereas it decreased at similar static loads. 
Both 1.2 and 2.4 MPa cyclic load levels inhibited metalloprotease specific activity in cellular 
matrix but increased it at static loading. Transmission electron microscopy data showed 
improved cells ultra structure and cell–matrix interactions under cyclic load whereas these 
deteriorated under static loadings. The study suggests that cyclic loading has a positive effect 
on chondrocytes metabolism and morphology whereas static load has a degenerative effect 
[113]. Mio et al (2007) [112] developed a more fundamental study. ERK (Extra-cellular signal-
Regulated Kinase) pathway was hypothesized to participate in hydrostatic pressure-induced 
mechanotransduction in chondrocytes. An inverse relationship between ERK phosphorylation 
and Sox9 expression was observed after loading. Quantification of Western blot analysis 
showed a significant decrease in ERK phosphorylation to 72% relatively to the control, while, in 
contrast, analysis of Sox9 expression showed a significant increase of 278% compared to the 
control as a result of pressure application [111]. Hydrostatic pressure may therefore modulate 
the negative effect on ERK pathway in chondrocytes and contribute towards cell homeostasis 
by stimulating Sox9 mRNA expression [111].  
 
6. CELL SOURCES USED IN DYNAMIC CULTURING STUDIES  
Since the emerging of Tissue Engineering as a research field [121], very distinct cell sources 
have been used by researchers in order to understand the influence of biomechanical 
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phenomena in cartilage tissue development. In order to analyze the progresses in this area, 
Figure 3 displays the cell sources used in the aforementioned studies along time.  We can 
observe that animal-origin chondrocytes were the most used, followed by human chondrocytes, 
however, a turnover to the study of stem cells, both of human and animal origin, has been 
occurring during the last 3-4 years. 
 
 
Figure 3 – Cell sources used in dynamic culturing studies to assess the effect of biomechanical forces 
in cartilage tissue engineering, from 1993 to 2011. From ISI Web of KnowledgeSM (Thomson Reuters, 
USA) and Scopus (Elsevier, The Netherlands) databases 
 
Additionally, Figure 4 displays the cell source used with each four dynamic culturing methods 
covered in this review. Animal origin chondrocytes, mostly from bovine articular cartilage, have 
been the most widely studied cell source. These cells have been dynamically cultured under 
shear stress, flow perfusion, direct or indirect, confined or unconfined compression, or under 
hydrostatic pressure. So far, human chondrocytes, either obtained from the nasal septum or 
from the articular joints (healthy or osteoarthritic) have been investigated, ensuing very 
satisfactory outputs. Human stem cells have scarcely been exploited in this context, despite 
their great capacity to differentiate into the chondrogenic lineage, and clinical potential. It would 
be of interest to assess the effect of dynamic culturing on aspects such as chondrogenic 
differentiation and correspondent extracellular matrix production, secretion and deposition. 
Bone marrow derived stem cells’ behavior has been recently studied under dynamic culturing, 
with some promising results. Other stem cell sources, such as adipose tissue, have solely been 
investigated under perfusion culturing.  
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Figure 4 – Correlation between cell source and mechanical stimuli under study.  
(BAC-Bovine Articular Chondrocytes; BBMSC-Bovine Bone Marrow Stem Cells; CAC-Canine Articular Chondrocytes; EAC-Equine Articular 
Chondrocytes; GAC-Goat Articular Chondrocytes; HAC-Human Articular Chondrocytes; HASC-Human Aipose Stem Cells; HDF-Human 
Dermal Fibroblasts; HESC-Human Embryonic Stem Cells; HNC-Human Nasal Chondrocytes; HOC-Human Osteoarthritic Chondrocytes; 
HBMSC-Human Bone Marrow Stem Cells; MAC-Murine Articular chondrocytes; MESC-Murine Embryonic Stem Cells; OAC-Ovine Articular 
Chondrocytes; PAC-Porcine Articular Chondrocytes; RAC-Rabbit Articular Chondrocytes; RBMSC-Rabbit Bone Marrow Stem Cells; RMC-
Rabbit Meniscus Cells) 
 
7. FINAL REMARKS 
Extensive and high quality research has been made in order to understand how chondrogenic 
cells, or stem cells, sense, detect and respond to mechanical loading of distinct nature in 3D 
constructs. The major aim has been to identify how this stimulation regulates and/or influences 
cartilage tissue homeostasis, what are the mechanotransduction molecules and pathways 
involved, and take advantage of this knowledge to engineer de novo tissue in vitro. Current 
strategies have provided remarkable outputs, however new and relevant routes should be 
taken to engineer functional tissue for cartilage lesions repair. Some approaches could include: 
The stimulation of cells with physiologically-relevant levels of loading; 
 The integration of multiple forces, mimicking the human articular joint; 
 The combination of hypoxia with mechanical loading. 
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Abstract   
Bone failure associated with aging, disease or trauma, is a limiting health drawback causing 
physical disability, pain and increased health costs. Due to the epidemic of musculoskeletal 
disease occurring worldwide the United Nations has endorsed the past decade as the Bone 
and Joint Decade [1]. Great effort was made to fight bone ailments in many lines of action, and 
Tissue Engineering, as an emerging field, greatly evolved to offer new functional therapeutic 
approaches to this application area. In the context of bone tissue engineering, autologous or 
allogenic cells can be used in combination with suitable biomaterial scaffolds and bioreactors 
aimed at providing biomechanical stimulation and environmental control. In this review, major 
outcomes attained by means of using dynamic culturing under flow perfusion, as major force 
governing osteocyte mechanotransduction are highlighted. Some insights on latest findings 
regarding vascularization of bone are discussed. 
  
1. INTRODUCTION 
In 2011, the average life expectancy in Europe and United States was estimated as 78.82 and 
78.37 years, respectively, corresponding to an 8 year increase relatively to 1970 [2]. 
Associated with aging phenomena, progressive increases in health problems, as those related 
with bone failure and internal organ failure being the most common, are creating a large 
economic and social impacts. There is clinical need to regenerate functional bone due to 
congenital defects such as hemimelia [3] and growing defects [4]; injury in cases of non-union 
fractures [5] or acute fractures (boneless) [6], and disease-related, namely after tumoral 
resection [7] or hip arthroplasty revision surgery [8], among others. Given this, it is believed that 
the field of tissue engineering and regenerative medicine can provide an invaluable contribution 
to the treatment of a large variety of bone related conditions. The present review aims to 
highlight the latest developments in bone tissue engineering by focusing on in vitro 
development of robust bone grafts of clinical-relevant dimension by using dynamic culturing, 
and specifically by flow stimulation; as well as to draw attention to the latest accomplishments 
on vascularization of those engineered tissues by spatio-temporal nourishment and culturing of 
cells (Figure 1). 
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Figure 1 – Schematic representation of possible approaches for engineering bone grafts. Current 
approaches begin with the use of a scaffold as support for osteo-progenitor cells to grow bone tissue. 
To improve bone-related outcomes, flow stimulation is applied to cell-scaffold construct obtaining robust 
mineralized matrix. On the other hand, to attempt growing vascularized bone, combination of 
endothelial progenitor cells with cell-scaffold construct results in the development of blood vessels 
within a bone-like graft. Moreover, could both approaches be combined in order to engineer a fully 
developed and functional vascularized bone graft? 
 
2. BONE BIOLOGY 
Bone is a dynamic and greatly vascularized support tissue, with the ability to adapt its mass 
and morphology to functional demand, owning a distinct capacity to heal and remodel itself 
without scar [9]. Bone is composed of three distinct cell types [9, 10]: support cells, including 
the matrix-producing osteoblasts located at the bone surface and the highly specialized 
osteocytes at the lacuno-canalicular porosities; and the remodeling cells, that include the 
tissue-resorbing osteoclasts, located at the Howship’s lacunae. Along with these cells, calcified 
bone is composed 70% by weight (wt.) by an inorganic mineral generically referred to as 
hydroxyapatite [Ca10(PO4)6(OH)2], and 25-30% wt. by a non-mineral matrix comprised of type I 
collagen (~94%)[11] and non-collagenous proteins, such as osteocalcin, osteopontin, 
osteonectin and bone sialoprotein [9]. 
At the macroscopic physiology level, the bones of an adult skeleton have a basic structure 
composed ~80% wt. by an outer cortical or compact zone, ~20% wt. by an inner trabecular or 
spongy zone, a periosteum and an endosteum [12, 13]. Cortical bone only 10% porous, so it 
forms a rigid outer shell that resists deformation, while the inner trabecular network provides 
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strength by acting as a complex system of internal supports [10, 13]. Compact bone contains 
osteocytes, canaliculi and blood vessels, and its layers of matrix are highly organized forming 
osteons (Haversian systems). On the other hand, cancellous bone is 50-90% porous, 
composed by a trabecular meshwork occupied by bone marrow [12]. This porosity makes 
cancellous bone 10 times weaker than cortical bone [12, 14].  
 
3. MECHANOBIOLOGY OF BONE AND CELL MECHANOTRANSDUCTION  
Gravity and locomotion generate mechanical loads responsible by stimulating bone remodeling 
and consequently maintaining its excellent performance. Nowadays, it is common knowledge 
that a sedentary lifestyle or prolonged periods of inactivity reduce mechanical stimulation of 
bone, resulting in net bone loss due to lower tissue formation and higher tissue resorption. 
While osteoblasts synthesize bone matrix, osteocytes are the major mechanotransducing cell 
in bone [15, 16]. When mechanically stimulated, osteocytes express multiple paracrine factors, 
which stimulate osteoblast function and decrease osteoclast activity [9, 17]. Those factors 
include majorly nitric oxide (NO), prostaglandin E2 (PGE2), and insulin-like growth factor (IGF) 
[15]. This mechanical stimulation is majorly driven by flow – the most widely accepted model of 
osteocyte mechanotransduction [15, 18-21]. Compressive forces acting on the bone stimulate 
flow of interstitial fluid through lacuno-canalicular porosities where osteocytes reside [21]. 
Consequently, shear stresses generated are predicted to range 8 – 30 dyn/cm2, analogous to 
vascular wall shear stress [22]. More detailed studies performed on the geometry of the lacuno-
canalicular porosity propose that flow is sensed by osteocyte’s processes rather than by cell 
body [22, 23]. While osteocytes are the major cell responsible for sensing mechanical loading 
in bone, these signals are transmitted by putative mechanotransducers that include 
mechanosensitive ion channels and integrin adhesions. A rapid and transient increase in 
intracellular calcium is stimulated by shear stress, which leads to the paracrine factor NO and 
PGE2 production [17, 21]. More recently, it has been shown that PGE2 also plays an important 
role in mediating the activation of β-catenin signaling pathway in response to the fluid flow 
shear stress [16]. For more details on the molecular interactions regulating osteoblast 
functioning and bone remodeling we advise reading Robling et al. 2006 [19] and Papachroni et 
al. 2009 [24].  
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4. ENGINEERING BONE BY DYNAMIC CULTURING – FLOW AS MAJOR MODEL OF OSTEOCYTE 
MECHANOTRANSDUCTION 
The bone tissue engineering has been extensively exploring in vitro mechanical stimulation, as 
a tool for promoting the development of bone-like tissue. Bioreactor systems designed for 
cultivating bone tissue attempt to elongate, compress or deflect cells grown on different 
substrates. However, as previously stated, flow is the major inducer of osteocyte 
mechanotransduction, therefore special focus is given solely to the latest studies exploring the 
effect of fluid flow on bone biosynthesis in a tissue engineering perspective. Table I presents 
experimental work published in the last 3 years concerning this subject. 
 
Table I - Experimental studies developed in order to evaluate the effect of fluid flow over bone 
biosynthesis. Compiled from references [25-32]  
Specie Cell 
type 
Scaffold Conditions* Major results /Key findings Ref. 
Human BMSC Bovine 
DCB 
(TMJ– 
shaped) 
1x106 cells/mL 
 
1.8 mL/min 
 
5 weeks 
Confluent layers of lamellar bone (by SEM), 
increased volume of mineralized matrix (µCT), 
formation of osteoids (histologically) 
[25] 
Human BMSC PET 1.9x106/cm3 
 
0.1 ml/min 
 
35 days 
Increased differentiation in perfusion cultured 
shown by lower CFU-F ability and decreased 
expressions of stem-cell genes of Rex-1 and 
Oct-4, and higher expression level of 
osteonectin gene  
[26] 
Human BMSC Bovine 
DCB 
3x107 cells/mL 
 
80, 400, 800, 
1200, 1800 µm/s 
 
5 weeks 
Flow velocity increase affected cell morphology, 
cell–cell interactions, matrix production, 
composition and expression of osteogenic 
genes 
 
Flow velocities 400 and 800 µm/s yielded the 
best osteogenic responses 
[33] 
Human BMSC Silk-HA 3x107 cells/mL 
 
400 µm/s 
 
5,10 weeks 
Formation of bone-like structures;  
4-fold or 8-fold increase in equilibrium Young’s 
modulus (at 5 or 10 weeks, respectively) in 
correlation with the initial HA content in 
scaffolds. 
[28] 
Rat BMSC SPCL 5x105 
cells/scaffold 
 
1 mL/min 
 
8 or 16 days 
All data corroborate that lipase coupled with 
flow perfusion improved osteogenic 
differentiation of MSCs and enhanced ECM 
mineralization 
[29] 
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Human Ob CG 4x106 
cells/scaffold 
 
1 mL/min;  
1h every 7h, 24h  
 
28 days 
Flow perfusion bioreactor improved construct 
homogeneity and enhanced osteogenic 
phenotype over static controls 
 
No difference in the compressive modulus 
between bioreactor and static groups 
[30] 
Human SVF HA 1.2x107 
cells/scaffold 
 
1 mL/min 
 
5 days + 
8 weeks in vivo  
Endothelial and mesenchymal progenitors 
formed capillary networks, which anastomosed 
with host vasculature 1 week after implantation 
 
Maintenance of endothelial/mesenchymal SVF 
cell fractions is crucial to generate osteogenic 
constructs with enhanced engraftment capacity 
[31] 
Human ASC Bovine 
DCB 
1.5x106 
cells/scaffold 
 
400 µm/s 
 
5 weeks 
Medium perfusion markedly improved 
distribution of cells and bone matrix deposition 
in engineered constructs 
[32] 
 
ASC – adipose stem cell; BMSC – bone marrow mesenchymal stem cell; CFU-F - colony forming units-fibroblast; 
CG – collagen-glycosaminoglycan; DCB – decellularized bone; ECM- extracellular matrix; HA – Hydroxyapatite; 
µCT – micro computed tomography; Ob – osteoblasts; PET - poly(ethylene terephthalate); SEM - Scanning 
electron microscopy; SPCL - starch and poly(e-caprolactone); SVF – stromal vascular fraction; TMJ - 
temporomandibular joint. 
 
As it can be observed in Table I, the majority of studies investigating effect of fluid flow over 
bone biosynthesis used human bone marrow mesenchymal stem cells (hMSC). These cells 
have extraordinary osteogenic differentiation potential [34, 35], and respond positively to flow 
by increasing osteogenic differentiation [26, 33] and bone-tissue outcomes [28, 33], either 
directly by responding to shear stress applied at its surface or indirectly by benefiting from 
improved exchange of gas and nutrients through construct. Moreover, hMSC respond 
differently to distinct levels of flow - high velocities do not necessarily promote increased bone 
outcomes [33]. For the first time, a viable human bone graft of clinical relevant dimension, was 
engineered by using hMSC and a ‘‘biomimetic’’ scaffold-bioreactor system, which have been 
designed specifically for this purpose [25]. In spite of these achievements, these studies did not 
explore modifications in mechanotransduction molecules, such as NO, PGE2 or IGF, which 
would be of major interest to understand how hMSC respond to applied flow, and possibly to 
define opportunities for better benefiting from such response when developing bone grafts. In 
addition, in native bone, cells experience fluctuating shear forces that are induced by pulsatile 
interstitial flow associated with habitual loading, which makes physiological flow not static. It 
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would be interesting to attempt mimicking this dynamic nature of flow for in vitro bone tissue 
development. Lastly, Frohlich and co-workers [32] demonstrated that hASC also respond to 
fluid flow, by enhancing bone matrix deposition, although flow by itself was not enough to 
induce osteogenic differentiation in hASC - osteogenic supplements were required for such 
purpose. This questions if either the magnitude of shear stress was too low (approximately 
0.01 Pa), or the nature of flow not the ideal (steady, unidirectional shear vs. oscillating flow). 
Another important question regards the importance of phenotype pre-commitment of hASCs 
when mechanically stimulated, in order to assure that cells sense, interpret and respond to 
shear stress [32]. Accurate answers should be given to these questions, so that hASC’s 
potential (as further discussed) could be enhanced towards the engineering of functional and 
clinically relevant bone grafts.  
 
5. BONE VASCULARIZATION 
The vascularized component of engineered bone graft is critical for its survival and function 
after in vivo implantation. This major concern has led to the development of several studies in 
order to 1) achieve a vascularized bone graft and 2) understand the cross-talk between bone 
and vascular cells. Table II summarizes most recent findings in this domain. 
 
Table II – Co-culture and single-cell approaches for bone vascularization. Compiled from references 
[36-42]  
Co-culture approach Scaffold In vitro evaluation In vivo evaluation Ref. 
HDMEC 
1.3x105 
HOb 
0.2x105 
Silk fibroin 
nets 
7 and 14 days [43] SCID mice, subcutaneous 
14 days 
in vitro pre-formed 
microcapillary anastomosed 
with host vasculature 
[36] 
HUVEC 
(1:2) 
HOP 
(1:2) 
Alginate 
micro-
spheres 
Dynamic culturing, 3 weeks 
Upregulation of AP and OCN 
GE and increased 
mineralization deposits;  
Increased VEGF secretion 
SCID mice, femur defect 
3 and 6 weeks  
Mineralization significantly 
increased when HOPs were 
co-immobilized with HUVECs 
[37] 
HUVEC 
(1:1) 
hMSC 
(1:1) 
n/a DMEM + M199 (1:1 v/v),  
3 weeks  
Promotion of osteogenic 
differentiation and significant 
increase on hMSC proliferation 
n/a [38] 
HUVEC 
1x106 
hMSC 
2.5x105 
Collagen- 
fibronectin 
hMSC osteoinduction,  
1 week 
SCID mice, subcutaneous 
8 weeks 
[39] 
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(4:1) (4:1) gel 
+ 
PLGA 
scaffold 
Scaffolds were then seeded 
with collagen-fibronectin gel 
containing HUVEC and MSC 
and implanted subcutaneously 
in SCID mice 
HUVECs formed tube-like 
structures and networks 4–7 
days after implantation; 
anastomosis occurred by day 
11;  
At 4 weeks, network was 
mature and mineralization 
occured 
cEPC cMSC Collagen 
fiber mesh 
scaffold 
n/a SCID mice, subcutaneous 
12 weeks 
Co-implanted EPCs increased 
neovascularization;  
Bone area was greater in the 
MSC+EPC group  
[40] 
HUVEC 
1x105 + 
2x105 
hMSC 
1x106 
 
Fibrin/ 
Matrigel 
+ 
Tutobone 
hMSC osteoinduction,  
3 days 
 
SCID mice, orthotopic calvarial 
defect, 6 weeks 
HUVECs formed complex 3D 
networks of perfused 
neovessels;  
MSCs supported bone 
formation 
[41] 
Single-cell approach 
hASC 
1x106 
cells/cm
2 
- Hydroxy-
apatite 
scaffold 
Co-differentiation, 3 weeks 
M199 + osteogenic and 
endothelial GF 
 
 
Nude rats, calvarial defect,  
3 weeks  
ASC adhesion, distribution, 
proliferation and GE 
demonstrated a full osteogenic 
and vasculogenic commitment 
in vitro and in vivo 
[42] 
 
AP – alkaline phosphatase; cEPC – canine endothelial progenitor cells; cMSC - canine mesenchymal stem cells; 
DMEM - Dulbecco's Modified Eagle's medium; GE – gene expression; GF – growth factors; hASC – human 
adipose stem cells; HDMEC - human dermal microcapillary endothelial cells; hMSC - human mesenchymal stem 
cells; HOb – human osteoblasts; HOP- human osteoprogenitors; HUVEC - human umbilical vein endothelial cells; 
M199 – medium; n/a – non applicable; OCN – osteocalcin; PLGA - poly(DL -lactide-co-glycolide); SCID – severe 
combined immunodeficiency; VEGF - vascular endothelial growth factor; v/v - volume/volume 
 
A clear trend is observed by analyzing Table II: in the last three years, HUVECs and hMSC 
interactions have been the most thoroughly explored in order to respectively develop vascular 
and osteogenic compartments. This is an evolution relatively to earlier studies, well reviewed 
by Santos and Reis 2010 [44] when HDMECs and human osteoblasts (hOb) were the most 
used cell sources.  
HUVECs are a key cell source on what concerns the formation of functional vascular 
structures. While HDMEC develop microvascular structures, HUVECs are capable of forming 
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large blood vessels, which is a beneficial characteristic on aiming to engineer stable functional 
vascularized bone grafts. 
hMSC are a more advantageous cell type than hOb, once MSCs have the potential to undergo 
two main roles: 1) as osteogenic progenitors, forming mineralized bone matrix [34, 35]; and 2) 
as pericytes, responsible for stabilizing vascular networks. In this regard, recent publications 
have been supporting this fact, majorly when MSC are co-cultured with mature endothelial cells 
[39, 41]. Data summarized in Table II may support this vision: in most studies, better outcomes 
for both tissue compartments were obtained when endothelial cells were co-immobilized/co-
implanted with osteo-progenitors [37, 40].   
The close interaction between MSCs and HUVECs in co-culture systems is yet target of 
extensive research [38, 39, 41]. A reliable in vitro model composed of these cells, could 
become a great tool to clarify and specify the molecular mechanisms that regulate inter-cellular 
interactions, relevant not only in the scope of engineering vascularized bone grafts, but also to 
provide a platform to study disease conditions and/or developmental processes.  
On the other hand, given the final therapeutic aim, hASC present a clear lead over the HUVEC-
hMSC approach, once the same cell source is used to fully develop the vascularized bone 
graft. hASC have proven to be no less capable of osteogenic differentiation and bone tissue 
development than bone-marrow MSC [32, 45], which confirms as a promising alternative for 
cell based therapies of bone [46]. In addition, hASC have demonstrated its intrinsic potential for 
endothelial differentiation and capillary formation [47-49]. As mentioned in table II, when 
nourished with a cocktail of both osteogenic and vasculogenic growth factors, hASC show to 
commit to both lineages, by expressing correspondent specific markers, such as osteopontin, 
osteonectin, osteocalcin, and collagen type I, for bone; and CD31, von Willebrand Factor and 
VEGF, for vasculogenesis [42]. Besides this potential, hASC present other key characteristics 
such as:  
a. Adipose tissue (AT) is harvested from the patient by either dedicated or non-dedicated 
procedures. AT can be obtained repeatedly in large quantities under local anesthesia 
and with a minimum of patient discomfort; 
b. Can be used used in an autologous manner, but still presents a high potential for 
allogeinic purposes; 
c. Adipose tissue yields very high cell numbers, as compared to bone-marrow harvest 
procedures [50].  
Although hASC present such attractive characteristics, the major challenge - to fully engineer 
functional bone and vessels concurrently - is yet to be achieved.  
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6. CONCLUSIONS AND FUTURE PERSPECTIVES 
In this concise review, we have highlighted several aspects, namely the need to fulfill current 
clinical demands of bone grafts, the basics of bone biology, as well as the biomechanical 
mechanisms by which bone tissue remodels and maintains its specific architecture. Under this 
transversal scope we have further addressed the most recent studies on dynamic engineering 
of bone grafts using flow perfusion (and inherently shear stress – the major force type  
governing osteocyte mechanotransduction).  
While hMSC remains the major cell source studied under this domain during the past three 
years; hASC have emerged as an alternative and promising cell source for exploitation. In fact, 
hASC have proved its potential for development of both osteogenic compartment and blood 
vessel network, which would enable the engineering of a functional tissue graft from a unique 
cell source. Taken these two approaches together we believe and suggest that flow can also 
be used to mechanically stimulate endothelial / stem cells in order to induce better vasculature 
within the engineered bone, and reduce the overall culturing period time. 
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This chapter describes the materials used and the experimental methods employed in the set 
of studies described in this thesis. Although each individual chapter contains a brief specific 
materials and methods section, this chapter will provide additional information about the 
procedures used and how they were performed, as well as more details about the materials 
chosen for the experimental development of both cartilage and vascularized bone tissue. 
 
1. MATERIALS 
1.1. GELLAN GUM 
Gellan gum (GG) is a high molecular weight polysaccharide obtained by microbial fermentation 
of Sphingomonas elodea, an anaerobic, non-pathogenic gram-negative bacterium [1]. GG is a 
water-soluble gelling agent commonly used in food and pharmaceutical industry, due to its 
processing into transparent gels resistant to heat and acid stress. The general chemical 
structure of GG is presented in Figure 1, initially described by Moorhouse et al. [2] Its structure 
is composed of tetrasaccharide (1,3-β-D-glucose, 1,4-β–D-glucuronic acid, 1,4-β-D-glucose, 
1,4-α-L-rhamnose) repeating units, containing one carboxyl side group. The thickness and 
hardness of the GG is determined by acetyl groups present in the gellan gum obtained from the 
microbial culture: with acetyl groups, the gel is soft and elastic; without acetyl groups, firmer 
gels are obtained [3]. Both are commercially available, being the later the most common. Both 
form thermo-reversible gels with different mechanical properties in the presence of metallic 
ions and upon temperature decrease. In addition to food and pharmaceutical applications, GG 
has proven its potential application in Tissue Engineering and Regenerative Medicine field. 
Once GG presents a thermo-sensitive behavior, with gelation close to body temperature, its 
application as an injectable formulation for repair of cartilage defects is promising. In our group, 
Oliveira JT et al [4-6] firstly described its use as a biomaterial for cartilage regeneration, 
proving deposition of cartilaginous extracellular matrix in vitro and in vivo by articular 
chondrocytes, nasal chondrocytes and adipose-derived stem cells. Furthermore, Correia JS et 
al increased structural and mechanical integrity of GG hydrogel by modifying the polymer with 
specific functional groups (i.e. methacrylates). Free radical polymerization occurs in the 
presence of a photo-initiator and upon exposure to UV light [7]. The studies performed in the 
scope of this thesis (chapter IV) were developed with non-modified gellan gum, purchased from 
Sigma-Aldrich - GelzanTM CM, Cat # G1910. 
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1.2. SILK FIBROIN 
Silkworm silk fibroin (SF) has been used in textile production for centuries, and in the last 
decades it has found wide clinical use as biomedical sutures. SF extracted from the silkworm 
Bombix mori cocoon (Figure 2A), consists primarily of two protein components: fibroin and 
sericins (Figure 2B). Fibroin is the structural protein of the silk fibers composed of heavy and 
light chain polypeptides of 350 and 25 kDa, respectively, connected by a disulfide link [8]. It is a 
protein dominated in composition by the amino acids glycine, alanine and serine, which form 
antiparallel ß-sheets in the spun fibers, leading to the stability and mechanical features of the 
fibers [9, 10]. Sericins are the water-soluble glue-like proteins that bond the fibroin fibers 
together [11]. The highly repetitive primary sequence that characterizes fibrous proteins such 
as silk, lead to significant homogeneity in secondary structure (ß-sheets), which allow silk 
fibroin to exhibit extraordinary strength, ranging 15–17 GPa [12]. Because of this impressive 
mechanical performance, in combination with its biocompatibility and biodegradability 
characteristics, silk fibroin provides an important set of material options for biomaterials and 
scaffolds for tissue engineering [12-16]. In particular for bone tissue engineering, silk fibroin 
has been studied thoroughly in order to achieve an ideal scaffold [17-22]. In this thesis, silk 
fibroin scaffolds were used in chapters V, VI and VII. 
 
Figure 2 – A – Bombix mori silk cocoon, B – Silk fiber composed by fibroin and outer layer of sericin. 
www.dermasilk.com.   
Figure 1. Molecular structure of gellan gum. Consists of a linear repeating tetrasaccharide unit (n) 
composed of glucose, rhamnose and glucuronic acid. www.kelco.com 
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1.3. BOVINE TRABECULAR BONE 
Trabecular bone was obtained from the subchondral region of carpometacarpal joints of 2-
week to 4-month old bovine calves. Demineralized bone matrix is an osteo-inductive 
biomaterial due to the presence of bone-derived growth factors [23]. As a result, various forms 
of demineralized bone matrix, bone morphogenetic proteins, and bone graft substitutes are 
commonly used in clinical applications for bone repair [24]. Decellularized bone (DCB), per se, 
provide the osteoinductive growth factors in addition to mechanical and architectural properties, 
making these suitable for bone tissue engineering purposes. DCB scaffolds have been 
employed for bone tissue-engineering applications [24, 25], and will be used in chapter V as a 
gold standard, and chapter VIII as part of the in vitro model developed. 
 
2. SCAFFOLDS PRODUCTION 
2.1. GELLAN GUM HYDROGELS 
Gellan gum hydrogel was produced according to the procedure described by Oliveira JT et al 
[26, 27]. Briefly, powdered gellan gum (GelzanTM Sigma G1910) was dissolved in distilled water 
under constant stirring at room temperature into a 1.5% (w/v) solution. This solution was 
progressively heated up to 90ºC, temperature at which complete and homogenous dissolution 
of the material was obtained. After 20-30 min, temperature was progressively decreased to 37-
40ºC, for cell encapsulation. PBS (Sigma P4417) was added to GG solution at 1:20 (v/v) ratio. 
Before gelation, GG solution was cast into a cylindrical mould and PBS was used as a cross-
linking agent to stabilize the hydrogel structure. Discs with 4 mm diameter and 2 mm height 
were cut using a scalpel, and used in experiments described in chapter IV. 
 
2.2. SILK FIBROIN SCAFFOLDS 
Silk fibroin from silkworm (Bombix mori) cocoons was extracted with 0.02 M sodium carbonate 
(Na2CO3) solution, rinsed in distilled water, dissolved in a 9.3 M lithium bromide (LiBr) solution 
and dialyzed for 48h against distilled water in benzoylated dialysis tubing (Sigma D7884). 
Dissolved silk fibroin was centrifuged for 20 min at 9000 rpm (4oC). The resulting solution was 
determined by weighing the remaining solid after drying, yielding a 6-wt % aqueous silk fibroin 
solution. 
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2.2.1. AQUEOUS-BASED POROUS SCAFFOLDS 
Aqueous-derived silk fibroin porous sponges were prepared by salt leaching methods. NaCl 
salt was sieved with metal mesh to obtain particle size of 250–500 µm (Aq-250), or 500–1000 
µm (Aq-500), and added into silk fibroin aqueous solution at a 2:1 (w/v) ratio, in disk-shaped 
containers. The container was covered and left at room temperature. After 24h, the container 
was immersed in water to extract NaCl salt for 2 days with water changes. Discs with 4 mm 
diameter and 2 mm height were cored and used in experiments described in chapter V. 
 
2.2.2. AQUEOUS-BASED LAMELLAR SCAFFOLDS 
Aqueous-derived silk fibroin lamellar scaffolds (Aq-Lam) were prepared by pouring silk fibroin 
aqueous solution into silicon tubing (6 mm i.d.), frozen at -80ºC, lyophilized for 1 day, and 
autoclaved to induce the formation of the β-sheet structure and insolubility in aqueous solution. 
4 mm diameter and 2 mm height discs were cored and used in experiments described in 
chapter V. 
 
2.2.3. HFIP-DERIVED POROUS SCAFFOLDS 
HFIP-derived silk fibroin scaffolds (HFIP-400) were prepared as previously described [28], and 
used in chapters V, VI and VII. Silk fibroin aqueous solution was lyophilized and further 
dissolved with HFIP, resulting in a 17-wt % HFIP-derived silk fibroin solution. Granular NaCl 
(400–600 µm) were added to 2 mL of silk fibroin in HFIP at 2:1 (w/v) ratio. The containers were 
covered overnight to reduce evaporation of HFIP and to provide sufficient time for 
homogeneous distribution of the solution. Subsequently, the solvent was evaporated at room 
temperature for 3 days. The matrices were then treated in 90% (v/v) methanol for 30 min, to 
induce the formation of the β-sheet structure, followed by immersion in water for 2 days to 
remove the NaCl.  
 
2.3. DECELLULARIZED BONE SCAFFOLDS 
Trabecular bone cylinders (4 mm diameter) were cored from the subchondral region of 
carpometacarpal joints of bovine calves, and washed with a high velocity stream of water to 
remove bone marrow from pore spaces. Scaffolds were further washed for 1h in phosphate-
buffered saline (PBS) with 0.1% ethylenediamine tetraacetic acid (EDTA) at room temperature 
(RT), followed by sequential washes in hypotonic buffer (10 mM Tris and 0.1% EDTA) 
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overnight at 4o C, in detergent (10 mM Tris and 0.5% sodium dodecyl sulfate) for 24 h at RT, 
and in enzyme solution (100 U/mL DNAse, 1 U/mL RNAse, and 10 mM Tris) for 6 h at 37o C, to 
fully remove cellular material. Scaffolds were then rinsed in PBS, freeze-dried, and cut into 2 
mm thick cylindrical plugs. The scaffolds within the density range of 0.28–0.38 mg/mm3 
(calculated based on the dry weights and exact dimensions) were selected for experiments of 
chapters V and VIII.  
 
3. CELL ISOLATION AND EXPANSION 
3.1. ISOLATION AND EXPANSION OF HUMAN NASAL CHONDROCYTES 
Transphenoidal biopsy was collected from patients undergoing neurosurgery. The patients had 
signed an informed consent document approved by the Ethical Committee of Hospital S. 
Marcos, Braga, Portugal. Nasal cartilage was dissected and digested with collagenase type II, 
according to protocol described elsewhere [29]. Briefly, the tissue was washed with sterile PBS 
(Sigma P4417), diced into 2-3 mm thickness cubes, immersed in 20 mL trypsin-EDTA solution 
(Invitrogen 25300-062) and incubated for 30 minutes at 37ºC in a rotator. Tripsin-EDTA 
solution was removed and 20 mL of collagenase type II (2 mg/mL, Sigma C6885) was added 
and allowed to incubate for 15h at 37ºC in a rotator. The digested tissue was filtered and the 
cell suspension centrifuged at 1200 rpm for 8 minutes. The cell pellet was washed twice with 
PBS and cells counted with a hemocytometer using the viability stain trypan blue (Sigma). 
Chondrocytes were expanded with chondrogenic expansion medium composed by D-MEM 
high glucose (Sigma D5671), 1% non-essential amino-acids (1xMEM Invitrogen 11140-035); 
20 mM L-alanyl-L-glutamine (Sigma G8541); 1% antibiotic/antimicotic 100x (15240-062 Gibco); 
10 mM HEPES (Sigma H4034); 10% Fetal Bovine Serum (Biochrom, Germany, Heat 
inactivated 30 min., 57ºC), supplemented with basic fibroblast growth factor (b-FGF) 10 ng/mL 
(Peprotek 100-18B, UK). Chondrocytes were expanded until passage 3 and detached from the 
culture flask with trypsin-EDTA (Invitrogen 25300-062) and used in studies of chapter V. 
 
3.2. ISOLATION AND EXPANSION OF HUMAN ADIPOSE STEM CELLS 
Human adipose stem cells (hASCs) were isolated from liposuction aspirates of subcutaneous 
adipose tissue (AT), donated with written consent by patients undergoing elective liposurgery. 
AT was distributed into 50 mL falcon tubes to which PBS (1:1) was added, and vigorously 
agitated. The mixture was centrifuged 200g for 5 minutes at RT and infranatants discarded. 1 
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mL of collagenase solution 0.2 U/mL (Collagenase NB 4 Standard grade, SERVA 
Electrophoresis, Cat. No. 17454) was added per gram of washed AT, shaked vigorously and 
incubated at 37ºC for 45 min in a water bath with agitation at 200 rpm. Digested AT was further 
centrifuged at 1200g, 3minutes, RT and supernatants discarded. The remaining pellet was 
suspended with erythrocyte lysis buffer (ELB) and further centrifuged at 400g, 10 min, RT. 
Supernatant was discarded and pellet suspended in alpha-MEM media (GIBCO 12000-063) for 
filtering through a cell strainer. The stromal vascular fraction (SVF) was plated in cell culture 
plates, and adhered cells were further were expanded to the third passage in high-glucose 
Dulbecco’s modified Eagle’s medium (DMEM) (GIBCO 11965) supplemented with 10% fetal 
bovine serum (FBS) (GIBCO 26140), penicillin–streptomycin (1%) (GIBCO 15140) and 1 
ng/mL basic fibroblast growth factor (bFGF) (Peprotech 100-18B). p0 cells were examined for 
surface marker expression using flow cytometry and used in experiments described in chapters 
IV, V, VI and VII. The presence of specific antigens such as CD105, CD45, CD34, CD73 and 
CD90 were analyzed, as previously published [30, 31]. hASCs were tested for their 
differentiation capacity into the osteogenic, chondrogenic and adipogenic lineages.  
 
 
 
Figure 3. Major steps performed for isolation of human adipose stem cells. 
 
3.3. EXPANSION OF HUMAN BONE MARROW STEM CELLS 
Bone marrow-derived human mesenchymal stem cells (MSCs) were isolated from the 
mononuclear fraction of a bone marrow aspirate obtained from a commercial source (Cambrex, 
CA) based on their attachment to tissue culture plastics [25], expanded in high glucose DMEM 
supplemented with 10 % FBS, 1 % Pen–Strep and 1 ng/mL basic fibroblast growth factor 
(bFGF) to the 3rd passage. These cells have been characterized for their ability to differentiate 
into osteogenic, chondrogenic, and adipogenic phenotypes in vitro and for their ability to give 
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rise to new bone formation in vitro and in vivo [22, 25, 32].  These expanded MSCs were used 
in the experiments described in chapter VIII. 
 
3.4. EXPANSION OF HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS 
Fresh umbilical veins were obtained from the neonatal unit at Columbia University following an 
approved IRB protocol (IRBAAAC4839). To isolate human umbilical vein endothelial cells 
(HUVECs), the vein was flushed with HEPES buffer to remove residual blood and treated with 
trypsin for 15 minutes to remove the endothelial cells. Cells were flushed from the vein with 
HEPES and collected in centrifuge tubes. The suspension was centrifuged at 300 g for 5 
minutes and the supernatant was discarded. Cells were resuspended in EGM and cultured in 
tissue culture flasks. Non-adherent cells were washed out after 1 day. When the HUVECs grew 
to confluence, they were trypsinized, counted and cryopreserved. For experiments described in 
chapter VIII HUVECs were expanded in EGM media to passage four. 
 
4. IN VITRO STUDIES 
4.1. CARTILAGE TISSUE DEVELOPMENT BY HYDROSTATIC PRESSURE STIMULATION 
Two original easy-to-use devices were developed to generate hydrostatic pressure forces, 
which uniformly load constructs in culture (chapter IV). The High Hydrostatic Pressure 
Bioreactor (HHPB) was designed to generate physiological amplitudes of hydrostatic pressure 
(up to 10 MPa), and the Low Hydrostatic Pressure Bioreactor (LHPB) was projected to load 
culturing constructs with lower HP amplitudes (up to 0.5 MPa). Both devices enclose particular 
key characteristics, such as: 
a. Possibility to perform long term culturing, up to several weeks; 
b. Culture of multiple 3D constructs within a high range of dimensions; 
c. Tunable loading parameters: pressure amplitudes may range 0 - 0.4 MPa (for LHPB) 
and 1.5 - 10 MPa (for HHPB); frequency may range between 0 - 1 Hz; 
d. Operation of devices inside standard biohazard hoods, and CO2 incubators at 37ºC, in 
complete sterile conditions; 
e. LHPB is disposable, composed by standard, off-the-shelf components, while HHPB is 
reusable, composed by sterilizable stainless steel components. 
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4.1.1. HIGH HPB 
The High-HPB system consists of a stainless steel device (15 cm diameter x 18 cm height), 
composed of a culture chamber (CC), an air chamber (AC) and a piston. The air pressure 
driven piston creates hydrostatic pressure in the culture chamber, where constructs reside in 
culturing media. As filtered compressed house air enters the air chamber, piston is pushed up. 
Ratio of AC and CC area is 15:1. A pressure transducer (0-16 MPa, Swagelok, USA), with 
digital display is connected to the lid of the culture chamber providing real time pressure 
reading. Pulsatile pressurization is controlled by a Programmable Logic Controller unit (PLC – 
OMRON CPM1A-30CDR-A-V1, Netherlands), and solenoid valve (Camozzi A331-1C2, Italy). 
When non-pressurized, culture media is replenished through the culture chamber by a 
peristaltic pump (Ismatec, USA), from a standard 50 mL schott bottle, with an adapted air filter.  
 
4.1.2. LOW HPB 
The Low-HPB system is composed by a 30 mL luer-lok polypropylene syringe (BD 
Biosciences), where the rubber piston is used as a physical division between the culture media 
and compressed air, used as mechanism of compression. An aluminum adapter is connected 
at the top of the syringe, together with a semi-rigid nylon tube (Legris) to conduct filtered 
compressed house air inside the chamber. At the bottom of the syringe, Pharmed BPT tubing 
(Masterflex, USA) is connected to allow gas exchange. PLC and solenoide valve used with 
HHPB allow controlled pulsatile pressurization of the culture media. Media is replenished 
through the Pharmed BPT tubing, using a syringe to avoid complex manipulation. 
 
4.1.3. CELL ENCAPSULATION  
Gellan gum hydrogel was produced according to the procedure published by Oliveira JT et al 
(2010) [26, 27] and described in section 2.1. Powder GG, autoclave-sterilized was dissolved in 
distilled water at 1.5% (w/v). When temperature of GG solution was decreased to 37-40ºC, a 
cell-suspension prepared at a final concentration of 10x106 cells/mL of PBS was added at 1:20 
ratio (v/v) under constant stirring. Cylindrical discs were made with a mould and PBS was used 
as a cross-linking agent to stabilize the hydrogel structure. Discs with 4 mm diameter and 2 
mm height were cut using a borer. 
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4.2. BONE TISSUE DEVELOPMENT BY PULSATILE PERFUSION  
4.2.1. PERFUSION BIOREACTOR 
The perfusion bioreactor system used in chapter VI has been widely used in bone tissue 
engineering studies [22, 32-34]. It has the dimensions of a 10-cm glass Petri dish, and the 
glass cover of this dish serves as the removable bioreactor cover. It allows culturing multiple 
scaffolds (4 to 10 mm in diameter and up to 4 mm high) and imaging capabilities. Scaffolds are 
placed into six wells arranged in a radial pattern, press-fit in place into a layer of 
polydimethylsiloxane (PDMS). Each bioreactor enabled simultaneous cultivation and uniform 
perfusion of the six scaffolds. Culture medium enters the bioreactor through a central port from 
where it flows to the center of the bioreactor and is evenly distributed into six channels leading 
to the scaffolds. A multi-channel peristaltic pump (Ismatec, USA) is used to maintain re-
circulating flow. The flow rate was determined by the cross-sectional area of the tube as the 
length of the column of fluid being pumped and the rate of pumping remained constant among 
groups. Figure 4 displays the bioreactor design [33].  
 
 
 
Figure 4 – Perfusion bioreactor: (A) Schematic presentation of the perfusion bioreactor system. (B) 
Computational Fluid Dynamics simulation of flow through channels indicating uniform flow to all six 
wells. (C) Complete experimental set-up. (D) Imaging of tissue constructs in situ. 
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4.2.2. CELL SEEDING 
For perfusion studies performed in chapter VI, HFIP-derived silk fibroin scaffolds were sterilized 
in 70% (v/v) ethanol overnight, washed in PBS and incubated in culture media prior to seeding. 
Expanded hASCs at passage 4 were suspended at 30x106 cells/mL. A 40 µL aliquot of cell 
suspension was pipetted to the top of blot-dried scaffods, pipetted up and down to ensure even 
distribution of cells. After 15 minutes in the incubator, scaffolds were rotated 180º, and 10 µL of 
cell-free medium was added to prevent these to dry. This process was repeated four times, to 
allow uniform cell distribution, after which, osteogenic media (low glucose DMEM, 10% FBS, 
1% penicillin–streptomycin, 10 mM sodium-b-glycerophosphate, 10 mM HEPES, 100 nM 
dexamethasone and 50 µg/mL ascorbic acid-2-phosphate) was added. Scaffolds were then 
cultured in static conditions (well-plate) for 3 days to allow cell attachment.  
 
4.3. SILK SCAFFOLD SCREENING 
In chapter V, the four formulations of silk scaffolds described in 2.2, were cultured with human 
adipose stem cells (hASC), in order to assess bone tissue development. All scaffolds were 
sterilized in 70% ethanol overnight, washed in PBS and incubated in culture medium prior to 
seeding. Expanded P4 hASC were suspended in culture medium at 30x106 cells/mL. A 20 µL 
aliquot of cell suspension was pipetted into blot-dried scaffolds, and pipetted up and down to 
ensure even distribution of cells. After 15 minutes in the incubator, scaffolds were rotated 180º, 
and 10 µL of cell-free medium was added to maintain hydration. This process was repeated 
four times, to achieve uniform cell distribution, after which, osteogenic media (low glucose 
DMEM, 10% FBS, 1% penicillin–streptomycin, 10 mM sodium-ß-glycerophosphate, 10 mM 
HEPES, 100 nM dexamethasone and 50 µg/mL ascorbic acid-2-phosphate) was added and 
cultured for 7 weeks. 
 
4.4. VASCULARIZED BONE DEVELOPMENT: SCREENING GROWTH FACTOR COCKTAILS 
4.4.1. HASC AS SINGLE CELL SOURCE FOR ENGINEERING VASCULARIZED BONE 
In chapter VII, hASC were used to engineer vascularized bone in vitro. Expanded hASC were 
suspended at 20x106 cells/mL. A 20 µL aliquot of cell suspension was pipetted to the top of 
blot-dried HFIP-derived silk scaffolds, pipetted up and down to ensure even distribution of cells. 
After 15 minutes in the incubator, scaffolds were rotated 180º, and 10 µL of cell-free medium 
was added to prevent these to dry. This process was repeated four times, to allow uniform cell 
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distribution, after which, constructs were incubated overnight to allow cell attachment (Fig.1). 
These hASCs, attached to silk fibroin scaffolds are intended for bone formation. At day 1, 
fibrinogen (Sigma F8630) was prepared at a concentration of 5 mg/mL and thrombin (Sigma 
T6200-1KU) was used at 10 Units/mL. Expanded hASCs intended to form vasculature network 
were encapsulated in fibrin at a density of 20x106 cells/mL. Thrombin was added to cross-link 
the gel, giving a final fibrin concentration of 4 mg/mL. Before cross-linking occurred, 20 µl of 
cell/gel suspension was pipetted into blot-dried scaffolds to allow uniform cell seeding 
throughout the scaffolds. Before the gels became cross-linked fully, they were aspirated under 
a light vacuum so that they coated the walls of the scaffolds, but did not fill the pore spaces. 
This step was performed on groups 1 to 5 at day 1, and on groups 6 and 7 only after 3 weeks 
of osteogenic culture. 
Seven experimental groups were defined. Two of these were ‘controls’:  
Group 1 where constructs were cultured in osteogenic medium (OM), which consisted of low 
glucose DMEM, 10% FBS, 1% Pen–Strep supplemented with osteogenic factors (all purchased 
from Sigma-Aldrich): 100 nM dexamethasone, 10 mM sodium-β-glycerophosphate, 10 mM 
HEPES and 50 µg/mL ascorbic acid-2-phosphate, for 5 weeks, to evaluate osteogenic 
differentiation and bone tissue development;  
Group 2, where endothelial growth media was used (EGM) (Lonza CC-3162), to evaluate 
endothelial differentiation and vascular tissue development. Five further groups were chosen 
for growing vascularized bone constructs.  
In Group 3, both osteogenic and vasculogenic supplements were provided simultaneously 
throughout the total period of culture - constructs were cultured for 5 weeks in a cocktail 
medium composed by EGM and OM at 1:1 ratio (cocktail group).  
Further, two sequential approaches were established: a) to induce vasculogenesis prior to 
osteogenesis (groups 4 and 5), and b) reverse the process, and induce osteogenesis prior to 
vasculogenesis (groups 6 and 7).  
At group 4, constructs were cultured in EGM for 2 weeks and in cocktail medium for remaining 
3 weeks (EGM|cocktail). Constructs at group 5, were cultured exactly as in Group 4 except 
that fresh hASCs were added into scaffold pore spaces at this 2-week time point. This is 
indicated as EGM|cocktail+ASC. In Group 6 and 7, we ‘reversed’ the process and induced 
osteogenic differentiation first. In these groups, hASCs were only seeded into the scaffolds and 
cultured in osteogenic media for 3 weeks.  Subsequently, hASCs in fibrin were added to the 
constructs and cultured either in EGM media (Group 6 - OM|EGM), either in cocktail medium 
(Group 7 - OM|cocktail).  
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4.4.2. HUVEC-MSC CO-CULTURE AS AN IN VITRO MODEL OF VASCULARIZED BONE 
In chapter VIII, a co-culture of HUVECs and MSCs was used to engineer vascularized bone in 
vitro. To induce bone formation, 20 µl suspension of MSCs at a density of 10 × 106 cells/mL 
was seeded into blot-dried decellularized bone scaffolds, divided into five groups, and 
incubated overnight to allow cell attachment.  
At day 1, solutions of fibrinogen (5 mg/mL) and thrombin (10 Units/mL) were prepared. In 
Groups 1 – 4, HUVECs and MSCs, intended to form stable vasculature network, were 
encapsulated in fibrin at a 2:1 ratio and a density of 30 × 106 cells/mL. Thrombin was added to 
crosslink the gel, giving a final fibrin concentration of 4 mg/mL. Before crosslinking occurred, 20 
µl of cell/gel suspension was pipetted into blot-dried scaffolds to allow uniform cell seeding 
throughout the scaffolds. Before the gels became fully cross-linked, they were aspirated under 
a light vacuum so that the fibrin gel coated the walls of the scaffolds, but did not fill the pore 
spaces. In Group 5, this same step was performed on MSC-seeded scaffolds after 4 weeks of 
osteogenic culture. 
Five experimental groups were established to study vascularized bone constructs, including 
three main groups and two controls.  
Group 1 (control for osteogenic conditions) utilized osteogenic medium (OM) throughout the 
culture, containing low glucose DMEM, 10% FBS, 1% Pen–Strep supplemented with 
osteogenic factors: 100 nM dexamethasone, 10 mM sodium-β-glycerophosphate, and 50 
µg/mL ascorbic acid-2-phosphate, supplemented with BMP-2 (at 10 ng/mL) for 6 weeks.  
Group 2 (control for vasculogenic conditions) utilized endothelial growth medium (EGM) 
throughout the culture.  
Group 3 utilized EGM for 2 weeks and then a cocktail medium composed by EGM and OM at 
1:1 ratio (EGM|cocktail) for 4 weeks.  
Group 4 was designed exactly as Group 3 except that osteo-induced MSCs were added into 
scaffold pore spaces at the 2-week time point (EGM|cocktail+MSC).  
In Group 5, MSCs only were seeded into the scaffolds and cultured in osteogenic medium for 4 
weeks, at which point HUVECs and MSCs in fibrin were added to the constructs and cultured 
in cocktail medium for an additional 2 weeks (OM|cocktail).  
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5. IN VIVO STUDIES 
5.1. SUB-CUTANEOUS IMPLANTATION OF ENGINEERED VASCULARIZED BONE IN NUDE MICE 
NOD/SCID mice (Nonobese diabetic / severe combined immune deficiency, NOD.CB17-
Prkdcscid/NCrHsd, Harlan) were used as in vivo model for subcutaneous implantation of 
engineered vascularized bone grafts, in chapter VIII. Mice were anaesthetized by a 
subcutaneous injection of ketamine (80-100 mg/kg) and xylazine (5-10mg/kg). Analgesia was 
provided with buprenorphine (0.05-0.1 mg/kg). Constructs were implanted into separate 
subcutaneous dorsal pockets (one construct per pocket, two pockets per animal) according to 
an approved Columbia University Institutional Animal Care & Use Committee (IACUC) protocol. 
 
6. BIOLOGICAL CHARACTERIZATION 
6.1. CELL VIABILITY AND PROLIFERATION 
6.1.1. MTS ASSAY 
Cell metabolic activity was assessed through MTS (3-(4,5-dimethylthiazol-2-yl)-5(3-
carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-tetrazolium) assay (VWR G3580). This substrate is 
bioreduced by dehydrogenase enzymes, active in live cells, into a brown formazan product. 
The intensity of colour, measured at OD 490 nm, is directly related to number of viable cells. In 
chapter V, constructs were washed in PBS and incubated with MTS solution prepared in 
serum-free culture medium without phenol red, at 37ºC for 3h. After incubation, 100 µL were 
transferred in triplicate into a 96-well plate for optical density (OD) measurement at 490 nm.  
 
6.1.2. LIVE/DEAD ASSAY 
The LIVE/DEAD assay provides a two-color fluorescence cell viability assay based on the 
simultaneous determination of live and dead cells. Live cells are distinguished by the enzymatic 
conversion of the cell-permeant calcein AM to the intensely fluorescent calcein (ex/em ~495 
nm/~515 nm), while dead cells are detected by fluorescence of ethidium homodimer (EthD-1) 
or propidium iodide (ex/em ~495 nm/~635 nm) that enters cells with damaged membranes 
binding to nucleic acids. LIVE/DEAD assay was used to evaluate cell viability. In chapter IV, 
live cells (indicated by calcein AM, Invitrogen C3099) and dead cells (indicated by propidium 
iodide, Alfagene P1304MP) were imaged through a Zeiss Axioimage (RZ1M) florescence 
microscope (Germany). In chapters V, VI, VII and VIII, LIVE/DEAD Viability/Citotoxicity kit 
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(Molecular Probes, OR/USA) was used to evaluate cell viability. Live cells (indicated by calcein 
AM) and dead cells (indicated by ethidium homodimer-1) were observed and imaged through a 
confocal microscope (Leica, Germany). Optical surfaces were taken from the surface up until 
160 µm deep, with 10 µm intervals. All images are presented as vertical projections. 
 
6.1.3. DNA QUANTIFICATION 
Quantitating double-stranded DNA (dsDNA) is a very accurate method to assess number of 
cells, once these two parameters are directly correlated. In tissue engineering experimentation, 
this method may be used to assess cell-seeding efficiency into proposed culturing scaffolds 
(chapter V), as well as to determine cell proliferation along construct development (chapters IV 
– VIII). Quant-iTTM PicoGreen® dsDNA reagent is an ultrasensitive fluorescent nucleic acid 
stain, therefore used thoroughly in all experimental studies described in this thesis. Briefly, 
constructs were harvested, washed in PBS, cut in half and weighed. Samples were digested 
with Proteinase K enzyme. 1 mL of proteinase K digestion buffer (10 mM Tris, 1 mM EDTA, 
0.1% Triton X-100, 0.1 mg/mL proteinase K) was added to samples and incubated overnight at 
56ºC. After centrifugation at 3000g, 10 minutes, the supernatants were removed, diluted, 
pippeted in duplicate into a 96-well plate and 1:1 ratio of picogreen solution (Quant-iTTM 
PicoGreen ® dsDNA Kit, Invitrogen) was added. Sample fluorescence was measured with 
fluorescent plate reader at excitation ~480 nm, emission ~520 nm. Lambda DNA was used to 
prepare the standard curve. Based on previous studies where DNA content of hASCs was 
determined, a conversion factor of 5 pg DNA per cell was used. 
 
6.2. HISTOLOGICAL ANALYSIS 
6.2.1. SOFT TISSUE HISTOLOGY 
In chapter IV, 10% formalin was used to fix samples for 1 day, and further dehydrated with 
graded ethanol washes. Samples were embedded in paraffin, sectioned to 5 µm and mounted 
on glass slides. To proceed to distinct stainings, sections were deparaffinized with Clearite and 
rehydrated with a graded series of ethanol washes.  
Safranin O and Alcian Blue staining were performed to detect articular cartilage extracellular 
matrix components, such as mucopolysaccharides and glycosaminoglycans. Briefly, safranin O 
staining was performed with Weigert’s iron hematoxylin, 10 min followed by running in tap 
water for 10 min. Slides were then immersed in 0.02% fast green solution, 5 min and rinsed 10-
15 sec in 1% acetic acid. Finally, samples were stained with 0.1% safranin O solution for 5 min. 
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Regarding alcian blue stain, slides were immersed 30 min in 0.01 g/mL alcian blue solution, 
and washed in running tap water for 2 min. A counterstain with nuclear fast red (0.5%) was 
performed for 5 min. Upon staining, sections were washed in running tap water, dehydrated 
with a graded series of ethanol, cleared with Clearite and mounted with resinous mounting 
media (Entellan Merck & Co., Inc. USA). 
In chapter V, samples were fixed in 4% formaldyhyde solution for 1 day. Bone scaffolds were 
decalcified with immunocal solution (Decal Chemical, Tallman, NY) for 1 day, and further 
dehydrated with graded ethanol washes, concurrently with remaining silk constructs. Samples 
were embedded in paraffin, sectioned to 5-µm slices and mounted on glass slides. For 
staining, sections were deparaffinized with CitriSolv and rehydrated with a graded series of 
ethanol washes. Samples were stained using standard hematoxylin and eosin.  
 
6.2.2. HARD TISSUE HISTOLOGY 
Hard tissue histology was performed in samples harvested from subcutaneous implantation in 
NOD SCID mice, described in chapter VIII. In order to assess new bone formation, contructs 
were not decalcified and further processed according to hard tissue histology methods: 
constructs were fixed in 10% formalin for 1 day and dehydrated with sequential washes in 70 % 
ethanol (2 days), 100 % ethanol (2 days with twice daily solution changes), and toluene (2 days 
with once daily solution change). Constructs were then washed in activated methyl 
methacrylate (MMA) with daily changes of MMA solution for four days at 4 °C, and then placed 
at 32 °C until the MMA cured. Plastic-embedded sections were sectioned to 8 µm on a Leica 
hard tissue microtome. Staining for the new osteoid formation was done using the traditional 
Goldner’s Masson trichrome stain (table I and II): 
 
Table I – Protocol for Goldner’s Masson trichrome stain 
Staining step Time (minutes) 
Weigert’s Hematoxylin 30 
Rinse tap water 2 
Ponceau working solution 5 
Acetic acid 0.2% 3 
Phosphotungstic-Phosphomolybdic acid 10 
Acetic acid 0.2% 3 
Light green 13 
70%, 95%, 100% Ethanol 2 (2x each) 
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Table II – Composition of solutions used in Goldner’s Masson trichrome stain 
Weigert’s Hematoxylin   Ferric chloride 29% aqueous solution 
Solution A   Ferric chloride, anhydrous  1.5 g 
Hematoxylin 1 g  Distilled water 99 mL 
95% Ethyl alcool 100 mL  Hydrochloric acid (concentrated) 1 mL 
Solution B   (Shelf life is 8 months.) 
Ferric chloride 29% aq. solution 4 mL  Masson Fuchsin Ponceau Orange G Stock 
Distilled water 95 mL  Ponceau 2R 2 g 
Hydrochloric acid (concentrated) 1 mL  Acid Fuchsin 1 g 
Working solution:   Orange G 2 g 
Mix equal amount of A and B. Use immediately.  0.2 % Acetic acid 300 mL 
(Shelf life of A and B is 8 months.)  Working solution:  
0.2% Acetic acid   Stock solution of F-P-O 10 mL 
Glacial acetic acid  2 mL  0.2 % Acetic acid 90 mL 
Distilled water 1 L  (Shelf life of F-P-O stock is 9-12 months.) 
(Shelf life is indefinite.)  Light green  
Phosphotungstic-Phosphomolybdic acid  Light green stain 0.1 g 
Phosphotungstic acid 5 g  0.2 % Acetic acid 100 mL 
Phosphomolybdic acid 5 g  (Shelf life is 6 months.) 
Distilled water 100 mL    
(Shelf life is 1-2 months.)    
 
6.2.3. IMMUNOHISTOCHEMISTRY 
Immunohistochemistry (IHC) is a method for demonstrating the presence and location of 
proteins in tissue sections, enabling the observation of processes in the context of intact tissue. 
IHC staining performed with antibodies that recognize the target protein. Antibodies are highly 
specific, binding only to the protein of interest in the tissue section. The engineered tissue 
developed in the context of this thesis, was evaluated by detecting the antibody-antigen 
interaction using a chromogenic detection, where an enzyme conjugated to the antibody 
cleaves a substrate, producing a colored precipitate at the location of the protein. 
In chapters V, VI and VII, silk fibroin scaffolds were to engineer bone tissue, while gellan gum 
hydrogels were used to engineer cartilage tissue in chapter IV. In these chapters, samples 
were fixed in 10% formalin for 1 day, embedded in paraffin, sectioned to 5 µm and mounted on 
glass slides. In chapter V and VIII, where decellularized bone scaffolds were also used to 
engineer bone tissue. In order to perform soft tissue histology, samples were decalcified for 2 
days with Immunocal solution (Decal Chemical, Tallman, NY, USA) before embedding in 
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paraffin. When starting IHC procedure, sections were deparaffinized with CitriSolv and 
rehydrated in a graded series of ethanol washes. Antigen retrieval was performed by heat-
induced method using a microwave and Citrate Buffer (0.1M Citric acid and 0.1M Sodium 
citrate), 20 min. Once horseradish peroxidase enzyme conjugate is used for protein detection, 
suppression of any endogenous peroxidase activity was performed by incubating sections 30 
min in H2O2 0.3% RT with agitation, to decrease background staining (false positives).  
After washing with PBS+0.025% Triton-X, normal horse serum - NHS (20 min, RT) was applied 
to reduce non-specific binding of primary antibody. Excess serum was blot, before incubation 
with diluted primary antibody (table III) overnight at 4ºC (in moist chamber). Negative controls 
were performed by omitting the primary antibody incubation step.  
Sections were further washed with PBS+0.025% Triton-X before incubation with biotin-labeled 
secondary antibody, 30 min, RT, after which, VECTASTAIN ABC reagent was applied. This is 
an avidin-biotinylated enzyme complex (ABC) that will bind to the biotinylated secondary 
antibody (Vectastain Universal Elite ABC Kit, PK-6200 Vector Laboratories).  
Finally, the tissue antigen is localized by incubation (5-10 min) with peroxidase substrate 
solution (3, 3'- diaminobenzidine), yielding a brown stain (DAB substrate kit SK-4100 Vector 
Laboratories). Counterstaining of cell nuclei was further performed with haematoxylin (2 min). 
Sections were lastly dehydrated, cleared in CitriSolv and mounted in organic mounting media. 
 
Table III – Primary anti-bodies used for immunohistochemistry in chapters IV - VIII 
Target protein Primary Antibody Dilution Company / Ref Chapter 
Collagen II (Col II) Rabbit anti-human 
polyclonal antibody 
1:50 Abcam / ab34712 IV 
Collagen I (Col I) Rabbit anti-human 
polyclonal antibody 
1:200 Abcam / ab292 IV 
CD31 Rabbit anti-human 
monoclonal antibody 
1:250 Millipore / 04-1074 VII, VIII 
von Willebrand Factor (vWF) Rabbit anti-human 
polyclonal antibody 
1:200 Sigma-Aldrich / F3520 VII, VIII 
Collagen I (Col I) Mouse anti-human 
monoclonal antibody 
1:500 Abcam / ab6308 V, VIII 
Osteopontin (OPN) Rabbit anti-human 
polyclonal antibody 
1:750 Chemicon / ab1870 V - VII 
Bone Sialoprotein (BSP) Rabbit anti-human 
polyclonal antibody 
1:1000 Millipore / ab1854 V - VIII 
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6.3. BIOCHEMICAL QUANTIFICATION 
6.3.1. GLYCOSAMINOGLYCAN QUANTIFICATION 
Glycosaminoglycans (GAGs) chains participate at the nano-scale level of cartilage. Chondroitin 
sulfate and keratan sulfate are covalently attached to the aggrecan protein backbone. In 
addition with ions such as Na+, Ca2+, SO3-, COO-, are responsible for AC swelling, for governing 
osmotic pressure of cartilage, and consequently contribute for its compressive stiffness [35].  
The 1,9-dimethylmethylene blue (DMB) metachromatic assay was used as standard procedure 
to quantify GAG deposition in cartilage tissue, engineered among experiments described at 
chapter IV.  This reagent entangles mechanically with GAGs present in solution, generating a 
peak shift at OD 525-530 nm. To this end, engineered constructs were added to 1 mL of 
papain digestion buffer (1.5 mg/mL L-cysteine hydrochloride, 0.125 mg/mL papain in PBE 
buffer – table IV) and incubated overnight at 60ºC for digestion. After centrifugation at 10000g, 
5 minutes, 10 µL of supernatant was removed and pippeted in duplicate into a 96-well plate. 
Chondroitin 6-sulfate C sodium salt was used to prepare the standard curve. Dilutions of a 50 
µg/mL stock solution were pipetted in duplicate to the 96-well plate. 250 µL of DMB solution 
(table IV) was added and sample absorbance was immediately measured using a microplate 
reader at OD 530 nm. 
 
Table IV – Solutions used for glycosaminoglycan quantification assay 
PBE buffer   DMB solution 
Na2HPO4 3.265 g  Solution A  
NaH2PO4 3.240 g  NaCl 0.59 g 
EDTA-Na2 500mM 5 mL  Glycine 0.76 g 
Distilled water 450 mL  Distilled water 225 mL 
(Adjust pH to 6.5)  Solution B  
   DMB 4 mg 
   100% Ethanol 1.25mL 
   Mix both. Adjust pH to 3.0. Complete to 250 mL. 
   (Shelf life is 3-6 months.) 
 
6.3.2. CALCIUM QUANTIFICATION 
Mineralized matrix is a key outcome for bone development. The direct quantification of mineral 
in engineered bone grafts is a fundamental tool to assess progression of osteogenic 
differentiation. Total calcium assessment can be performed by its direct combination with ortho-
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cresolphthalein complexone (OCPC) to form a stable color reaction. In this assay, calcium is 
disassociated from proteins in an acid solution, followed by its direct reaction with OCPC. In a 
subsequent alkaline medium, the Ca-OCPC complex turns purple, which is measured at 575 
nm. The amount of calcium in solution is directly proportional to the color intensity developed 
by the reaction. In chapters V, VI, VII, one-half of constructs were incubated in 1 mL TCA 5% 
(trichloroacetic acid 5% v/v) and calcium was extracted by disintegrating the construct using 
steel balls and MinibeadBeaterTM (Biospec, Bartlesville, OK/USA) (3x 25000 rpm, 10 seconds 
each). Samples were further incubated 30 min, RT after which a centrifugation step was 
performed for 10 min, 3000g. 10 µL of each sample were pippeted in duplicate into a 96-well 
plate, as well as Calcium standard prepared. 100 µL of calcium color and base reagent (1:1 
v/v) were added and incubated in the dark at RT for 5 min. Sample optical density was 
measured at 575 nm using a microplate reader. Calcium content and standard were quantified 
using StanbioTotal Calcium Liquicolor (Stanbio Laboratory/USA).  
 
6.3.3. ALKALINE PHOSPHATASE QUANTIFICATION 
Progression of osteogenic differentiation may be determined by alkaline phosphatase (AP) 
activity, a cell surface protein bound to the plasma membrane through phosphatidylinositol 
phospholipid complexes [36]. High AP activity is associated with the active formation of 
mineralized matrix. In chapters V and VII AP activity was determined by adding cell lysis 
solution to one-half of each scaffold, and these were disintegrated using steel balls and 
MinibeadBeaterTM. After centrifugation, 50 µL of supernatant were incubated with 50 µL pNPP 
(p-nitrophenyl-phosphate) substrate solution, at 37ºC for 20 min. Colourless pNPP is 
hydrolyzed by alkaline phosphatase produced by cells (at pH 10.5, 37ºC), to form yellow-
coloured free p-nitrophenol. The reaction was stopped with 50 µL of stop solution, and 
absorbance was read at 405 nm in a microplate reader. p-Nitrophenol at known concentrations 
was used to prepare the standard curve. All solutions were components of SensoLyte pNPP 
Alkaline Phosphatase Complete Kit (Cell Biolabs, CBA-302).  
 
6.4. MICRO COMPUTED TOMOGRAPHY (µCT) ANALYSIS  
The microstructure of engineered bone grafts can be qualitatively and quantitatively evaluated 
using a high-resolution µCT scanner, providing several bone morphometric parameters, and a 
visual distribution of mineral throughout the sample. BV/TV ratio is one of the most important 
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parameters. Total volume (TV) of the volume-of-interest (VOI) is measured in both 2d and 3d. 
The 2d measurement is simply the total number of voxels of (solid and space) in the VOI times 
the voxel volume. Bone Volume (BV) on the other hand, is the total volume of binarised objects 
within the VOI, measured in both 2d and 3d. Given this, the BV/TV ratio corresponds to the 
proportion of the VOI occupied by binarised solid objects. In chapters V, VI and VIII µCT was 
performed using the protocol described by Liu et al [37]. Samples were aligned in a 2 mL 
screw-cap centrifuge tube, which was clamped in the specimen holder of a vivaCT40 system 
(SCANCO Medical AG, Basserdorf, Switzerland). The 2 mm length of the scaffold was 
scanned at 21 µm isotropic resolution. A global thresholding technique, which only detects 
mineralized tissue, was applied to obtain the bone volume (BV) of samples.  
 
6.5. SCANNING ELECTRON MICROSCOPY (SEM) IMAGING 
Scanning Electron Microscopy (SEM) analysis provides images of the surface of a sample by 
scanning with a high energy beam of electrons. SEM was used in chapter V, to analyze the 
distribution, level and morphology of cell attachment on the surface of the scaffolds, as well as 
to analyze scaffold structure. To keep samples in their natural state, special methods of fixation 
and stabilization of the cells on the scaffolds are necessary. Samples were washed in PBS and 
then fixed in 2% gluteraldehyde in sodium cacodylate buffer for 2 h. Constructs were washed in 
buffer and freeze-dried overnight. Before imaging, samples were coated with gold and 
palladium and imaged in SEM machine (JEOL, JAPAN).  
 
6.6. MECHANICAL PROPERTIES EVALUATION 
Mechanical properties of the scaffold and consequent engineered tissue after culture, is of 
crucial importance for its integration upon implantation in lesion site. In chapters V and VI, 
Stiffness upon compression was determined under unconfined compression in wet conditions 
using a modification of an established protocol [38]. An initial tare load of 0.2 N was applied 
and was followed by a stress-relaxation step where specimens were compressed at a ramp 
velocity of 1% per second up to 10% strain and maintained at the position for 1800 s. The 
equivalent Young’s modulus was obtained from the equilibrium forces measured at 10% strain. 
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6.7. QUANTITATIVE REAL-TIME PCR ANALYSIS 
The fluorescence-based quantitative real-time PCR (polymerase chain reaction), is a 
methodology to detect and measure minute amounts of nucleic acids in a wide range of 
samples from numerous sources. In chapters IV, VI and VII, gene expression of specific 
chondrogenic, osteogenic and endothelial markers were quantified to assess cell differentiation 
stage and consequent tissue development. Slight protocol variations were performed in each 
chapter. 
For RNA extraction, constructs in chapter IV were added to 800 µL of TRIzol (Invitrogen 
15596-026) and disintegrated by mortar and pestle, using liquid nitrogen to maintain samples 
cold. Suspensions were centrifuged at 12,000 g for 10 min at 4°C to remove tissue debris and 
extracted with chloroform (JMGS C/4960/17). Colorless aqueous phase, containing RNA was 
removed and mixed with equal volume of isopropanol (Laborspirit 33539). Suspensions were 
again centrifuged at 12,000 g for 8 min at 4°C, supernatant discarded, and RNA pellet washed 
with 75% ethanol. Samples were centrifuged at 7,500 g for 5 min at 4°C, supernatant removed, 
pellet air-dried, and dissolved with RNAase-free water (Invitrogen 10977035). RNA was 
quantified using Nanodrop® ND‐1000. Approximately 1 µg of RNA was reversely transcribed 
with random hexameres using qScriptTM cDNA Synthesis Kit (Quanta Biosciences 95047). 
Collagen type II, aggrecan, Sox-9 and the housekeeping gene glyceraldehyde-3-
phosphatedehydrogenase (GAPDH) expression were quantified using PerfeCTaTM SYBR® 
Green FastMixTM  (Quanta Biosciences 95072) and the Eppendorf realplex4 System. Primer 
sequences and amplicon size are described on table V. The expression data were normalized 
to GAPDH and presented as average values for each group (n=3 ± standard deviation). 
 
In Chapters VI and VII, a different method was used. For RNA extraction, one-half of constructs 
were added to 800 µL of TRIzol (Invitrogen 15596-026, USA) and disintegrated by using 
steel balls and MinibeadBeaterTM (Biospec, Bartlesville, OK/USA), maintaining samples in ice. 
Suspensions were centrifuged at 12,000 g for 10 min at 4°C to remove tissue debris and 
extracted with chloroform (Sigma C2432). Colorless aqueous phase, containing RNA was 
removed and mixed with equal volume of isopropanol (Sigma I9516). Suspensions were again 
centrifuged at 12,000 g for 8 min at 4°C, supernatant discarded, and RNA pellet washed with 
75% ethanol. Samples were centrifuged at 7,500 g for 5 min at 4°C, supernatant removed, 
pellet air-dried, and dissolved with DEPC-water (Applied Biosystems AM 9920). RNA was 
quantified using Nanodrop® ND‐1000. Approximately 1 µg of RNA was reversely transcribed 
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with random hexameres using High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems 4368814). Osteopontin (OPN), bone sialoprotein (BSP), prostaglandin E2 synthase 
(PGE2S), CD31, von Willebrand factor (vWF) and the housekeeping gene glyceraldehyde-3-
phosphatedehydrogenase (GAPDH) expression were quantified using a 7500 Fast Real-Time 
PCR System (Applied Biosystems, USA). Gene expression assay ID, probe and amplicon size 
and are described on table V. All TaqMan® Gene Expression Assays were purchased from 
Applied Biosystems.  
The expression of each gene was normalized to GAPDH value of corresponding sample and 
relative gene expression was quantified according to the Livak method, considering that 
normalized expression ratio = 2-∆∆Ct. Average values for each group were presented. 
 
Table V – Primers and Gene Expression Assays used in quantitative RT-PCR analysis 
Gene Primers GEA ID Amplicon  Chapter 
Collagen II (Col II) F: 5’GACAATCTGGCTCCCAAC 
R: 5’ACAGTCTTGCCCCACTTA 
- 257 bp IV 
Aggrecan (Agrc) F: 5’TGAGTCCTCAAGCCTCCTGT 
R: 5’TGGTCTGCAGCAGTTGATTC 
- 129 bp IV 
Sox-9 F: 5’TACGACTACACCGACCACCA 
R: 5’TTAGGATCATCTCGGCCATC 
- 256 bp IV 
GAPDH F: 5’ACAGTCAGCCGCATCTTCTT 
R: 5’ACGACCAAATCCGTTGACTC 
- 94 bp IV 
Prostaglandin E2 synthase 
(PGE2S) 
- Hs00228159_m1 66 bp VI 
Osteopontin (OPN) - Hs00167093_m1 
 
65 bp VI 
Bone Sialoprotein (BSP) - Hs00173720_m1 
 
95 bp VI 
CD31 - Hs00169777_m1 
 
65 bp VII 
von Willebrand Factor 
(vWF) 
- Hs00169795_m1 70 bp VII 
GAPDH - Hs99999905_m1 
 
122 bp VI, VII 
 
bp – base pairs; GEA – gene expression assay; GAPDH - Glyceraldehyde 3-phosphate dehydrogenase 
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7. STATISTICAL ANALYSIS 
Data are presented as average (n=3) ± standard deviation. Statistical significance was 
determined using analysis of variance (ANOVA) followed by Tukey’s HSD (honestly significant 
difference) test using Prism software (Prism 4.0c, GraphPad Software Inc., San Diego, CA, 
USA). p< 0.05 were considered statistically significant 
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CHAPTER IV 
Dynamic culturing of cartilage tissue: the significance of hydrostatic pressure 
 
 
This chapter is based on the following publication: Correia C, Pereira AL, Duarte ARC, Pedro AJ, Frias 
AM, Oliveira JT, Sousa RA and Reis RL, 2011, Dynamic culturing of cartilage tissue: the significance of 
hydrostatic pressure - submitted. 
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Abstract  
Human articular cartilage functions under a wide range of mechanical loads in synovial joints, 
where hydrostatic pressure (HP) is the prevalent actuating force. We hypothesized that the 
formation of engineered cartilage can be augmented by applying such physiologic stimuli to 
chondrogenic cells or stem cells, cultured in hydrogels, using custom-designed hydrostatic 
pressure bioreactors. To test this hypothesis, we investigated the effects of distinct hydrostatic 
pressure regimens on cartilage formation in vitro by either human nasal chondrocytes (HNC) or 
human adipose stem cells (hASCs) encapsulated in gellan gum (GG) hydrogels. To this end, 
we varied the frequency of low HP, by applying pulsatile (PHP) or steady (SHP) load to HNC-
GG constructs over a period of 3 weeks, and evaluated their effects on cartilage tissue 
engineering outcomes. HNC (10x106 cells/mL) were encapsulated in GG hydrogels (1.5%) and 
cultured in chondrogenic medium under three regimens for 3 weeks: (1) 0.4 MPa Pulsatile HP; 
(2) 0.4 MPa Steady HP; and (3) Static. Subsequently, we applied the pulsatile regimen to 
hASC-GG constructs and varied the amplitude of loading, by generating both low (0.4 MPa) 
and physiologic (5 MPa) HP levels. hASC (10x106 cells/mL) were encapsulated in GG 
hydrogels (1.5%) and cultured in chondrogenic medium under three regimens for 4 weeks: (1) 
0.4 MPa Pulsatile HP; (2) 5 MPa Pulsatile HP; and (3) Static. In the HNC study, the best tissue 
development was achieved by the pulsatile HP regimen, while in the hASC study, greater 
chondrogenic differentiation and matrix deposition were obtained for physiologic loading, as 
evidenced by gene expression of aggrecan, collagen type II and sox-9, metachromatic staining 
of cartilage ECM and immunolocalization of collagens. We thus propose that both HNC and 
hASC detect and respond to physical forces, thus resembling joint loading, by enhancing 
cartilage tissue development in a frequency- and amplitude-dependant manner. 
 
1. INTRODUCTION 
Hydrostatic pressure has long been considered a variable influencing chondrocyte activity, 
since 1985 when Lippiello and co-workers [1] firstly evaluated the in vitro metabolic response of 
articular cartilage (AC) explants (both bovine and human) to different levels of hydrostatic 
pressure – 75 to 375 psi (0.5 - 2.5 MPa). Data suggested that AC chondrocytes have the 
capacity to rapidly and differentially transform mechanical signals derived from application of 
HP into metabolic events, which are also determined by the magnitude of the applied force [1].  
With the emerging of Tissue Engineering as an independent research field, and the 
understanding that chondrocytes are mechanically sensitive cells [2, 3], great efforts have been 
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made to comprehend how hydrostatic pressure and other mechanical stimuli relevant for 
articular cartilage, such as compression [4-7] and shear [8-12], may improve the development 
of cartilage tissue in vitro. In vivo, articular cartilage is exposed to a wide range of static and 
dynamic mechanical loads, ranging amplitudes of about 5–6 MPa for gait, and as high as 18 
MPa for other movements such as running or jumping [13, 14]. In accordance to the biphasic 
model of cartilage [15], the solid components of the extracellular matrix support shear stress, 
while the incompressible interstitial water is responsible for withstanding compressive loading, 
by driving out of the tissue. In view of this, 95% of overall applied joint load is supported by 
interstitial fluid pressurization, so hydrostatic pressure is the prevailing mechanical signal 
governing normal articular cartilage homeostasis [2, 16]. Most studies [17-27] have focused on 
the effects of hydrostatic pressure stimuli on chondrocyte-mediated synthesis and degradation 
of cartilage matrix macromolecules, such as proteoglycans, collagens, non-collagenous 
proteins and glycoproteins. Articular chondrocytes, usually from animal source, respond 
positively to pulsatile (0.0125–1 Hz) HP loadings ranging 0.3–5 MPa, by increasing 
glycosaminoglycan synthesis and deposition, as well as expression of healthy AC markers 
such as collagen type II, aggrecan and sox-9 transcription factor [17-19, 22, 23]. However, 
when high HP magnitudes are applied, in the order of 50 MPa, cell apoptosis is observed [21]. 
The same outcome was observed when culturing human osteoarthritic chondrocytes under 
physiologically normal pressure magnitudes (5 MPa) [20]. In our study, we consider two 
clinically relevant cell sources as potentially responsive to HP dynamic culturing: Human nasal 
chondrocytes (HNC) have demonstrated to respond to physical forces resembling joint loading 
[28], therefore this cell source was used as proof-of-principle. Nasal cartilage tissue is 
characterized as hyaline cartilage, containing differentiated chondrocytes which express the 
extracellular matrix molecules typical of articular cartilage [29, 30], and are responsive to 
physical forces resembling joint loading [28]. Nasal septum cartilage may be obtained under 
local anesthesia, through a procedure considered to be less invasive as compared to localized 
tissue harvesting from non-load-bearing areas of the joint. This last biopsy procedure is the one 
normally employed when treating articular cartilage lesions using cell-based therapies such as 
autologous chondrocyte implantation or matrix-induced chondrocyte implantation [31, 32]. We 
aim to understand whether HNC respond to hydrostatic pressure loading, and consequently 
improve in vitro cartilage tissue development. Furthermore, and considering a more challenging 
approach, adipose tissue derived stem cells (ASCs) appear to be a promising alternative cell 
source for cell based therapies [33-35], as well as for cartilage tissue regeneration [36-39] due 
to their excellent features. ASCs may be easily isolated from adipose tissue, proliferate quickly, 
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and their chondrogenic differentiation potential have been proven [40-42]. This known, we 
additionally hypothesize if hASC respond to biomechanical stimuli, particularly hydrostatic 
pressure, and if this could be employed to enhance and ameliorate cartilage tissue 
development in vitro, with the aim of reducing time-to-therapy, and ultimately increasing graft 
implantation success. To achieve these outcomes, two custom-designed bioreactors were 
developed allowing long term culturing, and control of loading parameters. In this study we 
evaluated the effects of loading amplitude (0.4 and 5 MPa) and frequency (pulsatile versus 
steady pressurization). Assays of the produced tissues evaluated the significance of these 
treatments on cartilage tissue development, as compared to a static culture condition (control 
condition).  
 
2. MATERIALS AND METHODS 
2.1. DEVELOPMENT OF HYDROSTATIC PRESSURE BIOREACTORS (HPB)  
Two original easy-to-use devices were developed in order to generate hydrostatic pressure 
forces, which uniformly load constructs in culture. The High Hydrostatic Pressure Bioreactor 
(HHPB) was designed to generate physiological amplitudes of hydrostatic pressure (up to 10 
MPa), and the Low Hydrostatic Pressure Bioreactor (LHPB) was projected to load culturing 
constructs with shorter HP amplitudes (up to 0.5 MPa). Both devices enclose particular key 
characteristics, such as: 
a) Possibility to perform long term culturing, up to several weeks; 
b) Culture of multiple 3D constructs within a high range of dimensions; 
c) Tunable loading parameters: pressure amplitudes may range 0 - 0.4 MPa (for LHPB) 
and 1.5 - 10 MPa (for HHPB); frequency may range between 0 - 1 Hz; 
d) Operation of devices inside standard biohazard hoods, and CO2 incubators at 37ºC, in 
complete sterile conditions; 
e) LHPB is disposable, composed by standard, off-the-shelf components, while HHPB is 
reusable, composed by sterilizable stainless steel components. 
 
2.1.1. HIGH-HPB 
The High-HPB system (Fig.1A and 1B) consists of a stainless steel device (15 cm diameter x 
18 cm height), composed of a culture chamber (CC), an air chamber (AC) and a piston. The air 
pressure driven piston creates hydrostatic pressure in the culture chamber, where constructs 
reside in culturing media. As filtered compressed house air enters the air chamber, piston is 
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pushed up. Ratio of AC and CC area is 15:1, so that 15x the applied pressure is generated in 
the upper CC. A pressure transducer (0-16 MPa, Swagelok, USA), with digital display is 
connected to the lid of the culture chamber providing real time pressure reading. Pulsatile 
pressurization is controlled by a Programmable Logic Controller unit (PLC – OMRON CPM1A-
30CDR-A-V1, Netherlands), and solenoid valve (Camozzi A331-1C2, Italy). When non-
pressurized, culture media is replenished through the culture chamber by a peristaltic pump 
(Ismatec, USA), from a standard 50 mL schott bottle, with an adapted air filter.  
 
2.1.2. LOW-HPB 
The Low-HPB system (Fig.1D and 1E) is composed by a 30 mL luer-lok polypropylene syringe 
(BD Biosciences), where the rubber piston is used as a physical division between the culture 
media and compressed air, used as mechanism of compression. An aluminum adapter is 
connected at the top of the syringe, together with a semi-rigid nylon tube (Legris) to conduct 
filtered compressed house air inside the chamber. At the bottom of the syringe, Pharmed BPT 
tubing (Masterflex, USA) is connected to allow gas exchange. PLC and solenoide valve used 
with HHPB allow controlled pulsatile pressurization of the culture media. Media is replenished 
through the Pharmed BPT tubing, using a syringe to avoid complex manipulation. 
 
 
Figure 1. Custom-designed hydrostatic pressure bioreactors. A) Schematic representation of High 
Hydrostatic Pressure Bioreactor (HHPB); B) Photograph of High Hydrostatic Pressure Bioreactor 
(HHPB); C) Schematic representation of HP forces applied to cell encapsulated gellan gum construct; 
D) Schematic representation of Low Hydrostatic Pressure Bioreactor (LHPB); E) Photograph of Low 
Hydrostatic Pressure Bioreactor (LHPB). 
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2.2. ISOLATION, EXPANSION AND CELL ENCAPSULATION IN GELLAN GUM HYDROGELS 
2.2.1. HUMAN NASAL CHONDROCYTES (HNC) 
A transphenoidal biopsy was collected from patients undergoing neurosurgery. All patients 
signed an informed consent document approved by the Ethical Committee of Hospital S. 
Marcos (Braga, Portugal). Nasal cartilage was dissected and digested with collagenase type II, 
according to a protocol described elsewhere [43]. Briefly, the tissue was washed with sterile 
PBS (Sigma P4417), diced into 2-3 mm thickness cubes, immersed in 20 mL trypsin-EDTA 
solution (Invitrogen 25300-062, USA) and incubated for 30 minutes at 37ºC in a rotator. 
Tripsin-EDTA solution was removed and 20 mL of collagenase type II (2 mg/mL, Sigma C6885, 
USA) was added and allowed to incubate for 15h at 37ºC in a rotator. The digested tissue was 
filtered and the cell suspension centrifuged at 1200 rpm for 8 minutes. The cell pellet was 
washed twice with PBS and cells counted with a hemocytometer using the viability stain trypan 
blue (Sigma). Chondrocytes were expanded with chondrogenic expansion medium composed 
by D-MEM high glucose (Sigma D5671), 1% non-essential amino-acids (1xMEM Invitrogen 
11140-035); 20 mM L-alanyl-L-glutamine (Sigma G8541); 1% antibiotic/antimicotic 100x 
(15240-062 Gibco, USA); 10 mM HEPES (Sigma H4034); 10% Fetal Bovine Serum (Biochrom, 
Germany, Heat inactivated 30 min., 57ºC), supplemented with basic fibroblast growth factor (b-
FGF) 10 ng/mL (Peprotek 100-18B, United Kingdom). Chondrocytes were expanded until 
passage 3 and detached from the culture flask with trypsin-EDTA Solution (Invitrogen 25300-
062).  
 
2.2.2. HUMAN ADIPOSE DERIVED STEM CELLS (HASCS) 
hASCs were isolated according to previously described methods [44] from liposuction aspirates 
of subcutaneous adipose tissue (AT), donated with written consent by patients undergoing 
elective liposurgery. Briefly, AT was washed with PBS (1:1 v/v), centrifuged 200g for 5 minutes 
at RT and infranatants discarded. 1 mL of collagenase solution 0.2 U/mL (Collagenase NB 4 
Standard grade, SERVA Electrophoresis, Cat. No. 17454) was added per gram of washed AT, 
shaked vigorously and incubated at 37ºC for 45 min in a water bath with agitation at 200 rpm. 
Digested AT was further centrifuged at 1200g, 3minutes, RT, supernatants discarded and the 
pellet (correspondent to the stromal vascular fraction - SVF) was plated in cell culture plates. 
Adhered cells (adipose stem cells – hASC) were further expanded to the third passage in high-
glucose Dulbecco’s modified Eagle’s medium (DMEM) (GIBCO 11965) supplemented with 
10% fetal bovine serum (FBS) (GIBCO 26140), penicillin–streptomycin (1%) (GIBCO 15140) 
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and 1 ng/mL basic fibroblast growth factor (bFGF) (Peprotech 100-18B). p0 cells were 
examined for surface marker expression using flow cytometry. The presence of specific 
antigens such as CD105, CD45, CD34, CD73 and CD90 were analyzed, as previously 
published [44, 45]. hASCs were tested for their differentiation capacity into the osteogenic, 
chondrogenic and adipogenic lineages.  
 
2.3. CELL ENCAPSULATION IN GELLAN GUM HYDROGELS 
Gellan gum (GG) is a water-soluble gelling agent commonly used in food and pharmaceutical 
industry, due to its processing into transparent gels resistant to heat and acid stress. The 
thickness and hardness of the GG is determined by acetyl groups present: with acetyl groups, 
the gel is soft and elastic; without acetyl groups, firmer gels are obtained [46]. Both form 
thermo-reversible gels with different mechanical properties in the presence of metallic ions and 
upon temperature decrease. Once GG presents a thermo-sensitive behavior [47-49], with 
gelation close to body temperature, its application as an injectable formulation, for repair of 
cartilage defects, is promising [50-53].  
Gellan gum hydrogel was produced according to the procedure described by Oliveira JT, Reis 
RL et al (2009)[50, 54]. Briefly, powdered gellan gum (GelzanTM Sigma G1910) was dissolved 
in distilled water into a 1.5% solution, and heated up to 90ºC. Temperature was subsequently 
decreased down to 37-40ºC, for cell encapsulation at a final concentration of 10x106 cells/mL. 
Cylindrical discs were made with a mould and phosphate buffer saline (PBS) (Sigma P4417) 
was used as a cross-linking agent to stabilize the hydrogel structure.  
 
2.4. BIOREACTOR CULTIVATION OF TISSUE CONSTRUCTS 
2.4.1. HNC STUDY 
The experimental design is outlined in Figure 2. Human nasal chondrocytes encapsulated in 
gellan gum hydrogel (HNC-GG) were cultured up to 3 weeks in three conditions (Fig.2A and 
2B): 1) Pulsatile Hydrostatic Pressure (PHP) – culture medium pressurized between 0.1 MPa 
and 0.4 MPa, at a frequency of 0.1 Hz, 3 hours/day, 5 days/week; 2) Steady Hydrostatic 
Pressure (SHP) – culture medium pressurized at 0.4 MPa for 3 hours/day, 5 days/week; 3) 
Static culturing (Static) - Constructs were cultured at atmospheric pressure conditions (0.1 
MPa) during the total culturing period. Equal individual devices were used for each culturing 
regime.  
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Figure 2. Hydrostatic Pressure (HP) profiles applied to constructs. HNC study: A) HP profile 
applied along 3 weeks of culture (SHP – Steady Hydrostatic Pressure; PHP – Pulsatile Hydrostatic 
Pressure); B) Daily HP profile applied to constructs. hASC study: C) HP profile applied along 4 weeks 
of culture; D) Daily HP profile applied to constructs.  
 
2.4.2. HASC STUDY 
Human adipose stem cells (hASC) encapsulated in gellan gum hydrogel (hASC-GG) were 
cultured up to 4 weeks in three conditions (Fig.2C and 2D): 1) High Hydrostatic Pressure (5 
MPa) - culture medium pressurized between 0.5 MPa and 5 MPa, at a frequency of 0.5 Hz, 4 
hours/day, 5 days/week; 2) Low Hydrostatic Pressure (0.4 MPa) - culture medium pressurized 
at 0.4 MPa, at a frequency of 0.5 Hz, 4 hours/day, 5 days/week; Static culturing (Static) - 
constructs were cultured at atmospheric pressure conditions during the total culturing period. 
 
2.5. CELL VIABILITY AND PROLIFERATION ASSESSMENT 
Cell viability was evaluated by a LIVE/DEAD assay. Live cells (indicated by calcein AM, 
Invitrogen C3099) and dead cells (indicated by propidium iodide, Alfagene P1304MP, Portugal) 
were imaged through a Zeiss Axioimage (RZ1M) florescence microscope (Germany). Cell 
metabolic activity was assessed through MTS (3-(4,5-dimethylthiazol-2-yl)-5(3-
Chapter IV – Dynamic culturing of cartilage tissue: the significance of hydrostatic pressure 
 
	  138	  
carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-tetrazolium) assay (VWR G3580). Constructs were 
washed in PBS and incubated with MTS solution at 37ºC for 3h, after which 100 µL were 
transferred to a 96-well plate for optical density (OD) measurement at 490 nm. OD is directly 
proportional to the cellular activity, being a measure of mitochondrial activity. 
 
2.6. BIOCHEMICAL CHARACTERIZATION 
Constructs were harvested, washed in PBS, cut in half and weighed. For DNA assay, one-half 
was added to 1 mL of proteinase K digestion buffer (10 mM Tris, 1 mM EDTA, 0.1% Triton X-
100, 0.1 mg/mL proteinase K) and incubated overnight at 56ºC for digestion. After 
centrifugation at 3000g, 10 minutes, the supernatants were removed, diluted, pippeted in 
duplicate into a 96-well plate and 1:1 ratio of picogreen solution (Quant-iTTM PicoGreen ® 
dsDNA Kit, Invitrogen) was added. Sample fluorescence was measured with fluorescent plate 
reader at excitation ~480 nm, emission ~520 nm. Lambda DNA was used to prepare the 
standard curve. For glycosaminoglycan (GAG) quantification, one-half of constructs was added 
to 1 mL of papain digestion buffer (100 mM Sodium Phosphate Buffer, 10 mM Na2EDTA, 1.5 
mg/mL L-cysteine hydrochloride, 0.125 mg/mL papain) and incubated overnight at 60ºC for 
digestion. After centrifugation at 10000g, 5 minutes, 10 µL of supernatant was removed, 
pippeted in duplicate into a 96-well plate and 250 µL of DMB solution (Dimethylmethylene 
blue) was added. Sample absorbance was measured with microplate reader at OD 530 nm. 
Chondroitin 6-sulfate C sodium salt was used to prepare the standard curve.  
 
2.7. HISTOLOGY AND IMMUNOHISTOCHEMISTRY 
10% formalin was used to fix samples for 1 day, and further dehydrated with graded ethanol 
washes. Samples were embedded in paraffin, sectioned to 5 µm and mounted on glass slides. 
To proceed to distinct stainings, sections were deparaffinized with Clearite and rehydrated with 
a graded series of ethanol washes.  
Safranin O and Alcian Blue staining were performed to detect articular cartilage extracellular 
matrix components, such as mucopolysaccharides and glycosaminoglycans, respectively. 
Briefly, safranin O stain was performed by staining with Weigert’s iron hematoxylin, 10 min 
followed by running in tap water for 10 min. Slides were then immersing in 0.02% fast green 
solution during 5 min and rinsed 10-15 sec in 1% acetic acid. Finally, samples were stained 
with 0.1% safranin O solution for 5 min. Regarding alcian blue staining, slides were immersed 
30 min in 0.01 g/mL alcian blue solution, and washed in running tap water for 2 min. A 
Chapter IV – Dynamic culturing of cartilage tissue: the significance of hydrostatic pressure 
 
	   139	  
counterstain with nuclear fast red was performed for 5 min. Upon stainings, sections were 
washed in running tap water, dehydrated with a graded series of ethanol, cleared with Clearite 
and mounted with resinous mounting media. 
For immunohistochemistry sections were blocked with normal horse serum (NHS), stained 
sequentially with primary antibody (rabbit anti-human collagen type II polyclonal antibody, 
abcam ab34712 and rabbit anti-human collagen type I polyclonal antibody, abcam ab292; NHS 
for negative control), secondary antibody (Vectastain Universal Elite ABC Kit, PK-6200 Vector 
Laboratories) and developed with biotin-avidin system (DAB substrate kit SK-4100 Vector 
Laboratories).  
 
2.8. QUANTITATIVE REAL TIME RT-PCR (QRT-PCR) 
For RNA extraction, constructs were added to 800 µL of Trizol (Invitrogen 15596-026) and 
disintegrated by mortar and pestle. Suspensions were centrifuged at 12,000 g for 10 min at 
4°C to remove tissue debris and extracted with chloroform (JMGS C/4960/17). Colorless 
aqueous phase, containing RNA was removed and mixed with equal volume of isopropanol 
(Laborspirit 33539). Suspensions were again centrifuged at 12,000 g for 8 min at 4°C, 
supernatant discarded, and RNA pellet washed with 75% ethanol. Samples were centrifuged at 
7,500 g for 5 min at 4°C, supernatant removed, pellet air-dried, and dissolved with RNAase-
free water (Invitrogen 10977035). RNA was quantified using Nanodrop® ND‐1000. 
Approximately 1 µg of RNA was reversely transcribed with random hexameres using qScriptTM 
cDNA Synthesis Kit (Quanta Biosciences 95047). Collagen type II, aggrecan, Sox-9 and the 
housekeeping gene glyceraldehyde-3-phosphatedehydrogenase (GAPDH) expression were 
quantified using PerfeCTaTM SYBR® Green FastMixTM (Quanta Biosciences 95072, 
Gaithersburg, MD, USA) and the Mastercycler ep realplex4 (Eppendorf, Hauppauge, NY, USA). 
Primer sequences and amplicon size are described on Table I. The expression data were 
normalized to GAPDH and presented as average values for each group (n=3 ± SD). 
 
Table I. Primers used for qRT-PCR  
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2.9. STATISTICAL ANALYSIS 
Data are presented as average (n=3) ± standard deviation. Statistical significance was 
determined using analysis of variance (ANOVA) followed by Tukey’s HSD (honestly significant 
difference) test using Prism software (Prism 4.0c, GraphPad Software Inc., San Diego, CA, 
USA).  
 
3. RESULTS 
3.1. CELL PROLIFERATION AND VIABILITY 
Human Nasal Chondrocyte (HNC) metabolic activity was quantified by the reduction of MTS 
reagent at the beginning and end of culture (Fig. 3A). No significant differences were obtained 
from day 1 to week 3 of culture, or among experimental groups. Live/Dead imaging of HNC 
encapsulated in gellan gum hydrogels corroborate with MTS data, as green viable cells are 
visualized by fluorescence microscopy. 
DNA contents of human adipose stem cells (hASC) encapsulated in gellan gum hydrogels, was 
quantified at beginning and end of culture. hASC cultured in static conditions proliferated more 
than those cultured in 5 MPa HP (p<0.05) and was the only group that significantly increased 
cell number relatively to beginning of culture (p<0.01). Live/Dead viability assay allowed the 
observation, by fluorescence microscopy, of green viable cells which enzymatically converted 
nonfluorescent cell-permeant calcein AM into the intensely fluorescent calcein (Fig. 3B).  
 
 
Figure 3. Cell viability and proliferation assessment. A) HNC study Top: Cell metabolic activity 
evaluated by MTS reduction. Horizontal line indicates day 1 values. n=3, no statistically significant 
differences between groups. Bottom) Live/Dead imaging of constructs after 3 weeks of culture. Scale 
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bar = 50 µm. B) hASC study Top: Cell proliferation evaluated by DNA concentration. Horizontal line 
indicates day 1 values. n=3, *p<0.05; **p<0.01 to day 1. Bottom) Live/Dead imaging of constructs after 
4 weeks of culture. Scale bar = 50 µm. 
 
3.2. CARTILAGE TISSUE DEVELOPMENT 
3.2.1.  HNC STUDY 
Cartilage tissue developed by HNC-GG cultured under 0.4 MPa pulsatile or steady hydrostatic 
pressure was evaluated after 3 weeks, and compared with static culturing. Cartilage 
extracellular matrix components, namely collagen type II (Col II) and glycosaminoglycans 
(GAGs) were localized in cross-sections of constructs (Fig. 4). Safranin O and Alcian Blue 
stainings reveal the presence of negatively charged glycosaminoglycans (GAGs) in cultured 
constructs. 
 
Figure 4. HNC study: Cartilage development evaluation after 3 weeks of culture. 1st & 2nd row) 
Histological stainings of cartilage extracellular matrix, namely Glycosaminoglycans (by Safranin O and 
Alcian Blue); 3rd & 4th row) Immunohistochemical localization of Collagen type II and Collagen type I. 
Scale bar = 100 µm. PHP – Pulsatile Hydrostatic Pressure; SHP – Steady Hydrostatic Pressure. 	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We observed that pulsatile hydrostatic pressure (PHP) induced a great increase in GAG 
deposition as shown by intense Safranin O staining and higher Alcian Blue staining, as 
compared to constructs cultured under steady hydrostatic pressure (SHP), or under static 
culturing conditions. Also, deposition of collagen type II, the major component of articular 
cartilage, was increased in the PHP group, while the least deposition was observed for the 
SHP group. Collagen type I, was not detected in any of the experimental groups, which is a 
positive marker of development of healthy articular cartilage (Fig.4). Gene expression profile 
corroborate with these observations (Fig.5). Collagen type II relative gene expression was 
over-expressed in cells cultured under PHP conditions, significantly different (p<0.05) than 
SHP or Static groups. Sox-9 gene expression, an important transcription factor in 
chondrogenesis, was also up-regulated in the PHP group, statistically different than SHP and 
Static groups. Among these, SHP culturing did not improve either Collagen type II nor Sox-9 
relative gene expression over Static culturing. Aggrecan gene expression, though, was 
significantly inferior (p<0.05) in cells cultured under SHP as compared to Static conditions. 	  
 
Figure 5. HNC study: Relative gene expression obtained after culture. Collagen II, aggrecan and 
sox-9 gene expression relative to GAPDH. n = 3, *p<0.05. PHP – Pulsatile Hydrostatic Pressure; SHP – 
Steady Hydrostatic Pressure. 
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3.2.2.  HASC STUDY 
Safranin O and Alcian Blue stainings were performed to detect glycosaminoglycans (GAGs) in 
hASC-GG constructs cultured under high (5 MPa) or low (0.4 MPa) pulsatile hydrostatic 
pressure (PHP), and compared to static culture conditions (Fig.6). Both dyes stained intensely 
the glycosaminoglycans present in constructs cultured under 5 MPa of PHP. Moreover, it was 
evident the presence of cells in lacunae, characteristic of articular cartilage tissue. Less stain 
intensity was observed for constructs cultured under 0.4 MPa of PHP in comparison to 5 MPa 
group, yet higher than the one observed for constructs cultured under static conditions. The 
same trend was observed for immunolocalization of collagen type II (Fig.6): higher deposition 
of this articular cartilage protein was observed in constructs of group 5 MPa, relatively to 
constructs of 0.4 MPa group, which per se, demonstrated higher collagen II deposition than 
constructs that were not mechanically stimulated (Static group).  
 
 
Figure 6. hASC study: Cartilage development evaluation after 4 weeks of culture. 1st & 2nd row) 
Histological stainings of cartilage extracellular matrix, namely Glycosaminoglycans (by Safranin O and 
Alcian Blue); 3rd & 4th row) Immunohistochemical localization of Collagen type II and Collagen type I. 
Scale bar = 100 µm.  
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Regarding collagen type I, the opposite trend was observed: constructs of Static group 
demonstrated deposition of this protein to a higher extent than constructs cultured under low 
PHP (0.4 MPa group). Constructs of 5 MPa group demonstrated the smaller deposition of 
collagen type I. The increased deposition of Collagen type II and low deposition of Collagen 
type I are indicative of the development of mature and healthy articular cartilage. The relative 
expression of genes encoding for major articular cartilage extracellular matrix components, 
such as collagen II and aggrecan, were determined by qRT-PCR and found to be consistent 
with histology staining (Fig.7). Aggrecan relative gene expression (GE) of cells exposed to 5 
MPa PHP was significantly higher (p<0.05) than GE quantified for both 0.4 MPa and Static 
groups. Regarding collagen type II, the highest expression was obtained for cells exposed to 
0.4 MPa, which was found to be significantly different from GE quantified for both 5 MPa and 
Static groups. Regarding gene expression of Sox-9 transcription factor, no significant 
differences were detected between culturing groups. The extracellular matrix components were 
also directly quantified by biochemical assays. The amount of quantified glycosaminoglycans in 
the constructs was superior for the 5 MPa group, and found to be significantly different 
(p<0.05) than those observed for static culturing (Fig.8). 
 
Figure 7. hASC study: Relative gene expression obtained after culture. Collagen II, aggrecan and 
sox-9 gene expression relative to GAPDH. n = 3, * p<0.05. 
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Figure 8. hASC study: Glycosaminoglycan quantification obtained after 4 weeks of culture. n = 3, 
*p<0.05.  
 
4. DISCUSSION  
Dynamic culturing has long been adopted [55-57] as a strategy to improve the development of 
cartilage tissue in vitro as opposed to standard static culturing techniques. We understand 
dynamic culturing, as the use of biomechanical stimuli that are relevant to the tissue being 
engineered. Articular cartilage tissue in joints such as the hip or the knee, is subjected to 
intermittent cyclic stress that can either be compressive or shear [2]. However, major joint load 
is supported by interstitial fluid pressurization [3, 58]. Hydrostatic pressure is so essential for 
cartilage homeostasis that joint immobilization or decreased loading results in cartilage thinning 
[59, 60]. Hydrostatic pressure is a fundamental mechanical stimulus governing the normal 
functioning of articular cartilage, which has justified its broad exploitation in our study. Two 
custom bioreactor systems were developed, being capable of generating and applying this 
mechanical stimulation to 3D tissue engineering constructs (Fig.1). These systems are novel 
and distinguish themselves from other systems described in the literature by several features, 
namely: a) the possibility to long term culture and stimulate cell-encapsulated / cell-seeded 
constructs in the same device up to 4 weeks (maximum evaluated). Other studies have 
explored HP pressurization for shorter periods, such as a few hours (1, 4 or 24h) [19-21, 23, 
24, 27], or up to two weeks [18, 22, 25, 26]. Carver et al 1999 [17], and lately, Gunja and co-
workers 2010 [61], cultured constructs up to 5 and 4 weeks respectively although requiring 
higher technical complexity. Our devices are user-friendly, and can be operated inside 
standard hoods and incubators during complete experimental periods, which is a feature not 
commonly observed in other studies [19, 21, 23, 24, 26, 27, 61].  
In order to validate the purpose of using hydrostatic pressure to improve cartilage tissue 
development in vivo, we performed a preliminary study, using healthy chondrocytes from 
hyaline cartilage source (nasal septum cartilage). Nasal septum was chosen as alternative 
model of healthy articular cartilage as HNC have proven to respond to mechanical stimulation 
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[28]. In our study, very positive outcomes were obtained, even under low level of hydrostatic 
pressure (0.4 MPa). This finding supported the subsequent study using human adipose derived 
stem cells (hASCs). Our major aim was to understand if hASCs respond positively to this 
mechanical stimulation and develops cartilage tissue with increased properties than those 
obtained under standard culturing conditions, for similar culturing periods. Furthermore, we 
questioned if higher level of HP within the physiological range found in human joints (5–6 MPa 
for gait) [13, 14], would improve cartilage formation. In both studies, gellan gum hydrogel [50] 
was used for cell encapsulation due to its proven performance on supporting cartilage tissue 
development in vitro [50, 51] and in vivo [53] with chondrocytes and adipose stem cells[53].  
For both studies, cell viability was assessed. We observed that hydrostatic pressure amplitudes 
of 0.4 MPa under both pulsatile and steady state regimes were not deleterious for human nasal 
chondrocytes, as no significant differences were obtained as compared to static conditions 
(Fig.3A). Furthermore, for the hASC study, DNA content for all groups measured at the end of 
culture was superior than the initial, which demonstrated that both 0.4 and 5 MPa pulsatile 
loading regimes were not harmful to cells (Fig.3B). Though, only hASC cultured under static 
conditions proliferated (p<0.01 to day 1 values), indicating that lack of HP allowed higher cell 
division in detriment of chondrogenic differentiation stimulation. 
Hydrostatic pressure culturing induced chondrogenic matrix deposition. In the HNC study, more 
than questioning if HP would improve cartilage tissue development by these cells, we 
questioned whether pulsatile or steady loading would provide increased tissue formation. 
Therefore, HNC-GG were cultured under 0.1 Hz or 0 Hz, 0.4 MPa HP loading. Higher 
extracellular matrix production and deposition, identified by increased GAG staining by 
Safranin O and Alcian Blue, as well as Collagen type II immunolocalization was obtained for 
pulsatile culturing (PHP group). Moreover, steady HP culturing (SHP group) seemed to 
suppress any chondrogenic development, once very low histological detection and gene 
expression was obtained for this group, even lower than for static culturing (Fig.4 and 5). To 
our knowledge, HNC response to HP mechanical stimulation has not been yet fully explored. In 
the context of mechanical stimulation, Candrian and colleagues [28] evaluated HNC response 
to distinct compression loading regimens, and observed that these expressed collagen II, 
aggrecan and hyaluronan to different extents as response to those specific regimes. Bouchet 
et al [62] cultured HNC in spinner flasks, demonstrating that this stimulation improved aggrecan 
and collagen type II gene expression and deposition on CellagenTM beads. Although we have 
used HNC as a cell model, we also recognize its interest as a possible heterologous approach 
for the treatment of cartilage focal lesions. In fact, the use of HNC 1) avoids the need of biopsy 
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harvesting of hyaline cartilage from non-bearing articular sites; and 2) allows good cell 
response to mechanical stimuli that are physiological relevant, anticipating a good adaptation 
of the engineered tissue to the implantation site environment. From this preliminary study, we 
conclude that: 1) HNC respond to hydrostatic pressure mechanical stimulation by increasing 
cartilage formation outcome as compared to engineered constructs cultured under static 
conditions; 2) Pulsatile HP stimulated HNC to secrete cartilaginous ECM, while SHP appears 
to suppress cartilage development. Therefore, pulsatile hydrostatic pressure at 0.4 MPa was 
chosen to stimulate hASC in gellan gum hydrogels towards chondrogenic differentiation and 
hyaline cartilage tissue formation. Herein, more than hypothesizing the ability of hASC to sense 
and respond to pulsatile HP mechanical stimulation at 0.4 MPa, by increasing chondrogenic 
differentiation and improving cartilage tissue development, we also questioned the influence of 
physiologic levels of HP (5 MPa) on the magnitude of these outcomes. Both hypotheses were 
proven. Data shown demonstrates increased aggrecan gene expression, intense GAG staining 
and correspondent increased GAG quantification for the 5 MPa group, relatively to both 0.4 
MPa and Static groups (Fig. 6, 7 and 8). Moreover, same outputs were found greater for 0.4 
MPa group as compared to Static group, indicating an amplitude-related response of hASC to 
HP, since cartilage related outputs were found to vary proportionally to the HP magnitude: 5 
MPa > 0.4 MPa > Static. Our results are additive to those obtained by Ogawa and co-workers 
[39], which remains, to our knowledge, the only study that previously explored the response of 
hASC to HP. In this work, hASC were exposed to pulsatile low HP (0.5 MPa) for 1 week, 
followed by 3 weeks of static culturing, and evidenced increased collagen II, aggrecan and sox-
9 gene expression and ECM staining in the pressurized group, as compared to the static 
group. We suggest that physiologic levels of HP (10x higher), and longer loading periods 
provide a more mature tissue, which is better adapted to the environment found in vivo. Given 
this, we conclude that 1) hASC sense and respond to pulsatile hydrostatic pressure stimulation 
at both low (0.4 MPa) and physiologic (5 MPa) pressure amplitudes; 2) Physiologic HP 
amplitudes promoted a higher and better tissue matrix distribution, which resembles native 
articular cartilage.  
 
5.  CONCLUSIONS 
By aiming the improvement of in vitro engineering of cartilage tissue, two custom-made 
bioreactor systems were developed, being capable of generating and applying, in a controlled 
manner, hydrostatic pressure (HP) as biomechanical stimuli - at high and low magnitudes - to 
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3D tissue engineering constructs. In addition, HNC and hASC were encapsulated in gellan gum 
hydrogels (ASC-GG), and cultured under several HP regimens in order to evaluate 
cartilaginous tissue formation. We observed that HNC enhance secretion of cartilaginous ECM 
when cultured under pulsatile low HP, while same levels of HP (0.4 MPa) applied continuously 
inhibit ECM secretion. Moreover, hASC cultured under same pulsatile low HP (0.4 MPa) 
secrete less chondrogenic ECM than under pulsatile physiologic levels of HP (5 MPa). We 
conclude that hASC not only sense and respond to HP loading, but also respond in different 
proportions in accordance to magnitude of loading applied. Further experimental studies are 
needed to understand the mechanotransduction mechanisms occurring that lead to the 
observed cell response. 
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CHAPTER V 
Development of silk-based scaffolds for tissue engineering of bone from human 
adipose derived stem cells 
 
This chapter is based on the following publication: Correia C, Bhumiratana S, Yan LP, Oliveira AL, 
Gimble JM, Rockwood D, Kaplan DL, Sousa RA, Reis RL, Vunjak-Novakovic G, 2011, Development of 
silk-based scaffolds for tissue engineering of bone from human adipose derived stem cells - submitted. 
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Abstract  
Silk fibroin is a potent alternative to other biodegradable biopolymers for bone tissue 
engineering, because of its tunable architecture and mechanical properties, and demonstrated 
ability to support bone formation, in vitro and in vivo. In this study, we investigated a range of 
silk scaffolds for bone tissue engineering using human adipose-derived stem cells (hASCs), an 
attractive cell source for engineering autologous bone grafts. Our goal was to understand the 
effects of scaffold architecture and biomechanics and to use this information to optimize silk 
scaffolds for bone tissue engineering applications. Silk scaffolds were fabricated using different 
solvents (aqueous vs. hexafluoro-2-propanol - HFIP), pore sizes (250-500µm vs. 500-1000µm) 
and structures (lamellar vs. spherical pores). Four types of silk scaffolds combining the 
properties of interest were systematically compared with respect to bone tissue outcomes with 
decellularized trabecular bone included as a “gold standard”. The scaffolds were seeded with 
hASC and cultured for 7 weeks. The porous HFIP silk scaffold with 400-600 µm pores 
performed better than any other scaffold, while the lamellar scaffolds performed better than 
spherical-pore scaffolds. Based on the collected data, we propose a conceptual model 
describing the effects of silk scaffold design on bone tissue formation. 
 
1. INTRODUCTION  
Numerous approaches have been made towards development of an “ideal” scaffold for bone 
tissue engineering[1, 2]. Silk fibroin, obtained from silk-worms, demonstrates great 
biocompatibility along with outstanding mechanical properties [3] and proteolytic degradation 
[4]. In tissue engineering, silk fibroin has been extensively used for multiple types of scaffolds 
[5-8]. Various modifications of silk scaffolds have been fabricated with a wide range of 
chemical, structural and biomechanical modifications [6, 9, 10]. Silk sponges have been used 
for cartilage [11-13], fat [14, 15], silk tubes for blood vessels [16] and silk fibers for ligaments 
[17, 18]. Porous sponge scaffolds were suitable for bone tissue formation, by enhancing cell 
attachment, proliferation and migration. In addition, the high porosity (92-98%)[19-21] facilitates 
nutrient and waste transport into and out of the scaffolds.  
Porous silk sponges can be fabricated using porogens, gas foaming, or lyophilization methods 
[22, 23]. Among these, NaCl salt leaching is among the simplest and most effective fabrication 
methods, resulting in scaffolds with spherical-shaped pores and different morphologies. Silk 
scaffolds are generally fabricated using two different silk preparation methods: aqueous- and 
solvent (HFIP)-based. HFIP does not solubilize salt particles, therefore pore sizes in these 
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sponges reflect the size of the porogen used in the process [22, 23]. On the other hand, 
aqueous-based silk sponges demonstrate pore sizes 10-20% smaller than the size of salt 
crystals. This is due to partial solubilization of the surface of the salt particles during 
supersaturation of the silk solution before solidification [3, 24]. This partial solubilization results 
in rougher surfaces of the pores, which improved cell attachment [22, 25]. For comparison, 
aqueous-based processing results in sponges with higher porosity [22, 25], and higher 
degradation rates [22, 25].  
Besides silk sponges with spherical-shaped pores, our laboratory developed a novel silk 
scaffold fabrication method to produce lamellar-like structure using a freeze drying technique 
[26]. This structure mimics bone lamellae structure. Human bone marrow mesenchymal stem 
cells, cultured on osteogenic media, attached, proliferated and assembled new extracellular 
matrix on this patterned structure [26].  
Tissue engineers have explored silk scaffolds for bone regeneration by using bone marrow 
mesenchymal stem cells (BM-MSC) as the preferred cell source with superior outcomes 
validated with both aqueous-based [19, 26, 27] and HFIP-derived scaffolds [6, 21, 28]. Human 
adipose derived stromal/stem cells (hASCs), on the other hand, present features comparable 
to BM-MSC and are a promising alternative for cell based therapies [29] such as bone tissue 
regeneration. ASCs may be easily isolated from adipose tissue with a high yield of cells per 
unit tissue volume [30]. Furthermore, ASCs proliferate quickly, and their osteogenic potential is 
comparable to that of bone marrow mesenchymal stem cells [31]. Our research group has 
engineered half-centimeter–sized bone constructs in vitro by using human adipose-derived 
stem cells (hASCs) that were seeded in decellularized bone scaffolds and cultured dynamically 
in perfusion bioreactors [32]. 
Still, silk scaffold and hASCs are two potential components for bone tissue engineering 
applications, which have not been yet investigated in combination. In this study, five different 
scaffolds were investigated: 1) aqueous, spherical-pore structure, small pores (250-500 µm), 
and 2) aqueous, spherical-pore structure, large pores (500-1000 µm); 3) aqueous, lamellar 
structure, 4) HFIP, medium pore sizes (400-600 µm), and 5) decellularized bovine trabecular 
bone used as a “gold standard”, to evaluate hASCs osteogenic responses and bone tissue 
development. 
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2. MATERIALS AND METHODS 
2.1. PREPARATION OF SILK FIBROIN SCAFFOLDS 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. Silk 
scaffolds were prepared according to Figure 1. Silk fibroin from silkworm (Bombix mori) 
cocoons was extracted with 0.02 M sodium carbonate (Na2CO3) solution, rinsed in distilled 
water, dissolved in a 9.3 M lithium bromide (LiBr) solution and dialyzed for 48h against distilled 
water in benzoylated dialysis tubing (Sigma D7884). Dissolved silk fibroin was centrifuged for 
20 min at 9000 rpm (4oC). The resulting solution was determined by weighing the remaining 
solid after drying, yielding a 6-wt % aqueous silk fibroin solution. 
Aqueous-derived silk fibroin porous sponges were prepared by salt leaching methods. NaCl 
salt was sieved with metal mesh to obtain particle size distributions between 250–500 µm (Aq-
250), or 500–1000 µm (Aq-500), and added into silk fibroin aqueous solution at a 2:1 (w/v) 
ratio, in disk-shaped containers. The container was covered and left at room temperature. After 
24h, the container was immersed in water to extract NaCl salt for 2 days with water changes.  
Aqueous-derived silk fibroin lamellar scaffolds (Aq-Lam) were prepared by pouring silk fibroin 
aqueous solution into silicon tubing (6 mm i.d.), frozen at -80ºC, lyophilized for 1 day, and 
autoclaved to induce the formation of β-sheet structure and insolubility in aqueous solution. 
HFIP-derived silk fibroin scaffolds (HFIP-400) were prepared as previously described [25]. Silk 
fibroin aqueous solution was lyophilized and further dissolved with HFIP, resulting in a 17-wt % 
HFIP-derived silk fibroin solution. Granular NaCl particles (400–600 µm) were added to 2 mL of 
silk fibroin in HFIP at 2:1 (w/v) ratio. The containers were covered overnight to reduce 
evaporation of HFIP and to provide sufficient time for homogeneous distribution of the solution. 
Subsequently, the solvent was evaporated at room temperature for 3 days. The matrices were 
then treated in 90% (v/v) methanol for 30 min, to induce the formation of the β-sheet structure, 
followed by immersion in water for 2 days to remove NaCl porogens. Porous silk scaffolds were 
then freeze-dried.  All scaffolds were cut and cored into cylinders of 4 mm in diameter and 2 
mm thickness. 
 
2.2. PREPARATION OF TRABECULAR BONE SCAFFOLDS 
Trabecular bone scaffolds were decellularized as in our studies [32, 33]. Trabecular bone 
cylinders (4 mm diameter) were cored from the subchondral region of carpometacarpal joints of 
bovine calves, and washed with a high velocity stream of water to remove bone marrow from 
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pore spaces. Scaffolds were further washed for 1h in phosphate-buffered saline (PBS) with 
0.1% ethylenediamine tetraacetic acid (EDTA) at room temperature (RT), followed by 
sequential washes in hypotonic buffer (10 mM Tris and 0.1% EDTA) overnight at 4o C, in 
detergent (10 mM Tris and 0.5% sodium dodecyl sulfate) for 24 h at RT, and in enzyme 
solution (100 U/mL DNAse, 1 U/mL RNAse, and 10 mM Tris) for 6 h at 37o C, to fully remove 
cellular material. Scaffolds were then rinsed in PBS, freeze-dried, and cut into 2 mm thick 
cylindrical plugs. The scaffolds within the density range of 0.28–0.38 mg/mm3 (calculated 
based on the dry weights and exact dimensions) were selected for experiments.  
 
 
 
Figure 1. Silk scaffold development. Silk fibroin is extracted from silk worm cocoons into an aqueous 
solution. Aqueous-based spherical pore scaffolds (Aq-250 and Aq-500) are produced by salt-leaching 
method, where small (250-500 µm) or large (500-1000 µm) NaCl particles are used as porogen. 
Aqueous-based lamellar scaffolds (Aq-Lam) are produced by lyophilizing the frozen aqueous silk 
solution cast in a silicon tube. HFIP-derived porous scaffolds (HFIP-400) are developed by dissolving 
the lyophilized aqueous silk solution in HFIP solvent, to which NaCl particles (400-600 µm) are added 
to form the porous structure. NaCl particles used in salt-leaching method are further dissolved in water. 
Bold text represent step where ß-sheet formation occur.  
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2.3. ISOLATION, CHARACTERIZATION AND EXPANSION OF HASCS  
hASCs were isolated according to previously described methods [34] from liposuction aspirates 
obtained from the Pennington Biomedical Research Center, under protocols approved by the 
Institutional Review Board. hASC were expanded to the fourth passage in high-glucose 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS), penicillin–streptomycin (1%), and 1 ng/mL basic fibroblast growth factor (bFGF).  
Passage zero (P0) cells were examined for surface marker expression using flow cytometry. 
The presence of specific antigens such as CD29, CD105, CD45, CD34, CD44, CD73 and 
CD90 were analyzed, as previously published [34, 35]. hASCs were confirmed for their 
differentiation capacity into the adipogenic and osteogenic lineages in monolayer cultures 
following induction with adipogenic and osteogenic inductive medium for up to 14 days and 
histochemical analysis of neutral lipid (Oil Red O) or mineralization (Alizarin Red) staining as 
published [36].   
 
2.4. CONSTRUCT SEEDING AND CULTURE 
All scaffolds were sterilized in 70% ethanol overnight, washed in PBS and incubated in culture 
medium prior to seeding. Expanded P4 hASCs were suspended in culture medium at 30x106 
cells/mL. A 20 µL aliquot of cell suspension was pipetted into blot-dried scaffolds, and pipetted 
up and down to ensure even distribution of cells. After 15 minutes in the incubator, scaffolds 
were rotated 180º, and 10 µL of cell-free medium was added to maintain hydration. This 
process was repeated four times, to achieve uniform cell distribution, after which, osteogenic 
media (low glucose DMEM, 10% FBS, 1% penicillin–streptomycin, 10 mM sodium-b-
glycerophosphate, 10 mM HEPES, 100 nM dexamethasone and 50 µg/mL ascorbic acid-2-
phosphate) was added and cultured for 7 weeks. 
 
2.5. LIVE/DEAD ASSAY 
LIVE/DEAD Viability/Citotoxicity kit (Molecular Probes, OR/USA) was used to evaluate cell 
viability. Live cells (indicated by calcein AM) and dead cells (indicated by ethidium homodimer-
1) were observed and imaged through a confocal microscope (Leica, Germany). Optical 
surfaces were taken from the surface up until 160 µm deep, with 10 µm intervals. All images 
are presented as vertical projections. 
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2.6. BIOCHEMICAL CHARACTERIZATION 
Constructs were harvested, washed in PBS, cut in half and weighed. For DNA assay, one-half 
was added to 1 mL of digestion buffer (10 mM Tris, 1 mM EDTA, 0.1% Triton X-100, 0.1 
mg/mL proteinase K) and incubated overnight at 56ºC for digestion. After centrifugation at 
3000g, during 10 minutes, the supernatants were removed, diluted, pippeted in duplicate into a 
96-well plate and 1:1 ratio (v/v) of Picogreen solution (Quant-iTTM PicoGreen ® dsDNA Kit, 
Invitrogen) was added. Sample fluorescence was measured with fluorescent plate reader at 
excitation of ~480 nm, emission of ~520 nm. Lambda DNA was used to prepare the standard 
curve. Based on previous studies [32], 5 pg DNA/cell was used as the conversion factor to 
determine the cell number. For calcium quantification, one-half of constructs were incubated in 
1 mL TCA 5% (trichloroacetic acid 5% v/v) and calcium was extracted by disintegrating the 
construct using steel balls and MinibeadBeaterTM (Biospec, Bartlesville, OK/USA). Calcium 
content and standard were quantified using StanbioTotal Calcium Liquicolor (Stanbio 
Laboratory/USA). Sample optical density was measured at 575 nm using a microplate reader. 
Alkaline Phosphatase (AP) activity was determined by adding cell lysis solution to one-half of 
each scaffold, and these were disintegrated using steel balls and MinibeadBeaterTM. After 
centrifugation, 50 µL of supernatant were incubated with 50 µL pNPP (p-nitrophenyl-
phosphate) substrate solution, at 37ºC for 20 min. The reaction was stopped with 50 µL of stop 
solution, and absorbance was read at 405 nm. p-Nitrophenol at known concentrations was 
used to prepare the standard curve. All solutions were components of SensoLyte pNPP 
Alkaline Phosphatase Complete Kit (Cell Biolabs, CBA-302).  
 
2.7. HISTOLOGY AND IMMUNOHISTOCHEMISTRY 
After harvest, the samples were fixed in 4% formaldyhyde solution for 1 day. Bone scaffolds 
were decalcified with immunocal solution (Decal Chemical, Tallman, NY) for 1 day, and further 
dehydrated with graded ethanol washes, concurrently with remaining silk constructs. Samples 
were embedded in paraffin, sectioned to 5-µm slices and mounted on glass slides. For 
staining, sections were deparaffinized with CitriSolv and rehydrated with a graded series of 
ethanol washes. Samples were stained using standard hematoxylin and eosin. 
Immunohistochemistry was performed on sections as follows: sections were blocked with 
normal horse serum (NHS), stained sequentially with primary antibody (rabbit anti-human 
Osteopontin (OPN) polyclonal antibody, Chemicon ab1870; rabbit anti-bone sialoprotein (BSP) 
polyclonal antibody, Millipore ab1854; mouse monoclonal to Collagen I, Abcam ab6308; NHS 
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for negative control), secondary antibody (Vectastain Universal Elite ABC Kit, PK-6200 Vector 
Laboratories) and developed with biotin-avidin system (DAB substrate kit SK-4100 Vector 
Laboratories).  
 
2.8. MICROCOMPUTED TOMOGRAPHY (µCT) ANALYSIS 
µCT was performed using the protocol described by Liu et al [37]. Samples were aligned in a 2 
mL screw-cap centrifuge tube, which was clamped in the specimen holder of a vivaCT40 
system (SCANCO Medical AG, Basserdorf, Switzerland). The 2 mm length of the scaffold was 
scanned at 21 µm isotropic resolution. A global thresholding technique, which only detects 
mineralized tissue, was applied to obtain the bone volume (BV) of samples.  
 
2.9. SCANNING ELECTRON MICROSCOPY (SEM) 
Samples were washed in PBS and then fixed in 2% glutaraldehyde in sodium cacodylate buffer 
for 2 h. Constructs were washed in buffer and freeze-dried overnight. The samples were 
coated with gold and palladium and imaged in SEM machine (JEOL, JAPAN).  
 
2.10. MECHANICAL TESTING 
Young’s modulus upon compression of constructs after culture was determined under 
unconfined compression in wet conditions using a modification of an established protocol [38]. 
An initial tare load of 0.2 N was applied and was followed by a stress-relaxation step where 
specimens were compressed at a ramp velocity of 1% per second up to 10% strain and 
maintained at the position for 1800 s. The Young’s modulus was obtained from the equilibrium 
forces measured at 10% strain. 
 
2.11. STATISTICAL ANALYSIS 
Data are presented as average (n=3) ± standard deviation. Statistical significance was 
determined using analysis of variance (ANOVA) followed by Tukey’s HSD (honestly significant 
difference) test using Prism software (Prism 4.0c, GraphPad Software Inc.).  
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3. RESULTS 
3.1. CHARACTERIZATION OF UNDIFFERENTIATED HASCS 
The immunophenotype of undifferentiated hASCs was evaluated using flow cytometry (Fig. 
2A). The antigen expression profile observed was consistent with our previous study [39]: 
expression of adhesion molecules integrin b1 (CD29) and endoglin (CD105), high expression 
of ecto 5’ nucleotidase (CD73) surface enzyme as well as extracellular matrix proteins such as 
Thy-1 (CD90) and glycoprotein CD34. Hyaluronate (CD44) receptor molecule was less 
expressed than expected, however, expression of hematopoietic marker CD45 was accordingly 
very low. Multilineage potential of hASCs was evaluated by cultivation of cell monolayers in 
adipogenic or osteogenic medium. The isolated hASCs exhibited multi lineage differentiation as 
shown with formation of Oil Red O staining lipid droplets (Fig. 2C) and Alizarin Red staining 
extracellular mineralization (Fig. 2D). 
 
 
Figure 2. Phenotypic characterization and evaluation of multipotency of human adipose stem 
cells. A) Percentage of antigen expression in primary hASCs, B) Toluidine blue staining of 
undifferentiated stromal cells, C) Oil red O staining for adipogenesis, D) Alizarin red staining for 
osteogenesis. 
 
3.2. CELL VIABILITY AND PROLIFERATION 
Cell seeding efficiency, calculated as a fraction of the initial cells detected in the scaffold after 
seeding, ranged from 60 to 75% in all five groups, without statistically significant differences 
(Fig. 3A).  DNA assay (Fig. 3B) demonstrated that, after two weeks of culture, proliferation 
occurred to the same extent (approximately 1.6-fold increase in cell numbers) in all spherical 
porous silk sponges, either aqueous or HFIP-based (Aq-250, Aq-500, HFIP-400). In contrast, 
the lamellar structure maintained the initial cell numbers throughout the culture period. In 
aqueous scaffolds, the cell numbers achieved by week 2 were maintained through week 7. In 
HFIP scaffold group, the cell number increased continuously. In the decellularized bone group, 
the cell numbers decreased at the end of culture period. Live/Dead assay confirmed cell 
viability and attachment throughout all scaffolds (Fig. 3C).  
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Figure 3. Cell viability and proliferation. A) Cell seeding efficiency. No significant differences were 
observed between groups. B) Cell proliferation evaluated by changes in the number of cells per 
scaffold. *p<0.05, **p<0.01, ***p<0.001; a p<0.05, b p<0.01, c p<0.001 to Aq-Lam; d p<0.05 to Aq-250 
and HFIP-400; e p<0.05 to Aq-500 and HFIP-400; C) Cell viability (Live/Dead assay) after 7 weeks of 
culture. Scale bar = 200 µm. 
 
Good distribution of cells at periphery and center of the constructs was observed through H&E 
staining in all groups (Fig. 4 top). Cells attached to scaffold surfaces, and filled the pore 
spaces. Rough pore surfaces were observed by H&E staining (Fig. 4 top) and SEM  (Fig. 4 
middle) in aqueous spherical-pore scaffolds in contrast to smooth pore surfaces in HFIP 
scaffolds. Matrix density appeared greater in aqueous porous scaffolds (Aq-250 and Aq-500) 
and the trabecular bone scaffold than in HFIP-derived scaffolds.  
 
3.3. BONE TISSUE DEVELOPMENT 
Distribution of bone tissue matrix was evaluated through immunolocalization of bone matrix 
proteins after 7 weeks of culture in osteogenic media. The expression of osteopontin (OPN), 
bone sialoprotein (BSP) and collagen type I (Col I) were similar in both small (Aq-250) and 
large (Aq-500) pore size aqueous silk sponges (Fig. 5).  These bone matrix markers were 
distributed throughout the decellularized bone scaffold. The most robust groups were the 
aqueous lamellar and HFIP-derived sponges, with high intensity of immunolocalization of OPN 
and BSP, and somewhat lower intensity of collagen type I. 
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Figure 4. Scaffold structure. Constructs were analyzed after seven weeks of culture. Top row: 
Hematoxylin & Eosin (H&E) staining, scale bar = 200 µm; Middle row: Scanning electron microscope 
(SEM) images 50x, scale bar = 500 µm. Bottom row: SEM images 400x, scale bar = 50 µm. 
 
 
Figure 5. Accumulation of bone matrix proteins in tissue constructs. Data are shown after 7 weeks 
of culture. Top row: Osteopontin (OPN); Middle row: Bone Sialoprotein (BSP); Bottom row: Collagen 
type I. Scale bar = 100 µm. 
 
3.4. QUANTIFICATION OF BONE DIFFERENTIATION PARAMETERS 
Alkaline phosphatase (AP) activity, an early marker of osteoblastic phenotype peaked after 2 
weeks of culture, as expected, at similar levels in all groups, except for the significantly higher 
expression in the Aq-Lam group (Fig. 6A). As an indicator of ECM maturation and calcification, 
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AP activity levels decreased by seven weeks of culture. The calcium deposition increased in 
parallel to the decrease in AP activity, between weeks 2 and 7, with significantly higher levels 
in HFIP and decellularized bone scaffolds than in other groups (Fig. 6B). Consistent with the 
biochemically measured calcium levels, the bone volume (BV) detected by µCT analysis was 
also higher is HFIP than aqueous scaffolds and the highest in the decellularized bone group 
(Fig 6C). Although not significantly different, HFIP-derived sponges (HFIP-400) demonstrated 
increased bone volume relative to aqueous-based groups. The equilibrium modulus of the 
constructs was also highest for the decellularized bone group, and higher for the HFIP than 
aqueous porous scaffolds (Fig. 6D). Interestingly, the aqueous-based silk fibroin lamellar 
structure (Aq-Lam) was 3x stiffer than the corresponding aqueous-based porous silk sponges 
(Aq-250 and Aq-500) (p<0.01). This is evidence of the importance of the scaffold architecture 
for the resulting mechanical properties of engineered tissue.  Furthermore, the mineralized 
tissue was better distributed in HFIP-400 group (Fig. 6E), where small spherical-like structures 
were observed, whereas in aqueous groups, mineral deposited less uniformly throughout the 
construct, forming plate-like structures. 
 
 
Figure 6. Biochemical and mechanical characterization of constructs. A) Alkaline phosphatase 
activity *p<0.001; a p<0.05, b p<0.01 to Aq-250; d p<0.05  to Aq-Lam; e p<0.05, f p<0.01, g p<0.001 to 
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Bone. B) Calcium change from day 1 measured at two and seven weeks of culture, *p<0.05, **p<0.01, 
***p<0.001; a p<0.05, b p<0.01 to Bone. C) Bone volume (BV) of constructs at week 7 # p<0.05 to 
Bone. D) Equilibrium modulus at week 7 *p<0.05, **p<0.01, ***p<0.001. E) µCT reconstruction images 
of constructs after 5 weeks of culture. Scale bar = 1 mm.  
 
4. DISCUSSION 
In this study, we investigated different types of silk-based scaffolds varying in fabricated 
composition, chemistry, and structure as a potential material of choice for bone tissue 
engineering applications [19, 26], with focus on hASCs as a cell source. Notably, the hASCs 
showed expression patterns of surface markers characteristic for mesenchymal stem cell 
(CD105+, CD73+, CD90+, CD45-, CD44-) (Fig. 2A) consistent with that of the BM-MSCs, which 
have been successfully used for engineering of bone [40]. The multi-lineage differentiation 
capability (adipogenic and osteogenic) was also verified and similar to that observed for BM-
MSCs (Fig. 2B-D). Our previous studies confirmed the maintenance of high expression of the 
surface markers for hASC stemness and differentiation capability over several passages [32]. 
Four different types of silk scaffolds were investigated. Aqueous-based silk fibroin sponges 
were produced with three distinct pore size and morphology; Aq-250 resembled the pore size 
of native trabecular bone, Aq-500 was the scaffold successfully used by Kim et al (2005) [19], 
and Aq-Lam, while scaffold architecture developed by Oliveira et al (2008) [26] resembled the 
lamellar microstructure of bone. In addition to aqueous-based scaffold, HFIP-400, another silk 
scaffold, which previously demonstrated rapid bone formation when cultured with BM-MSCs 
was also studied [21]. The decellularized trabecular bone was used as a “gold standard”. The 
hASC osteogenic activity and bone formation among different scaffolds were directly 
compared.  
The differences in silk chemistry, composition, pore size, and structure did not affect the 
hASCs seeding efficiency (Fig.3A) suggesting insignificant effect of silk chemistry and 
structure on hASCs attachment. After cultivation for 7 weeks, cell number increased in all 
groups except Aq-Lam (Fig.3B). Based on histology and SEM (Fig.4), the significant structural 
difference of Aq-Lam was likely the cause, as cells fully occupied the pore spaces.    
Over 7 weeks, hASCs differentiated and expressed osteogenic markers in all groups but with 
different intensity. Bone tissue development for aqueous-based scaffolds, both small and large 
pore size (Aq-250 and Aq-500), was found to be similar. Pore size did not influence seeding 
efficiency or cell proliferation. Cell viability, morphology (Fig.3C), and distribution throughout 
individual pores or entire scaffold were very similar between the two groups (Fig.4 top). Bone 
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proteins, such as osteopontin, bone sialoprotein and collagen type I, were produced and 
retained in the form of extracellular matrix in an analogous extent (Fig.5). In addition, pore size 
did not affect amount of alkaline phosphatase production, calcium deposition and bone volume. 
Equilibrium moduli of Aq-250 and Aq-500 were also similar. We postulate that while smaller 
pores promote increased mechanical strength, on the other hand, the larger pores were 
associated with a more homogenous matrix [25], characteristics that may compensate the 
compressive capacity. Among all four silk scaffold groups in this study, both Aq-250 and Aq-
500 were inferior. 
Lamellar aqueous-based silk fibroin scaffolds (Aq-Lam) showed some interesting features. The 
equilibrium modulus was the highest among all silk scaffold groups which due to the small 
inter-lamellar distance (25-100µm). Furthermore, the cells of Aq-Lam group expressed the 
most alkaline phosphatase activity at week 2 of culture (Fig.6A), showing enhancement of 
osteogenic differentiation. This was confirmed by increased deposition of bone proteins such 
as OP, BSP and Col I (Fig.5). Calcium deposition and mineralization did not follow the same 
trend with amounts similar to those observed for Aq-250 and Aq-500 groups (Fig. 6B, 6C). This 
result may not be surprising as the native lamellar bone is generated more slowly than woven 
bone and is less mineralized [41]. 
Out of the four silk scaffold groups, HFIP-derived sponge supported superior hASCs 
osteogenic induction and bone-like formation. The similarity of cell proliferation and morphology 
to aqueous-based scaffolds demonstrated that the higher silk concentration and HFIP solvent 
did not alter the abilities for hASCs to adhere and proliferate. The equilibrium modulus of HFIP-
based silk scaffold was superior to aqueous-based constructs with spherical pore, possibly due 
to the higher concentration of silk material (Fig. 6D). More importantly, HFIP-derived scaffolds 
enhanced hASCs deposition of matrix proteins (OPN, BSP, Col I) and mineralization, quantified 
by calcium retention in scaffold and mineralized bone volume (BV). According to microCT 
image (Fig. 6E), the bone formation was equally distributed throughout the scaffold in this 
group showing homogenous osteogenic activity of hASCs. The decellularized trabecular bone 
scaffolds have been used successfully in bone tissue engineering [32, 33, 42]. Although bone-
forming structure and mechanical properties of the silk scaffolds were inferior to the trabecular 
bone scaffold, the osteogenic cellular activities in Aq-250 and Aq-500 groups were similar to 
bone scaffold and were enhanced in Aq-Lam and HFIP-400 groups (Fig.5 and 6A).  
Taken together, data collected in this study are consistent with the conceptual model shown in 
Fig. 7.  Two distinguishable scaffold properties – scaffold architecture and mechanical stiffness 
– appear to affect bone formation (Fig. 7). First, scaffold stiffness is positively correlated with 
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osteogenic differentiation of ASCs resulting in an increase in bone ECM secretion (Fig. 7A). 
The importance of mechanical properties in bone tissue engineering has been well established 
[19, 43]. Similar to previous findings, HFIP-derived silk fibroin scaffolds, which exhibited higher 
stiffness as compared to aqueous-based silk fibroin scaffolds, appear to provided a better 
platform for bone formation. Second, scaffold structure appears to alter cellular activities as 
well as bone tissue formation. Lamellar porous morphology is postulated to benefit ASC 
osteogenic differentiation into lamellar bone, which contains fewer cells, but higher mechanical 
properties once it is highly organized, while a spherical porous structure leads to the 
development of woven bone, which contains higher cellularity and mineral density but is far 
less organized [41, 44] (Fig. 7B). 
 
 
 
Figure 7. Proposed mechanism of regulation of bone formation by scaffold architecture and 
stifness. A) Scaffold mechanics. Mechanically stronger HFIP-derived silk scaffolds promote 
osteogenic differentiation of hASCs to result in increased bone volume (BV), calcium content and bone 
protein deposition, as compared to aqueous-based scaffolds. B) Scaffold architecture. Sponge like 
architecture with spherical pores serves as a template for the formation of woven bone, while a lamellar 
porous architecture serves as a template for the formation of lamellar bone. 
 
5. CONCLUSION 
This study demonstrated the optimization potential of silk scaffolds in terms of structure 
(porosity, pore dimensions, geometry and alignment) and biomechanics for bone tissue 
engineering applications. We demonstrated that human adipose derived stem cells (hASCs) 
interpret the extracellular environment, by responding differently to silk scaffolds’ architecture, 
and producing bone-like extracellular matrix in a manner that appears to depend on structure 
and stiffness of scaffolds. Based on collected data, we have proposed a conceptual model that 
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correlates bone tissue formation with architecture and stiffness of silk scaffolds, which 
emphasizes the importance of appropriate scaffold design when engineering bone. 
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CHAPTER VI 
Sequential application of steady and pulsatile medium perfusion enhanced the 
formation of engineered bone 
 
 
This chapter is based on the following publication: Correia C, Bhumiratana S, Sousa RA, Reis RL, 
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Abstract 
In native bone, cells experience fluctuating shear forces that are induced by pulsatile interstitial 
flow associated with habitual loading. We hypothesized that the formation of engineered bone 
can be augmented by replicating such physiologic stimuli to osteogenic cells cultured in porous 
scaffolds using bioreactors with medium perfusion. To test this hypothesis, we investigated the 
effect of fluid flow regime on in vitro bone formation by human adipose stem cells (hASCs) 
cultivated on porous three-dimensional silk fibroin scaffolds. To this end, we varied the 
sequential relative durations of steady flow (SF) and pulsatile flow (PF) of culture medium 
applied over a period of 5 weeks, and evaluated their effect on bone tissue formation. Porous 
silk-fibroin scaffolds (400-600 µm pore size) were seeded with hASCs (30x106 cells/mL) and 
cultured in osteogenic medium under four distinct fluid flow regimes: (1) PF for 5 weeks; (2) SF 
for 1 week, PF for 4 weeks; (3) SF for 2 weeks, PF for 3 weeks; 4) SF for 5 weeks. The PF was 
applied in 12 hours intervals, with the interstitial velocity fluctuating between 400µm/s and 
1200µm/s at a 0.5 Hz frequency for 2h, followed by 10h of SF. In all groups, SF was applied at 
400µm/s. The best tissue development was achieved for the sequence of 2 weeks of SF and 3 
weeks of PF, as evidenced by gene expression (including the PGE2 mechanotransduction 
marker), construct compositions, histomorphologies and biomechanical properties. We thus 
propose that osteogenesis in hASCs and the subsequent bone formation involve a mechanism, 
which detects and responds to the level and duration of hydrodynamic shear forces. 
 
1. INTRODUCTION  
The development and function of native bone largely depends on the balance between the 
endocrine drive towards bone resorption (by a number of biochemical and hormonal factors), 
and the mechanically-induced drive towards bone formation [1, 2]. A healthy balance between 
these two opposing factors is based on the biological mechanotransduction mechanisms, 
which may include streaming and piezoelectric potentials, damage to the extracellular matrix, 
and direct transduction of matrix strain [3]. The most widely accepted stimulator of bone cells in 
vitro has been the fluid flow, similar to that generated by loading-induced pressure gradients 
that stimulate the flow of interstitial fluid through the lacuno-canalicular porosities [4-6].  
Beneficial effects of flow on osteogenic differentiation and bone cells have been observed 
already in cell monolayers [7-9]. The promising results of cell monolayer studies inspired the 
application of fluid flow in bone tissue engineering, with the aim to improve quality of tissue, 
and/or reduce the time of culture. Both primary osteoblasts and bone marrow mesenchymal 
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stem cells, known to have strong osteogenic properties, improved bone-tissue formation when 
cultured under flow conditions as compared to static culture [10-14]. Human adipose tissue 
derived stem cells (hASCs) were also used to engineer bone with the application of interstitial 
fluid flow [15, 16].  
In recent years, hASCs have been generating a great deal of interest in the fields of tissue 
engineering and regenerative medicine. Multiple independent studies have proven their ability 
to selectively differentiate into chondrogenic, osteogenic and adipose cell lineages [17], and 
that this differentiation potential was not different from that observed fro the bone-marrow 
derived mesenchymal stem cells (BM-MSC) [16]. ASCs offer several advantages that make 
them a promising cell source for bone tissue engineering: adipose tissue is abundant, rapidly 
accessible, with possibility of repeated accessibility; the isolation process is simple, enzyme-
based, and results in high yield of cells per unit tissue volume [16, 17], and - with the increased 
incidence of obesity, - high volumes of adipose tissue resulting from liposuction procedures 
may be potentially used for cell based therapies [18].  
While fluid flow has been successfully used as stimulator for in vitro bone tissue development, 
the long-term differential effects of steady versus fluctuating shear stress on osteogenesis and 
bone tissue formation were not investigated. Physiologic shear stresses acting on the cells are 
generated by flow of interstitial fluid, and are intrinsically dynamic. According to Bacabac et al 
(2004), the frequency spectra of the forces acting on the human hip reach 1–3 Hz for walking 
and 8–9 Hz for running cycles [19]. Regarding the effect of shear stress on cell monolayers, 
Jacobs et al 1998, demonstrated that pulsing flow was a much higher stimulator than oscillating 
flow [3]. Jaasma et al 2008, using a tissue engineering approach, proved that intermittent flow 
proved advantageous for mechanically stimulating osteoblasts [20]. Several studies have 
utilized primary osteoblasts and osteocytes [21, 22], and cell lines [7, 8, 20] to demonstrate 
advantage of dynamic over steady shear stress. Taken together, these studies suggest that 
differentiated bone cells are capable of sensing environmental shear stresses [23, 24].  
In this context, it is of great interest to investigate the temporal responsiveness of stem cells 
differentiation to such environments, over periods of time that are relevant to the formation of 
bone. We hypothesized that the formation of bone by osteogenic hASCs can be augmented by 
a sequence of steady and fluctuating shear stress that mediate osteogenic differentiation and 
subsequent assembly of bone matrix. To test this hypothesis, we investigated the application of 
steady and pulsatile perfusion combinations, with different relative durations of both regimes, 
and evaluated the effect of these regimes on osteogenic differentiation of hASCs cultivated in 
silk fibroin scaffolds.  
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2. MATERIALS AND METHODS 
2.1. PREPARATION OF SILK FIBROIN SCAFFOLDS 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise 
stated. HFIP-derived silk fibroin scaffolds were prepared as previously described [25]. Silk 
fibroin from silkworm (Bombix mori) cocoons was extracted with 0.02 M sodium carbonate 
(Na2CO3) solution, rinsed in distilled water, dissolved in a 9.3 M lithium bromide (LiBr) solution 
and dialyzed for 48h against distilled water in benzoylated dialysis tubing (Sigma D7884). 
Dissolved silk fibroin was centrifuged for 20 min at 9000 rpm (4oC). The resulting solution was 
determined by weighing the remaining solid after drying, yielding a 6-wt % aqueous silk fibroin 
solution. Silk fibroin aqueous solution was lyophilized and further dissolved with HFIP 
(hexafluoro-2-propanol), resulting in a 16-wt % HFIP-derived silk fibroin solution. 4 g of 
granular NaCl, particle size 500–600 µm, were added to 2 mL of silk fibroin in HFIP. The 
containers were covered overnight to reduce evaporation of HFIP and to provide sufficient time 
for homogeneous distribution of the solution. Subsequently the solvent was evaporated at room 
temperature for 3 days. The matrices were then treated in 90% (v/v) methanol for 30 min, to 
induce the formation of β-sheet structure, followed by immersion in water for 2 days to remove 
NaCl. The porous silk scaffolds were then freeze-dried, and cored into cylinder of 4 mm in 
diameter and 4 mm thick. 
 
2.2. ISOLATION, CHARACTERIZATION AND EXPANSION OF HASCS  
hASCs were isolated according to previously established methods [26] from liposuction 
aspirates of subcutaneous adipose tissue, that were obtained from the Pennington Biomedical 
Research Center under a protocol approved by the Institutional Research Board. hASC were 
expanded to the fourth passage (P4) in high-glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM) (Gibco 11965) supplemented with 10% fetal bovine serum (FBS) (Gibco 26140), 
penicillin–streptomycin (1%) (Gibco 15140) and 1 ng/mL basic fibroblast growth factor (bFGF) 
(Peprotech 100-18B). p0 cells were examined for surface marker expression using flow 
cytometry. The presence of specific antigens such as CD29, CD105, CD45, CD34, CD44, 
CD73 and CD90 were analyzed, as previously published [26, 27]. hASCs were tested for their 
differentiation capacity into the osteogenic, chondrogenic and adipogenic lineages.  
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2.3. CELL SEEDING OF SILK SCAFFOLDS 
Scaffolds were sterilized in 70% (v/v) ethanol overnight, washed in PBS and incubated in 
culture media prior to seeding. Expanded hASCs at passage 4 were suspended at 30x106 
cells/mL. A 40 µL aliquot of cell suspension was pipetted to the top of blot-dried scaffods, 
pipetted up and down to ensure even distribution of cells. After 15 minutes in the incubator, 
scaffolds were rotated 180º, and 10 µL of cell-free medium was added to prevent these to dry. 
This process was repeated four times, to allow uniform cell distribution, after which, osteogenic 
media (low glucose DMEM, 10% FBS, 1% penicillin–streptomycin, 10 mM sodium-b-
glycerophosphate, 10 mM HEPES, 100 nM dexamethasone and 50 µg/mL ascorbic acid-2-
phosphate) was added. Scaffolds were then cultured in static conditions (well-plate) for 3 days 
to allow cell attachment.  
 
2.4. BIOREACTOR CULTIVATION OF TISSUE CONSTRUCTS 
Cell-seeded scaffolds were transferred into the perfusion bioreactors using a set-up already 
described in previous works [10-12, 15]. The perfusion bioreactor system has the dimensions 
of a 10-cm glass Petri dish, and the glass cover of this dish serves as the removable bioreactor 
cover. It allows culturing multiple scaffolds (4 to 10 mm in diameter and up to 4 mm high) and 
imaging capabilities. Scaffolds are placed into six wells arranged in a radial pattern, press-fit in 
place into a layer of polydimethylsiloxane (PDMS). Each bioreactor enabled simultaneous 
cultivation and uniform perfusion of the six scaffolds. Culture medium enters the bioreactor 
through a central port from where it flows to the center of the bioreactor and is evenly 
distributed into six channels leading to the scaffolds. A multi-channel peristaltic pump (Ismatec, 
USA) is used to maintain re-circulating flow. The flow rate was determined by the cross-
sectional area of the tube as the length of the column of fluid being pumped and the rate of 
pumping remained constant among groups. Four experimental groups were established by 
varying the relative durations of steady flow (SF) and pulsatile flow (PF) as follows: S0P5: PF for 
5 weeks; S1P4: SF for 1 week, PF for 4 weeks; S2P3: SF for 2 weeks, PF for 3 weeks; S5P0: SF 
for 5 weeks. Pulsatile fluid flow regime was composed of flow velocities following a sinus curve 
between the amplitudes of 400 µm/s (1.64 mL/min) and 1200 µm/s (4.92 mL/min), at 0.5 Hz 
frequency for 2h, followed by 10 hrs of SF. In all groups, SF was applied at a flow velocity of 
400 µm/s. The experimental design is schematically shown in Fig.1. 
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Figure 1. Experimental design. Bone tissue constructs were engineered by cultivation of adipose-
derived human mesenchymal stem cells in porous silk fibroin scaffolds with medium perfusion through 
the forming tissue.  A) The following perfusion regimes were applied: S0P5 (Pulsatile perfusion for 5 
weeks); S1P4 (Steady perfusion for 1 week, Pulsatile perfusion for 4 weeks); S2P3 (Steady perfusion for 
2 weeks, Pulsatile perfusion for 3 weeks); S5P0 (Steady perfusion for 5 weeks); B) Pulsatile perfusion 
profile; C) Estimated maximum and minimum shear stress generated in scaffold pores (500 – 600 µm 
diameter), at the fluid flow velocities of 400 and 1200 µm/sec.  
 
2.5. LIVE/DEAD ASSAY 
LIVE/DEAD Viability/Citotoxicity kit (Molecular Probes, OR/USA) was used to evaluate cell 
viability. Live cells (indicated by Calcein AM) and dead cells (indicated by Ethidium homodimer-
1, EthD-1) were imaged through a confocal microscope (Leica, Germany). Optical sections 
were made parallel to the external surface in 10 µm intervals up to 160 µm deep, and 
presented as vertical projections. 
 
2.6. BIOCHEMICAL CHARACTERIZATION 
Constructs were harvested at timed intervals, washed in PBS, dry blotted, cut in half and 
weighed. For DNA assay, one-half was added to 1 mL of digestion buffer (10 mM Tris, 1 mM 
EDTA, 0.1% Triton X-100, 0.1 mg/mL proteinase K) and incubated overnight at 56ºC for 
digestion. After centrifugation at 3,000g for 10 minutes, the supernatants were removed, 
diluted, pipetted in duplicate into a 96-well plate and a 1:1 ratio of Picogreen solution (Quant-
iTTM PicoGreen ® dsDNA Kit, Invitrogen, USA) was added. Sample fluorescence was 
measured with fluorescent plate reader at excitation ~480 nm, and emission ~520 nm. Lambda 
DNA was used to prepare the standard curve. For calcium quantification, one-half of constructs 
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were incubated in 1 mL TCA 5% (trichloroacetic acid 5% v/v) and calcium was extracted by 
disintegrating the construct using steel balls and MinibeadBeaterTM (Biospec, Bartlesville, 
OK/USA). The supernatant were transferred in duplicate into 96-well plate and calcium binding 
reagent was added at 1:10 ratio (StanbioTotal Calcium Liquicolor, Stanbio Laboratory/USA). 
Sample optical density was measured using a microplate reader set to 575 nm. Calcium 
standard was used to prepare the standard curve.  
 
2.7. IMMUNOHISTOCHEMISTRY 
Samples were fixed in 10% formalin for 1 day, embedded in paraffin, sectioned to 5 µm and 
mounted on glass slides. Sections were deparaffinized with CitriSolv and rehydrated in a 
graded series of ethanol washes. For immunohistochemistry, sections were blocked with 
normal horse serum (NHS), stained sequentially with primary antibody (rabbit anti-human 
Osteopontin - OPN - polyclonal antibody, Chemicon ab1870; rabbit anti-bone sialoprotein - 
BSP - polyclonal antibody, Millipore ab1854; NHS for negative control), secondary antibody 
(Vectastain Universal Elite ABC Kit, PK-6200 Vector Laboratories, USA) and developed with 
biotin-avidin system (DAB substrate kit SK-4100 Vector Laboratories, USA).  
 
2.8. MICROCOMPUTED TOMOGRAPHY (µCT) ANALYSIS 
µCT analysis was performed using an established protocol [28]. Samples were aligned in a 2 
ml screw-cap centrifuge tube that was clamped in the specimen holder of a vivaCT40 system 
(SCANCO Medical AG, Basserdorf, Switzerland). 4 mm length of each scaffold was scanned at 
21 µm isotropic resolution. A global thresholding technique, which only detects mineralized 
tissue, was applied to obtain the bone volume (BV) of samples.  
 
2.9. REAL-TIME RT-PCR 
For RNA extraction, one-half of constructs were added to 800 µL of Trizol (Invitrogen 15596-
026, USA) and disintegrated by using steel balls and MinibeadBeaterTM (Biospec, Bartlesville, 
OK/USA). Suspensions were centrifuged at 12,000 g for 10 min at 4°C to remove tissue debris 
and extracted with chloroform (Sigma C2432). Colorless aqueous phase, containing RNA was 
removed and mixed with equal volume of isopropanol (Sigma I9516). Suspensions were again 
centrifuged at 12,000 g for 8 min at 4°C, supernatant discarded, and RNA pellet washed with 
75% ethanol. Samples were centrifuged at 7,500 g for 5 min at 4°C, supernatant removed, 
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pellet air-dried, and dissolved with DEPC-water (Applied Biosystems AM 9920). RNA was 
quantified using Nanodrop® ND‐1000. Approximately 1 µg of RNA was reversely transcribed 
with random hexameres using High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems 4368814).  
Osteopontin (OPN), bone sialoprotein (BSP), prostaglandin E2 synthase (PGE2S) and the 
housekeeping gene glyceraldehyde-3-phosphatedehydrogenase (GAPDH) expression were 
quantified using a 7500 Fast Real-Time PCR System (Applied Biosystems, USA). Gene 
expression assay ID, probe and amplicon size and are described on Table I. All TaqMan® 
Gene Expression Assays were purchased from Applied Biosystems. The expression data were 
normalized to GAPDH and presented as average values for each group. 
 
Table I. Primers used for qRT-PCR   
 
 
2.10. MECHANICAL TESTING 
The equilibrium Young’s modulus of constructs was determined before and after culturing, 
under unconfined compression in wet conditions using a modification of an established protocol 
[29]. An initial tare load of 0.2 N was applied to each sample. Specimens were compressed at 
a strain rate of 1%/s up to 10% strain and subsequently maintained at this strain for 1800 s. 
The Young’s modulus was obtained from the equilibrium stress measured at 10% strain. 
 
2.11. STATISTICAL ANALYSIS 
Data are presented as average ± standard deviation (n=3). Statistical significance was 
determined using analysis of variance (ANOVA) followed by Tukey’s HSD (honestly significant 
difference) test using Prism software (Prism 4.0c, GraphPad Software Inc., USA).  
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3. RESULTS 
3.1. CELL PROLIFERATION AND VIABILITY 
After 5 weeks of dynamic bioreactor cultivation, the amounts of DNA increased over initial 
values in all groups, reaching levels that were slightly but not significantly different among the 
experimental groups (Fig. 2 - top). Live/Dead viability assay allowed the observation, by 
confocal microscopy, of green viable cells which enzymatically converted nonfluorescent cell-
permeant calcein AM into the intensely fluorescent calcein, and dead cells identified by bright 
red fluorescense of EthD-1 bound to nucleic acids of cells with damaged membranes (Fig. 2 - 
bottom). Viable cells at scaffold surfaces were observed in all experimental groups.  
 
Figure 2. Cell proliferation and viability. Top: Amount of DNA in tissue constructs at the end of the 5-
week culture period; the horizontal line indicates day 1 value (n = 3). Bottom: Live/Dead imaging of 
constructs after 5 weeks of culture. Scale bar = 75 µm. 
 
3.2. BONE TISSUE DEVELOPMENT 
Bone extracellular matrix proteins osteopontin (OPN) and bone sialoprotein (BSP) were 
immunolocalized in cross-sections of constructs harvested after 5 weeks of culture (Fig. 3). 
OPN deposition was clearly enhanced in all groups subjected to pulsatile fluid flow (PF) in 
comparison to the experimental group cultured under steady fluid flow (SF). The same trend 
was observed for the deposition of BSP. Among the three groups subjected to PF, we 
observed increased bone protein deposition (both OPN and BSP) in S2P3 group, where cell-
seeded scaffolds were cultured under steady fluid flow (SF) for 2 weeks, before the application 
of pulsatile fluid flow (PF) during 3 weeks. Constructs cultured under any regimen of PF 
demonstrated increased deposition and more uniform distribution of mineral throughout the 
scaffold as compared to constructs cultured exclusively under SF, as evidenced by µCT 
reconstruction (Fig. 3 – bottom row). Among the three pulsatile regimens, S2P3 was the one 
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that stimulated best mineralization of hASC, as shown by compact mineral deposition detected 
by µCT. 
 
 
Figure 3. Bone tissue development. Top row: Immunohistochemical localization of osteopontin 
(OPN); Middle row: Immunohistochemical localization of bone sialoprotein (BSP). Scale bars = 50 µm. 
Bottom row: µCT reconstruction images of mineralized tissue matrix. Scale bar = 1 mm.  
 
OPN gene expression profiles corroborates measured bone protein deposition (Fig. 4 - top), 
with highest OPN gene expression quantified for the S2P3 group and lowest OPN gene 
expression for S5P0 group. These values were significantly different (p<0.05). OPN gene 
expression (GE) progressively increased with the increase of osteogenic pre-differentiation 
period before application of pulsatile regimen – OPN GES0P5 < OPN GES1P4 < OPN GES2P3. 
BSP gene expression was not different among the groups studied.  
Gene expression of prostaglandin E2 synthase (PGE2S) was also quantified, since 
prostaglandin E 2 (PGE2) release is stimulated by shear stress in a dose-dependent manner 
[30] (Fig. 4 - bottom). This paracrine factor was also highly expressed by hASCs cultured in 
S2P3 pulsatile regimen, and significantly different (p<0.05) from the S5P0 group, that was not 
subjected to pulsatile fluid flow during culture. As observed for OPN, PGE2S GE progressively 
increased with the increase of osteogenic pre-differentiation period, and before application of a 
pulsatile regimen: PGE2S GES0P5 < PGE2S GES1P4 < PGE2S GES2P3. 
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Figure 4. Gene expression after 5 weeks of culture. Top: Osteopontin (OPN) and Bone Sialoprotein 
(BSP) gene expression normalized to GAPDH (n = 3) * p<0.05 relatively to S2P3. Bottom: 
Prostaglandin E 2 synthase (PGES2) gene expression normalized to GAPDH (n = 3)  *p<0.05 relative to 
S2P3.  
 
Mineralization was assessed through calcium quantification, and bone volume normalized by 
tissue volume (BV/TV) (Fig. 5). The highest amount of calcium was obtained in the S2P3 
culturing regimen, again significantly different (p<0.05) from S5P0 group where the lowest 
amount was quantified (Fig. 5 - top). BV/TV ratio corroborates calcium data and µCT 
reconstruction images, where S2P3 present the highest ratio, and S5P0 the lowest (Fig. 5 - 
bottom).  
 
Figure 5. Deposition of mineralized tissue after 5 weeks of culture. Top: Amount of calcium (n = 3), 
* p<0.05. Bottom: Ratio of bone volume (BV) to tissue volume (TV) (n=3). 
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Mechanical properties of cultured constructs are presented in Fig. 6. After culture, scaffolds 
became stiffer, although no statistical difference was detected among groups. In average, an 
increase of equilibrium modulus of 1.8 times at the end of culture. 
 
 
Figure 6. Biomechanical properties of tissue constructs. Equilibrium modulus measured after 5 
weeks of culture is compared to the initial value measured for the scaffold. 
 
4. DISCUSSION 
Perfusion bioreactors have been used in tissue engineering with the main purpose to improve 
gas transfer, nutrient supply and waste removal between tri-dimensional constructs and culture 
medium by reducing diffusional distances [31, 32]. Several studies have explored the use of 
perfusion to improve osteogenic differentiation and bone tissue formation with primary 
osteoblasts, bone marrow mesenchymal stem cells [11-14], and human adipose stem cells 
[15]. In the present work, we aimed to augment bone tissue formation by hASC osteogenic 
differentiation, in porous silk scaffolds, under a sequence of steady and pulsatile flows. We also 
aimed to understand the importance of osteogenic pre-differentiation of hASC in the 
achievement of this goal. Our aim was accomplished, as all pulsatile flow regimes improved 
bone tissue development over steady flow, and the best tissue was obtained for 2 weeks of 
osteogenic pre-differentiation preceding pulsatile regime.  
In native bone, the cells experience dynamic mechanical shear force[4, 33] due to the flow of 
interstitial fluid resulting from physical movement [9, 34, 35]. Ideally, bone tissue engineering 
should mimic such physiologic environment in which medium flow is dynamic and, hence, 
shear stress is variable. Previous studies demonstrated the positive effect of static shear force 
on osteogenic differentiation and tissue engineered bone formation[10-12, 15]; however, the 
physiologic shear force is not static[23, 35]. We hypothesized that osteogenic cells do not only 
respond to shear force but also to time and dynamic range of shear force application. In this 
study, we explored the dynamic flow paradigm by applying a sequence of steady and pulsatile 
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fluid flows, SF and PF respectively, to human adipose stem cells (hASCs) in silk fibroin 
scaffolds, in the context of bone tissue engineering.  
In order to estimate the hydrodynamic shear stress acting at cells within scaffolds, we have 
modeled the interconnected pore network of scaffolds as a bundle of parallel, cylindrical 
channels with an average diameter of 550 µm. In this model, we have considered a sufficient 
number of channels that assures a porosity of 90%, as in one of our previous studies12. 
According to our estimates, the calculated shear stress within tissue constructs ranged from to 
4.48 mPa (0.045 dyn/cm2) to 13.44 mPa (0.134 dyn/cm2) at flow velocities of 400 µm/s to 1200 
µm/s, respectively. According to the theoretical model proposed by Weinbaum et al (1994), the 
magnitude of the fluid induced shear stresses in vivo is in the range of 8 - 30 dyn/cm2. In our 
study, we did not reach these high levels of shear stress associated with the mature bone, but 
instead attempted to mimic the in vivo pulsatile profile for developing bone. To this end, we 
varied shear stress at a lower level, with a three-fold difference between the minimum and 
maximum shear stress levels (0.045 - 0.134 dyn/cm2) (Fig.1). In terms of frequency, we have 
used a regimen (0.5 Hz) that resembles the dynamic force spectra applied to the human hip 
during slow walking [19].  
As one of the drawbacks in perfusion culturing is the possibility of cell “wash out” from the 
scaffold, we assessed cell viability and proliferation and observed viable cells attached to the 
scaffold surface for all studied groups, as well as an increase in cell numbers at the end of 
culture (Fig.2). No significant differences were detected between groups, suggesting that 
proliferation occurred to a similar extent despite differences in fluid flow regimen. 
The constructs subjected to pulsatile fluid flow during 5 weeks demonstrated superior bone 
development in terms of bone protein deposition (Fig.3 – top and middle row) and gene 
expression (Fig.4 - top) of both osteopontin (OPN) and bone sialoprotein (BSP). Notably, OPN 
is a mechanosensitive gene, encoding the extracellular bone matrix protein osteopontin, which 
has been used to asses bone cell mechanoresponsiveness[36-38]. Bone sialoprotein mRNA 
expression has also been used to prove bone formation induced by mechanical signals[39]. 
Increased expression of PGE2S (Fig.4 - bottom), corroborate the hASCs response to dynamic 
mechanical stimulation, once PGE2 is one of the most important markers of mechanically 
induced bone formation [7, 20, 40]. In addition to gene expression and protein deposition, 
constructs cultured under dynamic shear stress (PF) increased mineralization as compared to 
constructs cultured under steady flow (SF) (Fig.3 – bottom row; Fig.5). Therefore, the 
pulsatile fluid flow culture improves human adipose stem cells (hASCs) osteogenic 
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differentiation and tissue engineered bone formation in contrast to conventional steady fluid 
flow.  
Furthermore, we determined the temporal development of the sensing mechanism for the 
exerted pulsatile forces in hASCs osteogenic differentiation. It was previously suggested that 
communicating osteocytes are the bone cells responsible for sensing small strains in the 
calcified matrix components of bone, through their osteocytic processes and not through the 
cell body [23, 24]. Human adipose stem cells lack these processes, which may lead to failure to 
response to mechanical stimuli. Therefore, we assumed that hASC should be first differentiated 
into the osteogenic lineage in order to be capable to sense the pulsatile fluid flow applied by 
dynamic culture of hASCs seeded silk scaffolds. Therefore, cells were cultured in osteogenic 
medium, first under steady fluid flow and then under pulsatile fluid flow for the remaining culture 
period (starting at 0, 1, 2 weeks, or maintaining SF throughout the culture). The best bone 
tissue development was achieved for hASC pre-differentiated for 2 weeks under SF, and only 
then subjected to the PF regime. Under these conditions, highest increases in bone protein 
deposition (both osteopontin and bone sialoprotein) and the corresponding gene expression, 
calcification and bone volume were detected.  
Mechanical loading is known to induce expression of prostaglandin E2 (PGE2), an important 
early stage bone formation marker [40, 41]. Thus, we looked into gene expression of PGE2 
synthase to assess if this marker would be differently expressed as response to changes in 
shear force. Interestingly, we have observed the following progression of PGE2 synthase and 
osteogenic differentiation: S0P5 < S1P4 < S2P3. These data are in support of our hypothesis that 
there is a temporal development of the sensing mechanism to the exerted shear stresses upon 
hASC differentiation, which makes cells to sense differently steady and pulsatile flow and 
hydrodynamic shear. Therefore, the mechanisms and key factors involved in 
mechanotransduction are interesting targets for modulating osteogenic differentiation of hASCs 
under dynamic shear stress.  
 
5. CONCLUSION 
A bone tissue engineering model consisting of human adipose stem cells cultured in porous 
silk fibroin scaffolds in a bioreactor with perfusion (interstitial flow) of culture medium was used 
to investigate the effects of pulsatile vs steady medium flow. Our hypothesis was that a 
sequence of steady flow followed by pulsatile flow will be optimal for supporting bone 
development, first by stimulating osteogenic cell differentiation and, second, by promoting 
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expression of bone tissue matrix. Pulsatile flow ranging from 400 µm/s to 1200 µm/s, at 0.5 
Hz, associated with fluctuating shear stresses (0.045 – 0.134 dyn/cm2) improved bone 
formation in comparison to steady flow at 400 µm/s. Furthermore, cell response to pulsatile 
fluid flow was progressively enhanced with the increase of steady flow culturing time, being 
maximum for 2 weeks of culture. These data are consistent with the notion that osteogenic 
hASCs gradually developed a mechanism to detect and respond to changes in shear stress.  
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CHAPTER VII 
Human adipose stem cells can serve as a single cell source for the in vitro 
cultivation of vascularized bone grafts 
 
 
This chapter is based on the following publication: Correia C, Grayson WL, Eton R, Gimble JM, Sousa 
RA, Reis RL, Vunjak-Novakovic G, 2011, Human adipose derived cells can serve as a single cell 
source for the in vitro cultivation of vascularized bone grafts, Journal of Tissue Engineering and 
Regenerative Medicine – in press. 
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Abstract 
Orthopedic surgery often requires bone grafts to correct large defects resulting from congenital 
defects, surgery or trauma. Great improvements have been made in tissue engineering of bone 
grafts. However, these grafts lack the vascularized component that is critical for their survival 
and function. From a clinical perspective, it would be ideal to engineer vascularized bone grafts 
starting from one single cell harvest obtained from the patient. To this end, we explored the 
potential of human adipose derived mesenchymal stem cells (hASC) as a single cell source for 
osteogenic and endothelial differentiation and the assembly of bone and vascular 
compartments within the same scaffold. hASC were encapsulated in fibrin hydrogel as a 
angioinductive material for vascular formation, combined with a porous silk fibroin sponge to 
support osteogenesis, and subjected to sequential application of growth factors. Three 
strategies were evaluated by changing spatio-temporal cues: 1) induction of osteogenesis prior 
to vasculogenesis, 2) induction of vasculogenesis prior to osteogenesis, or 3) simultaneous 
induction of osteogenesis and vasculogenesis. By 5 weeks of culture, bone development was 
evidenced by the deposition of bone matrix proteins, alkaline phosphatase activity and calcium 
deposition, along with the formation of vascular networks evidenced by endothelial cell surface 
markers, such as CD31 and von Willebrand factor, and morphometric analysis. Most robust 
development of the two tissue compartments was achieved by sequential induction of 
osteogenesis followed by the induction of vasculogenesis. Taken together, the collected data 
strongly support the utility of hASC as a single cell source for the formation of vascularized 
bone tissue. 
 
1. INTRODUCTION 
Bone vascularization has been a major hurdle for engineering viable and functional bone 
grafts. Several approaches have been proposed to reach this goal. The co-operation of 
endothelial cells (either EPCs - endothelial progenitor cells or HUVECs - human umbilical cord 
endothelial cells) and osteoblasts / osteo-progenitors have been the most studied [1-4]. 
Previous work of our own group [5], where HUVECs and hMSCs (human bone marrow 
mesenchymal stem cells) were co-cultured in decellularized bone scaffolds has demonstrated 
that vascular development was increased when vasculogenesis is induced prior to 
osteogenesis, and that the addition of fresh hMSCs (human bone marrow mesenchymal stem 
cells) at the osteogenic induction stage improved both tissue outcomes. The in vitro developed 
networks successfully anastomosed with the host vessels when implanted sub-cutaneously in 
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nude mice. In an alternate in vivo approach, Tsigkou et al. 2010 used a mouse model to 
develop a two-stage protocol for generating vascularized bone grafts using HUVECs and 
hMSC. Endothelial cells formed networks throughout the bone scaffold 4-7 days after 
implantation, which anastomosed with nude mice vasculature after 11 days. Vasculature was 
mature upon 4 weeks, at which time evidence of mineral deposition was also revealed [2]. 
Koob and co-workers 2011, also developed a completely in vivo approach, where HUVECs 
formed complex three-dimensional networks of perfused human neovessels in critical-sized 
calvarial defects in SCID mice. However, this neovasculature did not seem to improve MSC-
triggered bone regeneration [4].  
All these approaches combined osteogenic and vasculogenic cells from different sources, 
which limits their clinical utility. An ideal tissue engineering solution would use a complete 
autologous procedure (minimizing host rejection), and one single cell source (reducing therapy 
complexity and patient discomfort caused by multiple biopsy procedures) for the development 
of both independent structures – bone and vasculature.  
In the present study, we propose the use of human adipose derived stem cells (hASC) as 
single cell source to generate both the bone tissue matrix and the associated vascular network. 
Adipose tissue represents an attractive cell source for tissue engineering for several reasons. 
These cells can be used in an autologous fashion, as tissue is harvested from the patient at a 
dedicated or non-dedicated liposuction surgery. Adipose tissue can be obtained repeatedly in 
large quantities under local anesthesia and with a minimum of patient discomfort. Additionally, 
the simple enzyme-based isolation procedure results in very high cell yield, ~404 000 cells/mL 
of lipoaspirate [6]. Moreover, hASC are fairly well characterized, including their intrinsic 
potential to differentiate into osteogenic lineages – and thereby develop bone tissue [7-9] – and 
endothelial lineages, to form capillaries [10-16]. 
Herein, we hypothesize that a sequential application of osteogenic and endothelial growth 
factors to hASC cultured on biomaterial scaffolds, with different timing of addition of fresh cells 
can support the development of bone-like tissue containing an integrated vascular network. 
The experiments were performed by culturing hASC in porous silk fibroin scaffolds designed for 
bone tissue development in combination with fibrin-encapsulated hASC, to provide an 
environment conducive to the formation of capillary-like networks.  
 
Chapter VII – Human adipose stem cells can serve as a single cell source for the in vitro cultivation of vascularized bone grafts 
 
	   199	  
2. MATERIALS AND METHODS 
2.1. PREPARATION OF SILK FIBROIN SCAFFOLDS 
Silk fibroin from silkworm (Bombix mori) cocoons was extracted with 0.02 M sodium carbonate 
(Na2CO3) solution, rinsed in distilled water, dissolved in a 9.3 M lithium bromide (LiBr) solution 
and dialyzed for 48h against distilled water in benzoylated dialysis tubing (Sigma D7884). 
Dissolved silk fibroin was centrifuged for 20 min at 9000 rpm (4oC). The resulting solution was 
determined by weighing the remaining solid after drying, yielding a 6-wt % aqueous silk fibroin 
solution. HFIP-derived silk fibroin scaffolds were prepared as previously described [17]. Silk 
fibroin aqueous solution was lyophilized and further dissolved with HFIP (hexafluoro-2-
propanol), resulting in a 17-wt % HFIP-derived silk fibroin solution. 4 g of granular NaCl, 
particle size 400–600 µm, were added to 2 mL of silk fibroin in HFIP. The containers were 
covered overnight to reduce evaporation of HFIP and to provide sufficient time for 
homogeneous distribution of the solution. Subsequently the solvent was evaporated at RT for 3 
days. The matrices were then treated in 90% (v/v) methanol for 30 min, to induce the formation 
of the β-sheet structure, followed by immersion in water for 2 days to remove the NaCl. The 
porous silk scaffolds were then freeze-dried.  
 
2.2. ISOLATION, CHARACTERIZATION AND EXPANSION OF HASC  
hASC were isolated according to previously described methods [18] from liposuction aspirates 
of subcutaneous adipose tissue, at the Pennington Biomedical Research Center under 
protocols approved by the Institutional Review Board with informed patient consent. hASC 
were expanded to the third passage in high-glucose Dulbecco’s modified Eagle’s medium 
(DMEM) (GIBCO 11965) supplemented with 10% fetal bovine serum (FBS) (GIBCO 26140), 
penicillin–streptomycin (1%) (GIBCO 15140) and 1 ng/mL basic fibroblast growth factor (bFGF) 
(Peprotech 100-18B). Passage 0 (P0) cells were examined for surface marker expression 
using flow cytometry. The presence of specific antigens such as CD29, CD105, CD45, CD34, 
CD44, CD73 and CD90 were analyzed, and reproducibility of cells was confirmed from various 
donors [14, 18]. hASC were confirmed for their differentiation capacity into the adipogenic and 
osteogenic lineages in monolayer cultures following induction with adipogenic and osteogenic 
inductive medium for up to 14 days and histochemical analysis of neutral lipid (Oil Red O) or 
mineralization (Alizarin Red) staining as published [19]. 
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2.3. CELL ENCAPSULATION AND SCAFFOLD SEEDING  
Silk scaffolds were cut into 2mm thick, 4mm diameter cylinders, sterilized in 70% (v/v) ethanol 
overnight, washed in PBS and incubated in culture media prior to seeding, as in our previous 
studies [20]. Expanded hASC were suspended at 20x106 cells/mL and seeded into silk 
scaffolds according to a well-established procedure [9, 21, 22]: 20 µL aliquot of cell suspension 
was pipetted to the top of blot-dried scaffods, pipetted up and down to ensure even distribution 
of cells. After 15 minutes in the incubator, scaffolds were rotated 180º, and 10 µL of cell-free 
medium was added to prevent drying. This process was repeated four times to allow uniform 
cell distribution, after which, constructs were incubated overnight to allow cell attachment 
(Fig.1). hASC attached to silk fibroin scaffolds were intended for bone formation. At day 1, 
fibrinogen (Sigma F8630) was prepared at a concentration of 5 mg/mL and thrombin (Sigma 
T6200-1KU) was used at 10 Units/mL. Fibrin has been extensively used to create vascularized 
tissue constructs (bone, adipose tissue, skin, cardiovascular tissue) due to its excellent pro-
angiogenic properties [23]. Moreover, in a skin regeneration context, fibrin has proven to 
control ASC differentiation toward vascular cell types [24]. In our study, expanded hASC 
intended to form vasculature networks within the engineered bone tissue, were encapsulated in 
fibrin at a density of 20x106 cells/mL. Thrombin was added to cross-link the gel, giving a final 
fibrin concentration of 4 mg/mL. Before cross-linking occurred, 20 µl of cell/gel suspension was 
pipetted into blot-dried scaffolds to allow uniform cell seeding throughout the scaffolds. Before 
the gels became cross-linked fully, they were aspirated under a light vacuum so that they 
coated the walls of the scaffolds but did not fill the pore spaces. This step was performed on 
groups 1 to 5 at day 1, and on groups 6 and 7 only after 3 weeks of osteogenic culture (Fig.1).  
 
2.4. IN VITRO CULTIVATION  
Seven experimental groups of cell–biomaterial constructs were established as follows (Fig. 1), 
and the constructs were cultured for 5 weeks.  
Group 1 served as osteogenic control, with constructs cultured in osteogenic medium (OM), 
which consisted of low glucose DMEM, 10% FBS, 1% Pen–Strep supplemented with 
osteogenic factors (all purchased from Sigma-Aldrich): 100 nM dexamethasone, 10 mM 
sodium-β-glycerophosphate, 10 mM HEPES and 50 µg/mL ascorbic acid-2-phosphate,  
Group 2 served as vasculogenic control, where endothelial growth media-2 was used (EGM-2; 
Lonza CC-3162) to induce endothelial differentiation of hASCs as in prior studies [25]. This 
endothelial cell basal medium contains, among other important growth factors, VEGF (Vascular 
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endothelial growth factor) and FGF-b (basic fibroblast growth factor), known to stimulate 
endothelial differentiation, vasculogenesis and angiogenesis. Five further groups were chosen 
for growing vascularized bone constructs.  
In Group 3, both osteogenic and vasculogenic supplements were provided simultaneously 
throughout the total period of culture by using cocktail medium composed by EGM and OM at 
1:1 ratio (cocktail group).  
 
 
Figure 1. Experimental design. Groups 1 & 2 are controls, where constructs were provided osteogenic 
supplements (OM) or endothelial factors (EGM) for 5 weeks.  Group 3 was cultured with a cocktail of 
both OM & EGM (1:1) for 5 weeks. In Groups 4 & 5, vascular differentiation was induced for 2 weeks 
before adding osteogenic factors in a cocktail medium (EGM|cocktail). Additional hASC were added 
into the pore spaces at this point in Group 5 (EGM|cocktail+ASC). Groups 6 & 7 were seeded with 
hASC to silk scaffold and osteogenic differentiation was induced for 3 weeks; only at this time point, 
hASC in fibrin were added to the scaffold for vascular development. Constructs were cultured in either 
EGM (Group 6 – OM|EGM) or cocktail media (Group 7 – OM|cocktail) for the remaining 2 weeks. 
 
Further, two sequential approaches were established: a) induction of vasculogenesis prior to 
osteogenesis (groups 4 and 5), and b) the reverse: induction of osteogenesis prior to 
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vasculogenesis (groups 6 and 7). In both approaches, 2–week differentiation periods were 
chosen for vasculogenic induction, and 3 weeks for osteogenic differentiation. These time 
frames were based on prior studies: hASC cultured for 2 weeks in endothelial cell growth 
medium-2 (EGM-2) have demonstrated network formation of branched tube-like structures 
positive for CD31, CD144, and von Willebrand factor [25]. With respect to bone development, 
previous studies of our group have demonstrated osteogenic differentiation of hASCs and 
secretion of mineralized bone matrix as early as 2 weeks after osteogenic induction in this silk 
scaffold system [20], although 3 weeks was allowed for increased tissue development.   
In Group 4, constructs were cultured in EGM for 2 weeks to induce endothelial differentiation, 
and in cocktail medium for the remaining 3 weeks (EGM|cocktail) for maintenance and 
augmentation of endothelial phenotype, while simultaneously inducing osteogenesis. In Group 
5, the constructs were cultured exactly as in Group 4 except that fresh hASC were added into 
scaffold pore spaces at the 2-week time point, intended to respond more promptly to 
osteogenic cues. This is indicated as EGM|cocktail+ASC.  
In Group 6 and Group 7, we ‘reversed’ the process and induced osteogenic differentiation 
first. hASC were seeded into the scaffolds and cultured in osteogenic media for 3 weeks.  
Subsequently, hASC in fibrin were added to the constructs and cultured either in EGM media 
(Group 6 - OM|EGM), or in cocktail medium (Group 7 - OM|cocktail).  
 
2.5. LIVE/DEAD ASSAY 
LIVE/DEAD Viability/Citotoxicity kit (Molecular Probes) was used to evaluate cell viability at the 
end of culture. Live cells (indicated by calcein AM) and dead cells (indicated by ethidium 
homodimer-1) were observed and imaged through a confocal microscope. Optical surfaces 
were taken from the surface up until 160 µm deep, in 10 µm intervals. All images are 
presented as vertical projections. 
 
2.6. BIOCHEMICAL CHARACTERIZATION 
Constructs were harvested, washed in PBS, cut in half and weighed.   
For DNA assay, samples were added to 1 mL of digestion buffer (10 mM Tris, 1 mM EDTA, 
0.1% Triton X-100, 0.1 mg/mL proteinase K) and incubated overnight at 56ºC. After 
centrifugation at 3000g for 10 minutes, the supernatants were removed, diluted and pippeted in 
duplicate into a 96-well plate and a 1:1 ratio of picogreen solution (Quant-iTTM PicoGreen ® 
dsDNA Kit, Invitrogen) was added. Sample fluorescence was measured with fluorescent plate 
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reader at excitation ~480 nm, emission ~520 nm. Lambda DNA was used to prepare the 
standard curve.  
For calcium quantification, samples were incubated in 1 mL TCA 5% (trichloroacetic acid 5% 
v/v) and calcium was extracted by disintegrating the construct using steel balls and 
MinibeadBeaterTM. The supernatant were transferred in duplicate into 96-well plate and calcium 
binding reagent was added at 1:10 ratio (StanbioTotal Calcium Liquicolor). Sample optical 
density was measured using a microplate reader set to 575 nm. Calcium standard was used to 
prepare the standard curve. 
Alkaline Phosphatase (AP) activity was determined by adding cell lysis solution to one-half of 
each scaffold, and these were disintegrated using steel balls and MinibeadBeaterTM. After 
centrifugation, 50 µL of supernatant was incubated with 50 µL pNPP (p-nitrophenyl-phosphate) 
substrate solution, at 37ºC for 20 min. The reaction was stopped with 50 µL of stop solution 
and absorbance of was read at 405 nm. p-Nitrophenol at known concentrations was used to 
prepare the standard curve. All solutions were components of SensoLyte pNPP Alkaline 
Phosphatase Complete Kit (Cell Biolabs, CBA-302). 
 
2.7. HISTOLOGY AND IMMUNOHISTOCHEMISTRY 
Samples were fixed in 10% formalin for 1 day, dehydrated in graded ethanol washes, 
embedded in paraffin, sectioned to 5 µm and mounted on glass slides. Sections were 
deparaffinized with CitriSolv and rehydrated with a graded series of ethanol washes. For 
immunohistochemistry, sections were blocked with normal horse serum (NHS), stained 
sequentially with primary antibody (rabbit anti-human CD31 monoclonal antibody, Millipore 04-
1074; rabbit anti-human von Willebrand factor (vWF), Sigma-Aldrich F3520; rabbit anti-human 
Osteopontin (OPN) polyclonal antibody, Chemicon ab1870; rabbit anti-bone sialoprotein (BSP) 
polyclonal antibody, Millipore ab1854; NHS for negative control), secondary antibody 
(Vectastain Universal Elite ABC Kit, PK-6200 Vector Laboratories) and developed with biotin-
avidin system (DAB substrate kit SK-4100 Vector Laboratories).  
 
2.8. REAL-TIME RT-PCR 
For RNA extraction, samples were added to 800 µL of Trizol (Invitrogen 15596-026) and 
disintegrated by using steel balls and MinibeadBeaterTM. Suspensions were centrifuged at 
12,000 g for 10 min at 4°C to remove tissue debris and extracted with chloroform (Sigma 
C2432). Colorless aqueous phase, containing RNA was removed and mixed with equal volume 
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of isopropanol (Sigma I9516). Suspensions were again centrifuged at 12,000 g for 8 min at 
4°C, supernatant discarded, and RNA pellet washed with 75% ethanol. Samples were 
centrifuged at 7,500 g for 5 min at 4°C, supernatant removed, pellet air-dried, and dissolved 
with DEPC-water (Applied Biosystems AM 9920). RNA was quantified using Nanodrop® 
ND‐1000. Approximately 1 µg of RNA was reverse-transcribed with random hexamers using 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems 4368814). CD31, von 
Willebrand factor (vWF) and the housekeeping gene glyceraldehyde-3-
phosphatedehydrogenase (GAPDH) expression were quantified using the 7500 Fast Real-
Time PCR System (Applied Biosystems). Primer sequences, probe, amplicon size and gene 
expression assay ID are described on table I. All TaqMan® Gene Expression Assay were 
purchased from Applied Biosystems. The expression data were normalized to GAPDH and 
presented as average values for each group (n=3 ± standard deviation). 
 
Table I. Information about gene expression assays used for real time RT-PCR 
 
 
2.9. STATISTICAL ANALYSIS 
Data are presented as mean ± standard deviation (n=3). Statistical significance was 
determined using analysis of variance (ANOVA) followed by Tukey’s HSD (honestly significant 
difference) test using Prism software (Prism 4.0c, GraphPad Software Inc.). p< 0.05 were 
considered statistically significant. 
 
3. RESULTS AND DISCUSSION 
3.1. CELL VIABILITY AND PROLIFERATION 
The DNA content of constructs (Fig. 2A) revealed that cells within constructs cultured in EGM 
for the total 5 weeks proliferated significantly more than any other group, even osteogenic 
control group (p<0.05). This result is coherent with studies performed by Suga and colleagues, 
where ASC cultured with EGM-2 proliferated 105 times more in 2 weeks than those cultured 
with DMEM [26]. It is interesting to notice that, in a study performed by our group, where 
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HUVECs and hMSC (bone marrow derived) were used to develop a vascularized bone model, 
the opposite outcomes were obtained: these co-cultured cells proliferated better in OM rather 
than EGM media [5]. The mixture of OM and EGM to 1:1 ratio (group 3 - cocktail) resulted in 
significantly lower cell proliferation (p<0.05) than EGM alone. DNA contents obtained in group 
6 - OM|EGM and group 7 - OM|cocktail support this proliferative effect of EGM, once cells 
cultured with EGM after osteoinduction (OM for 3 weeks) proliferated 1.84x more than the 
corresponding constructs cultured in cocktail medium. Clearly, growth factors present in EGM 
enhance proliferation, and their effects are diminished after dilution to 1:1 ratio with osteogenic 
media. Accordingly, group 4 - EGM|cocktail show less DNA content than constructs of group 2 
(EGM alone), showing that replacement of EGM by cocktail media at week 3, resulted in less 
cell proliferation. Unexpectedly, the addition of fresh cells after 3 weeks of culture, when culture 
medium was switched from EGM to cocktail, did not increase DNA contents (group 5 - 
EGM|cocktail+ASC, Fig. 2A). Live/Dead imaging (Fig. 2B) show considerable cell viability in 
all experimental groups, with some cell debri found in group 7. 
 
 
 
Figure 2. Cell proliferation and viability after 5 weeks of culture. A) DNA quantification. Horizontal 
line indicates day 1 values. Data are shown as Ave ± SD (n=3), *p<0.001 to EGM group, #p<0.05 to all 
other groups; B) Live/Dead assay. Scale bar = 200 µm. 
 
3.2. VASCULAR DEVELOPMENT 
Endothelial cell markers - CD31 adhesion molecule and von Willebrand factor (vWF) - were 
used to identify and characterize specific endothelial cell types and evaluate vascular 
development in cultured tissues.  
Both the gene expression (GE) (Fig. 3) and protein deposition (Fig. 4) of endothelial cell 
markers were assessed. CD31 gene expression (Fig. 3A) in groups 1 through 4 - OM, EGM, 
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cocktail and EGM|cocktail respectively, was comparable to that observed at day 1 (horizontal 
line). In contrast, statistically significant increases in CD31 GE was shown by group 5 - 
EGM|cocktail+ASC (p<0.01), group 6 – OM|EGM (p<0.05) and group 7 – OM|cocktail 
(p<0.01), relatively to day 1. The addition of fresh hASCs in all these groups at later stages of 
culture appears crucial for enhanced endothelial cell differentiation. After 5 weeks of culture, 
group 5 - EGM|cocktail+ASC expressed significantly higher CD31 (p<0.01) than groups 1 
through 4. CD31 protein deposition (Fig. 4) correlates with the expression profile of the CD31 
gene, with the groups 1 through 4 showing weak deposition and groups 5 and 6 showing 
strong protein deposition. Additionally, we observe that culture conditions at group 6 – 
OM|EGM promoted the development of elongated and circumferential structures, 
corresponding to vascular lumen (indicated by arrow). In contrast, protein staining in group 7 – 
OM|cocktail, was relatively weak, although CD31 GE was relatively high. Though, it is not 
uncommon for protein and mRNA levels to differ [27]. vWF protein deposition was consistent 
with CD31 protein deposition, with very weak staining in group 7, and good staining in groups 5 
and 6. Again, elongated structures were stained for vWF at group 6 – OM|EGM.  
 
 
 
Figure 3. Gene expression of endothelial markers after culture. A) CD31 and B) vWF gene 
expression relative to GAPDH. Horizontal line indicates day 1 values. Data are shown as Ave ± SD 
(n=3), *p<0.01 to EGM|cocktail+ASC group.  
 
Groups 1 through 5 had comparable vWF gene expression (GE), which was upregulated 
relatively to day 1, although not significantly different. The same was not observed for groups 6 
and 7, where vWF GE was downregulated relative to day 1. No significant differences were 
obtained between groups. Regarding vWF protein detection by immunohistochemistry (Fig.4), 
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positive staining was obtained for groups 2 (EGM control), 3, 5 and 6. Among these, more 
elongated stained structures are observed in group 6, what is not observed in other 
experimental groups.  
Overall, the cultivation system comprised of hASC adhered to silk scaffold surface, and 
encapsulated in fibrin hydrogel, was not sufficient to support the formation of robust tube like 
structures in the vasculogenic control group (group 2 – EGM), as no lumens were detected 
despite positive staining for CD31 and vWF.  Previous work developed by Heydarkhan-Hagvall 
and colleagues demonstrated formation, by hASC, of branched tube-like structures positive for 
these endothelial markers as early as 2 weeks cultured in same endothelial media [25]. 
Miranville obtained similar observations when culturing in endothelial growth media 
supplemented with VEGF and IGF [10], as well as Planat-Bernard in methylcellulose medium 
[11] and Rehman when cultured ASC in EGM-2MV media [12]. In the current study, we 
observed that sequential nourishment of growth factors was most beneficial to vascular 
development, specifically when osteogenesis was induced before vasculogenesis, consisting of 
the addition of hASC with EGM media at the 3 week time point. Elongated structures were 
identified positive for both CD31 and vWF, in association with what appeared to be small lumen 
in histological sections (Fig.4, black arrow).  
 
 
 
Figure 4. Immunohistological analysis of constructs after 5 weeks. The expression of vascular and 
osteogenic proteins was evaluated. CD31 and von Willebrand Factor (vWF) were expressed in 
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endothelial control group (EGM) as well as in both groups where endothelial differentiation was firstly 
induced (EGM|cocktail & EGM|cocktail+ASC). These proteins were also detected in the group where 
EGM was supplemented after osteogenic differentiation (OM|EGM). Osteopontin (OPN) and bone 
sialoprotein (BSP) were expressed in the matrix of all groups with exception to EGM group, where these 
proteins were detected only at a cellular level. Scale bar = 100 µm. 
 
It is known that osteoblasts secrete not only VEGF but also BMPs, which induce endothelial 
migration, filopodia and tube formation (via activation of the transcription factor Id1 through 
SMADs or ERK signaling) [28, 29]. The osteogenic differentiation of hASC at a first stage may 
lead to the secretion of these growth factors (GF) as the BMPs have been detected at the 
mRNA level in previous studies [30]. Furthermore, hASC added to the system after 3 weeks 
are immediately in close proximity to the GF-secreting osteogenic induced cells. Consequently, 
these paracrine relationships may be playing an important role in stimulating the freshly 
delivered hASC into the endothelial lineage. Given the concurrent outcomes evaluated, we 
propose that culturing conditions provided in group 6 – OM|EGM are the most promising for 
vascular development in this synergistic approach to engineer vascularized bone.  
 
3.3. BONE TISSUE DEVELOPMENT 
Bone tissue markers were assessed in order to evaluate bone development in the proposed 
vascularized bone tissue culture. Bone Sialoprotein II (BSP) and Osteopontin were detected in 
cultured grafts through immunolocalization on histological slides (Fig. 4). As expected, the 
EGM group was the least stained, as this group was not supplemented with osteogenic growth 
factors. The group that showed the strongest osteogenesis was the cocktail group. It seems 
that the simultaneous presence of osteogenic and vasculogenic growth factors over 5 weeks of 
culture improved bone protein deposition. We hypothesized that hASC cultured in endothelial 
media, triggered by angiogenic cues for 2 weeks, would commit to the endothelial cell lineage, 
and consequently be less able to respond to osteogenic cues provided at the second induction 
stage. The addition of fresh hASC at this time-point would potentially respond to the osteogenic 
growth factors present in cocktail media and develop bone tissue, but differences in staining 
intensity were not that evident: groups 4 and 5 - EGM|cocktail and EGM|cocktail+ASC 
respectively, demonstrated comparable bone protein deposition. From groups 6 – OM|EGM 
and 7 – OM|cocktail, that were subjected to osteogenic cues before vasculogenic induction, 
superior staining of bone proteins was observed in group 6.  
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Alkaline phosphatase (AP) activity was quantified as an early marker of osteogenic 
differentiation [31] (Fig. 5). Constructs cultured in OM exhibited a typical progression of 
osteogenic differentiation, as AP activity peaked at 3 weeks of osteogenic induction, and 
decreased by the end culture in all groups. Lower AP activity was detected in groups 6 and 7 
(OM|EGM and OM|cocktail) as endothelial factors were provided at the last two weeks of 
culture. AP activity of cells cultured in EGM media the complete experimental period (EGM 
group) decreased throughout the 5-week culture period, while constructs cultured in cocktail 
media after endothelial media (groups 4 and 5), showed characteristic increases in AP activity, 
suggesting that osteogenesis still occur in these groups, but with delay. Constructs cultured 
during total 5 weeks in cocktail media demonstrated a decrease of AP activity after the first 2 
weeks, increasing by the end of the culture period. 
 
 
 
Figure 5. Alkaline phosphatase activity. n=3, *p<0.01 to EGM|cocktail+ASC.  
 
Mineralization of engineered tissue was evaluated by calcium quantification (Fig. 6). After 5 
weeks of culture, the osteogenic control group (OM) presented the highest amount of calcium, 
significantly different from all other groups (p<0.001), while the vasculogenic control presented 
the least.  Among groups where sequential induction of both lineages were evaluated, group 7 
- OM|cocktail presented the highest amount of calcium deposition, followed by group 6 – 
OM|EGM. Significant differences (p<0.05) were observed between these groups, suggesting 
that osteogenic growth factors present in cocktail media are essential to maintain bone 
development. Constructs from group 5 – EGM|cocktail+ASC demonstrated 1.7x higher 
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calcium content than group 4, suggesting that the addition of hASC at the osteogenic induction 
stage improved calcification of the overall system.  
 
 
Figure 6. Mineralization of tissue engineered grafts after 5 weeks. Calcium content. n=3, #p<0.001 
to all other groups, *p<0.01, **p<0.001.  
 
Taken altogether, in accordance to collected data for bone development in the culturing 
conditions evaluated, we suggest that the combination tested in Group 6 – OM|EGM promoted 
the most promising synergistic deposition of calcium and bone proteins.  
 
3.4. SYNERGISTIC DEVELOPMENT OF VASCULARIZED BONE 
The establishment of an environment suitable for the in vitro development of vascularized bone 
from a single cell source presents a considerable challenge. In this study we proposed 
changing spatio-temporal cues by manipulating delivery of cells to scaffolds and/or timing of 
vasculogenic and osteogenic cues leading to the concomitant formation of the bone and 
vascular compartments in the same scaffold. The collected experimental data are consistent 
with the model presented in Fig. 7. We postulate that hASC adhered to the silk scaffold wall, 
sense its stiff surface, which, in combination with osteogenic cues, trigger cells to undergo 
osteogenic differentiation and secrete mineralized matrix. At a second stage, hASC-
encapsulated in fibrin hydrogel sense the surrounding smooth environment and inherent 
vasculogenic properties, which in combination with vasculogenic growth factors such as VEGF 
and bFGF present in endothelial growth media, trigger undifferentiated hASC to undergo 
differentiation into endothelial cells. 
The results obtained in this study are promising.  However, fully developed networks within the 
bone compartment were not achieved. In a similar study performed by our group, where 
HUVECs and hMSC were co-cultured in order to develop a vascularized bone model, we 
obtained well-developed vasculature, with visible lumen formed after in vitro culture, which 
further anastomosed with host vasculature after 2 weeks of sub-cutaneous implantation in 
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nude mice. Vasculogenic induction with endothelial growth media was performed for 2 weeks, 
as in the present study, although HUVECs, a mature endothelial cell, were capable to 
successfully form tube-like structures and nourish the bone tissue [5]. This reinforces the 
hypothesis that a distinct approach may be needed to account for the undifferentiated state of 
the adipose stem cell. Actually, the fact that the opposite spatio-temporal application of cells 
and differentiation cues resulted in most promising outcomes is already an insight to guide 
future experiments.  
 
 
 
Figure 7. Model of in vitro coordination of bone and vascular tissue development. hASC (beige 
spindle-shape) adhered to silk scaffold wall, sense the hard surface and osteogenic factors provided, 
stimulate osteogenic differentiation (green cells) and deposition of mineralized matrix (grey). At a 
second stage, hASC encapsulated in fibrin hydrogel (light blue) are triggered by smooth vasculogenic 
surface growth factors provided, to undergo endothelial differentiation (red cells). 
 
Moreover, our results are additive to those obtained by Gardin and co-workers, which remains, 
to our knowledge, the only study that previously explored the concurrent osteogenic and 
endothelial in vitro commitment of hASC [32]. In this work, hASC loaded to a fibronectin coated 
hydroxyapatite scaffold were exposed to either osteogenic induction only, vasculogenic 
induction only, or a mixture of both osteogenic and vasculogenic growth factors for 21 days, in 
vitro. In their hands, concurrent gene expression of both osteogenic markers osteopontin, 
Chapter VII – Human adipose stem cells can serve as a single cell source for the in vitro cultivation of vascularized bone grafts 
 
	  212	  
osteonectin, osteocalcin, collagen type I and vasculogenic markers CD31, von Willebrand 
Factor, VEGF was achieved. Our study extends the work by Gardin et al to design an 
engineered vascularized bone graft.  We further explored the development of both tissues by 
investigating: 1) the sequential application of cells and/or osteogenic and vasculogenic growth 
factors to the system; and 2) evaluation of outcomes based on tissue formation where, besides 
gene expression, we also assessed the deposition of bone and endothelial specific proteins 
within the engineered graft, as well as mineralization of the tissue construct. Therefore, we may 
furthermore propose our approach as an in vitro model for studying and optimizing both spatial 
and temporal effects of cell and growth factor delivery. 
 
4. CONCLUSIONS 
This study supports the hypothesis that human adipose derived stem cells may be used as a 
single cell source for the formation of vascularized bone. Three culture approaches were tested 
in order to differentiate both osteogenic and endothelial lineage: 1) simultaneous construct 
nourishment with bone and vascular growth factors; 2) induction of vasculogenesis before 
osteogenesis; and 3) induction of osteogenesis before vasculogenesis, to show that the 
osteogenic induction was necessary before supplying the construct with fresh cells and growth 
factors for vascularization. This last combination, in particular the osteo-induction of hASC 
seeded to silk scaffold for 3 weeks, followed by addition (to the free pore spaces of the 
construct) of fibrin-encapsulated hASC to which vasculogenic cues were provided for 2 weeks, 
resulted in the most promising outcomes towards engineered vascularized bone grafts.  
Nevertheless, extensive research has yet to be performed in order to understand cell crosstalk 
and underlying mechanisms associated with multilineage cell differentiation of hASC and 
interactions responsible for the development of a robust functional vascularized bone graft 
useful for successful therapeutic applications. 
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Abstract 
Tissue engineering provides unique opportunities for regenerating diseased or damaged 
tissues using cells obtained from tissue biopsies. Tissue engineered grafts can also be used as 
high fidelity models to probe cellular and molecular interactions underlying developmental 
processes.  In this study, we co-cultured human umbilical vein endothelial cells (HUVECs) and 
human mesenchymal stem cells (MSCs) under various environmental conditions to elicit 
synergistic interactions leading to the colocalized development of capillary-like and bone-like 
tissues. Cells were encapsulated at the 1:1 ratio in fibrin gel to screen compositions of 
endothelial growth medium (EGM) and osteogenic medium (OM).  It was determined that, to 
form both tissues, co-cultures should first be supplied with EGM followed by a 1:1 cocktail of 
the two media types containing bone morphogenetic protein-2. Subsequent studies of HUVECs 
and MSCs cultured in decellularized, trabecular bone scaffolds for 6 weeks assessed the 
effects on tissue construct of both temporal variations in growth-factor availability and addition 
of fresh cells. The resulting grafts were implanted subcutaneously into nude mice to determine 
the phenotype stability and functionality of engineered vessels. Two important findings resulted 
from these studies: (i) vascular development needs to be induced prior to osteogenesis, and (ii) 
the addition of additional hMSCs at the osteogenic induction stage improves both tissue 
outcomes, as shown by increased bone volume fraction, osteoid deposition, close proximity of 
bone proteins to vascular networks, and anastomosis of vascular networks with the host 
vasculature. Interestingly, these observations compare well with what has been described for 
native development.  We propose that our cultivation system can mimic various aspects of 
endothelial cell – osteogenic precursor interactions in vivo, and could find utility as a model for 
studies of heterotypic cellular interactions that couple blood vessel formation with 
osteogenesis. 
 
1. INTRODUCTION 
In native bone, synergistic interactions between osteoblasts/osteogenic precursors and 
endothelial cells enable coordinated development of vasculature and mineralized tissue. In the 
process of intramembranous ossification during craniofacial bone growth, this cell coupling 
results in close spatial relationships between the two tissues in newly forming bone, with the 
vascular network serving as a ‘template’ for bone mineral deposition [1]. A synergy between 
the two cell populations has also been observed during endochondral ossification. A murine 
model was used to demonstrate that when the HIF-1α protein was constitutively activated in 
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osteoblasts by conditional deletion of the Vhl gene, the result was higher vascularity in long 
bones with complementary increases in bone volumes [2]. In a recent study, it was shown that 
osteoblast precursors occupy pericytic locations as they invade the cartilage template along 
with blood vessels to form new trabecular bone during ossification of long bones [3]. Still, many 
of the mechanisms guiding interactions between endothelial cells and osteogenic precursors 
remain largely unknown due to the complexity of the in vivo environment. 
The need to vascularize tissue engineered bone grafts, during culture and following 
implantation, has led to studies between endothelial cells and osteoblasts/osteo-progenitors [4-
7]. Interestingly, despite the preponderance of evidence linking vascular development and 
osteogenesis in vivo, it has been decidedly difficult to simultaneously form capillary-like 
networks and mineralized deposits in vitro, within a single culture environment. Whereas 
beneficial effects of osteogenic precursors on vascular network formation have been 
demonstrated [7, 8], adequate formation of bone-like tissue within the same constructs has not 
been achieved. The effect of endothelial population on osteogenesis remains conflicting: some 
studies have indicated a positive effect of endothelial cells on mineral deposition [6, 9-12], 
while other studies have described molecular pathways via which endothelial cells inhibited 
osteogenesis [13, 14]  
Recently, one group circumvented the difficulty of inducing adequate vascular development 
and osteogenic differentiation by seeding mesenchymal stem cells (MSCs) into polymer 
scaffolds and inducing osteogenesis prior to seeding MSCs and human umbilical vein 
endothelial cells (HUVECs) into a gel substrate [15]. When these constructs were implanted 
subcutaneously into the dorsum of nude mice, developed vascular networks anastomosed to 
the host vasculature, while after eight weeks of in vivo cultivation evidence of mineral 
deposition was revealed. Several other groups have shown that implanting biomaterial 
constructs with a mixture of mesenchymal and vascular or hematopoietic progenitor cells 
enabled the development of vascularized tissues in vivo [12, 16-18]. However, realistic in vitro 
cultivation models are required to elucidate the mechanistic interactions of both cell populations 
during the formation of vascularized bone. 
In this study, we hypothesize that the sequential application of growth factors, to firstly induce 
the formation of stable vasculature and subsequently initiate osteogenic differentiation, could 
provide a biologically-inspired in vitro model of bone vascularization. HUVECs and human 
MSCs were cultured in decellularized trabecular bone constructs using fibrin as a cell carrier to 
provide an environment conducive to the formation of capillary-like networks. Coordinated 
development of the two tissue compartments was evaluated over a two-stage procedure (6 
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weeks in vitro culture followed by a 2 week sub-cutaneous implantation), to establish an 
alternative model for engineering bone-like constructs containing vascular networks (Fig. 1).  
 
2. MATERIALS & METHODS 
2.1. MATERIALS 
Fetal bovine serum (FBS), Dulbecco’s Modified Eagle Medium (DMEM), Penicillin–
Streptomycin (Pen–Strep), HEPES and trypsin/EDTA were obtained from Invitrogen (Carlsbad, 
CA). Ascorbic acid-2-phosphate, dexamethasone, sodium-β-glycerophosphate, Triton X-100, 
fibrinogen and thrombin were obtained from Sigma-Aldrich (St. Louis, MO). Basic fibroblast 
growth factor (bFGF) and bone morphogenetic protein 2 (BMP2) were obtained from 
Peprotech (Rocky Hill, NJ). Endothelial Growth Medium-2 (EGM) was obtained from Lonza 
(Walkersville, MD). Phosphate buffered saline (PBS) and proteinase K were obtained from 
Fisher Scientific (Pittsburgh, PA). All other substances were of analytical or pharmaceutical 
grade and obtained from Sigma-Aldrich. 
 
2.2. HUMAN MESENCHYMAL STEM CELLS (MSCS) 
Bone marrow-derived human mesenchymal stem cells (MSCs) were isolated from the 
mononuclear fraction of a bone marrow aspirate obtained from a commercial source (Cambrex, 
CA) based on their attachment to tissue culture plastics [19] , expanded in high glucose DMEM 
supplemented with 10 % FBS, 1 % Pen–Strep and 1 ng/mL basic fibroblast growth factor 
(bFGF) to the 3rd passage. These cells have been characterized for their ability to differentiate 
into osteogenic, chondrogenic, and adipogenic phenotypes in vitro and for their ability to give 
rise to new bone formation in vitro and in vivo [19-21]. Three independent series of 
experiments were performed, each with triplicates of samples for each experimental group, 
data point and analytical method. 
 
2.3. HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS (HUVECS) 
Fresh umbilical veins were obtained from the neonatal unit at Columbia University following an 
approved IRB protocol (IRBAAAC4839). To isolate HUVECs, the vein was flushed with HEPES 
buffer to remove residual blood and treated with trypsin for 15 minutes to remove the 
endothelial cells. Cells were flushed from the vein with HEPES and collected in centrifuge 
tubes. The suspension was centrifuged at 300 g for 5 minutes and the supernatant was 
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discarded. Cells were resuspended in EGM and cultured in tissue culture flasks. Non-adherent 
cells were washed out after 1 day. When the HUVECs grew to confluence, they were 
trypsinized, counted and cryopreserved.  
 
2.4. MEDIUM SCREENING STUDIES 
In this study, HUVECs were expanded in EGM to the 4th passage. HUVECs used in preliminary 
screening studies were suspended in serum-free medium at 1 × 106 cells/mL and then 
incubated with 10 ml/mL of Vybrant DiI (Molecular Probes) for 30 minutes at 37 ºC. The cells 
were washed of excess dye three times prior to mixing with hMSCs in a 1:1 ratio, and 
encapsulation in fibrin hydrogel in the wells of a 96-well plate and cultured for 4 weeks in vitro. 
A 1:1 ratio was chosen in pilot studies (data not shown) as it provided robust and stable 
vascular networks while enabling bone formation. The hydrogels were divided into five groups 
depending on the various growth medium provided the constructs. These included osteogenic 
medium (OM) containing low glucose DMEM, 10% FBS, 1% Pen–Strep supplemented with 
osteogenic factors: 100 nM dexamethasone, 10 mM sodium-β-glycerophosphate, and 50 
µg/mL ascorbic acid-2-phosphate.  The other groups were provided EGM or a cocktail of OM 
and EGM in a 1:1 ratio. The temporal sequence was investigated by providing the cells EGM 
only for 2 weeks followed by cocktail for the subsequent two weeks or cocktail medium 
supplemented with 10 ng/ml of BMP-2. The development of vascular structures was imaged 
with a Zeiss 510 confocal microscope using an image stack 200 µm thick with 10 µm spacing 
between slices. 
 
2.5. DECELLULARIZED BONE SCAFFOLDS 
Bone plugs (4 mm diameter × 2 mm high) were prepared as in our previous studies [22]. 
Briefly, trabecular bone was cored from the subchondral region of carpometacarpal joints of 2-
week to 4-month old bovine calves, washed with high velocity stream of water to remove the 
marrow from the pore spaces, followed by sequential washes in PBS, hypotonic buffer, 
detergent and enzymatic solution to remove any remaining cellular material. At the end of the 
process, decellularized bone plugs were rinsed repeatedly in PBS, freeze-dried and cut into 
scaffolds for cell cultivation. The dry weight and exact length of each plug was measured and 
used to calculate the scaffold density and porosity. Scaffolds were sterilized in 70% ethanol for 
one day and incubated in culture medium overnight prior to cell seeding. 
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2.6. CELL ENCAPSULATION AND SEEDING 
To induce bone formation, 20 µl suspension of MSCs at a density of 10 × 106 cells/mL was 
seeded into blot-dried scaffolds, divided into five groups, and incubated overnight to allow cell 
attachment as shown in Fig. 1. At day 1, the solutions of fibrinogen (5 mg/mL) and thrombin 
(10 Units/mL) were prepared. In Groups 1 – 4, HUVECs and MSCs, intended to form stable 
vasculature network, were encapsulated in fibrin at a 2:1 ratio and a density of 30 × 106 
cells/mL. Thrombin was added to crosslink the gel, giving a final fibrin concentration of 4 
mg/mL. Before crosslinking occurred, 20 µl of cell/gel suspension was pipetted into blot-dried 
scaffolds to allow uniform cell seeding throughout the scaffolds. Before the gels became fully 
cross-linked, they were aspirated under a light vacuum so that the fibrin gel coated the walls of 
the scaffolds, but did not fill the pore spaces. In Group 5, this same step was performed on 
MSC-seeded scaffolds after 4 weeks of osteogenic culture. 
 
 
 
Figure 1. Schematic of experimental approaches. Groups 1 & 2 are ‘controls’ where constructs were 
provided osteogenic supplements (OM) or endothelial factors (EGM) for 6 weeks. In Groups 3 & 4, 
vascular differentiation was induced for 2 weeks before adding osteogenic factors in a cocktail medium 
(EGM+OM at 1:1 ratio). No additional cells were added at this point in Group 3 (EGM|cocktail), while 
osteo-induced MSCs were seeded into the pore spaces in Group 4 (EGM|cocktail+MSCs). These were 
compared with cultures in Group 5 where only MSCs were added initially and cultured in OM for 4 
weeks. A co-culture of HUVECs and MSCs were then added and constructs cultured in cocktail medium 
(OM|cocktail) for remaining 2 weeks. Constructs of all groups were implaneted sub-cutaneously in 
nude mice for additional 2 weeks. 
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2.7. IN VITRO CULTURE 
Five experimental groups were established to study vascularized bone constructs, including 
three main groups and two controls (Fig. 1). Group 1 (control for osteogenic conditions) 
utilized osteogenic medium (OM) throughout the culture, containing low glucose DMEM, 10% 
FBS, 1% Pen–Strep supplemented with osteogenic factors: 100 nM dexamethasone, 10 mM 
sodium-β-glycerophosphate, and 50 µg/mL ascorbic acid-2-phosphate, supplemented with 
BMP-2 (at 10 ng/mL) for 6 weeks. Group 2 (control for vasculogenic conditions) utilized 
endothelial growth medium (EGM) throughout the culture. Group 3 utilized EGM for 2 weeks 
and then a cocktail medium composed by EGM and OM at 1:1 ratio (EGM|cocktail) for 4 
weeks. Group 4 was designed exactly as Group 3 except that osteo-induced MSCs were 
added into scaffold pore spaces at the 2-week time point (EGM|cocktail+MSC). In Group 5, 
MSCs only were seeded into the scaffolds and cultured in osteogenic medium for 4 weeks, at 
which point HUVECs and MSCs in fibrin were added to the constructs and cultured in cocktail 
medium for an additional 2 weeks (OM|cocktail).  
 
2.8. IN VIVO IMPLANTATION 
After 6 weeks of in vitro culture, constructs of all groups were evaluated for 2 weeks in a 
subcutaneous implantation nude mouse model in vivo. NOD SCID mice (NOD.CB17-
Prkdcscid/NCrHsd, Harlan) were anaesthetized by a subcutaneous injection of ketamine (80-100 
mg/kg) and xylazine (5-10 mg/kg). Analgesia was provided with buprenorphine (0.05-0.1 
mg/kg). Constructs were implanted into separate subcutaneous dorsal pockets (one construct 
per pocket, two pockets per animal) according to an approved Columbia University Institutional 
Animal Care and Use Committee (IACUC) protocol. Implants were retrieved after 2 weeks for 
analysis of blood vessel anastomosis and bone growth. 
 
2.9. DNA ASSAY 
Constructs were washed in PBS, cut in half, placed into micro-centrifuge tubes and incubated 
overnight at 56°C in 1 mL of digestion buffer (10 mM Tris, 1mM EDTA and 0.1% Triton X-100) 
containing 0.1 mg/mL proteinase K. The supernatants were collected and diluted 10 times to 
bring into the linear range of the Picogreen assay.  A standard curve was prepared from a 
solution of bacteriophage λ DNA obtained from Molecular Probes. Picogreen dye (Molecular 
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Probes, OR) was added to the samples in 96-well plates (100 µL dye into each 100 µL 
sample) and read in a fluorescent plate reader (excitation 485 nm, emission 528 nm).  
 
2.10. LIVE-DEAD ASSAY 
Constructs were cut in half, washed in PBS, incubated with calcein AM (indicating live cells) 
and ethidium homodimer-1 (indicating dead cells) according to manufacturer’s protocol 
(LIVE/DEAD (R) Viability/Cytotoxicity Kit, Molecular Probes) and imaged on a confocal 
microscope. Optical slices were taken from the surface at 10 µm intervals, up to the depth of 
160 µm and presented as a vertical projection. 
 
2.11. IMMUNOHISTOCHEMISTRY 
Constructs were washed in PBS and fixed in 10% formalin for 1 day.  Samples were then 
decalcified for 2 days with Immunocal solution, dehydrated in graded ethanol washes, 
embedded in paraffin, sectioned to 5 µm and mounted on glass slides. Sections were 
deparaffinized with Citrisolv, rehydrated with a graded series of ethanol washes, blocked with 
normal serum, and stained with primary antibodies followed by the secondary antibody and 
development with a biotin/avidin system. Immunohistochemistry was performed for anti-human 
collagen I (Abcam ab6308), bone sialoprotein II (BSP) (Chemicon AB1854), CD31 (Millipore 
04-1074) and von Willebrand factor (vWF) (Sigma-Aldrich F3520). Counterstaining was 
performed with hematoxylin. The serum, secondary antibody and developing reagents were 
obtained from Vector Laboratories and included in the Vector Elite ABC kit (universal) 
(PK6200) and DAB/Ni Substrate kit (SK-4100). Negative controls were performed by omitting 
the primary antibody incubation step. 
 
2.12. MICRO COMPUTERIZED TOMOGRAPHY (µCT) 
µCT was performed on all five cell-seeded groups after 6 weeks of in vitro culture. As a control, 
unseeded scaffolds were remained in OM throughout culturing period and analyzed at this time 
point. A modification of a previously developed protocol was used [23]. The samples were 
aligned along their axial direction and stabilized in a 2 mL centrifuge tube that was clamped 
within the specimen holder of a vivaCT 40 system (SCANCO Medical AG, Basserdorf, 
Switzerland). The 2 mm length of the scaffold was scanned at a 21 µm isotropic voxel size. 
The total bone volume (BV), accounting for the sum of the bone matrix in the scaffold and the 
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new mineralized bone, was obtained from the application of a global thresholding technique so 
that only the mineralized tissue is detected. The bone volume fraction (BV/TV) was calculated 
as the ratio of the BV and the total volume (TV) of the sample. Spatial resolution of this full 
voxel model was considered sufficient for evaluating the micro-architecture of the samples.  
 
2.13. EVALUATION OF IN VIVO ANASTOMOSIS AND NEW BONE FORMATION 
After 2 weeks of subcutaneous implantation in NOD SCID mice, samples were harvested, 
washed in PBS and macroscopic photographs were taken with the stereomicroscope. Samples 
were cut in half, and used for soft and hard tissue histology. Anastomosis of in vitro developed 
capillary networks with host vasculature was evaluated by immunolocalization of human CD31 
(Millipore 04-1074) as described above. Counterstaining with hematoxylin was performed to 
detect mouse red blood cells within human capillary lumen. New bone formation was evaluated 
on undecalcified sections processed according to hard tissue histology methods: constructs 
were fixed in 10% formalin for 1 day and dehydrated with sequential washes in 70 % ethanol (2 
days), 100 % ethanol (2 days with twice daily solution changes), and toluene (2 days with once 
daily solution change). Constructs were then washed in activated methyl methacrylate (MMA) 
with daily changes of MMA solution for four days at 4 °C, and then placed at 32 °C until the 
MMA cured. Plastic-embedded sections were sectioned to 8 µm on a Leica hard tissue 
microtome. Staining for the new osteoid formation was done using the traditional Goldner’s 
Masson trichrome stain. 
 
2.14. STATISTICS 
Statistical analysis was performed using the GraphPad Prism 4.0c software. A one-way 
analysis of variance (ANOVA) with Tukey’s multiple comparison post-hoc test was used to 
verify statistically significant differences among groups. p< 0.05 were considered statistically 
significant. Data is presented as mean±SD. 
 
3. RESULTS 
3.1. FORMATION OF VASCULAR NETWORKS IN FIBRIN HYDROGELS 
We confirmed that capillary networks formed from HUVECs are stable in vitro only in the 
presence of MSCs (Fig. S1). Robust networks were observed in confocal microscopy within 
two weeks of culture in constructs cultured in endothelial growth media (Fig. S2 – EGM group) 
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and remained stable throughout the 6 weeks of cultivation.  When OM was used at the 
beginning of the culture period (Fig. S2 – OM group), the cells did not form networks. Instead, 
significant amounts of ‘debris’ from the diI-stained HUVECs were observed by confocal (and 
used as a pseudo parameter for evaluating HUVEC viability). Cells in the cocktail medium 
(EGM+OM 1:1 ratio) formed vascular networks, as evidenced via confocal imaging of the pre-
stained HUVECs, however high amount of cell debris was observed (Fig. S2 – cocktail group).   
Sequential induction was investigated in Group 3 and Group 4 constructs, using EGM first, 
since HUVECs did not survive well if OM was used first. In both groups, vascular networks that 
formed within the first two weeks were maintained for the duration of culture. However, 
supplementation of cocktail medium (EGM+OM 1:1 ratio) with BMP-2 (10 ng/mL) significantly 
decreased the amount of cell debris, suggesting that BMP-2 may help maintain the viability of 
the endothelial cell population (Fig. S2 – EGM|cocktail+BMP group).  
The amount and pattern of mineral deposition also differed significantly when sequential 
induction was utilized (Groups 3 and 4) as compared to the osteogenic conditions applied 
throughout culture (Group 1). Notably, the new mineral deposition was observed mostly in the 
close spatial proximity to vascular networks, particularly in the EGM|cocktail+BMP2 group.  
From these studies, it was determined that sequential induction was needed to facilitate the 
development of both structures within single constructs for bone tissue engineering 
applications. 
 
 
 
Figure 2. DNA contents of constructs after 6 weeks of in vitro culture. Upper: Horizontal line 
indicates day 1 values. n = 3; * indicate p < 0.05 in comparison to day 1 values. # indicate p < 0.05 
among groups. Lower: Live/dead imaging of constructs after in vivo culture. Scale bar =200µm. 
 
Chapter VIII – In vitro model of vascularized bone: synergizing vascular development and osteogenesis 
 
	  226	  
3.2. FORMATION OF BONE AND CAPILLARY NETWORKS IN SCAFFOLDS CULTURED IN VITRO 
Based on the screening studies performed on fibrin gel, we chose to supplement all osteogenic 
medium with BMP-2 for its role in maintaining the viability of the endothelial population. 
HUVECs and hMSCs were seeded uniformly throughout the decellularized bone scaffold and 
located predominantly on the wall surfaces (Fig. S3). The DNA content of constructs revealed 
that OM enhanced cell proliferation considerably more than EGM (p < 0.05). This was clearly a 
specific cellular response to factors in the OM medium since EGM|cocktail also had more cells 
than EGM only. Not surprisingly, Group 4 (EGM|cocktail+MSC ) and Group 5 (OM|cocktail) 
had the most cells (Fig. 2), given that more cells were added to these constructs. Confocal 
microscopy demonstrated cell viability in all groups (Live/Dead assay) and robust capillary 
networks, in Group 3 and Group 4 (calcein assay) (Fig. 2).  
The two control groups, OM (Group 1, osteo-induction) and EGM (Group 2, vascular induction) 
were compared to Groups 3, 4 and 5 where vascular supplements were applied in sequence 
with osteogenic supplements. Anti-human CD31 and vWF staining demonstrated formation of 
vascular structures in all groups except for the OM (Group 1). Vascular structures were clearly 
most developed in EGM|cocktail (Group 3) and EGM|cocktail+MSC (Group 4). While there 
were CD31 and vWF positive cells in the OM|cocktail groups, the vascular networks did not 
show signs of maturity as evidenced by the sizes of lumens in the structures (Fig. 3). 
 
 
Figure 3. Immunohistological analysis of constructs cultured in vitro. Engineered bone grafts were 
evaluated for the expression of vascular and osteogenic proteins. CD31 (black arrows) and vWF 
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(indicated by *) expression was observed in constructs from all groups. Vascular structures were most 
developed in EGM|cocktail and EGM|cocktail+MSC groups. Collagen I & BSP were readily apparent 
in the OM group. Expression was observed in individual cells in EGM group, but not distributed through 
matrix. Both collagen I & BSP were observed in all other groups. In EGM|cocktail+MSC group, BSP 
appeared in close proximity to the vascular structures. Scale bar = 20 µm. 
 
The OM group stained most intensely for collagen I and bone sialoprotein II (BSP), which are 
indicative of osteogenic differentiation, with incorporation of both collagen and BSP into the 
new tissue matrix. In contrast, the osteogenic markers in the EGM group were confined to 
individual cells. In the EGM|cocktail+MSC group, high expression of BSP was observed in 
spatial proximity to lumenal structures (Fig. 3). BV/TV of tissue constructs, determined by µCT, 
demonstrated a concordant trend: constructs that were cultured for 6 weeks in osteogenic 
medium showed the highest BV/TV, while those cultured in endothelial growth medium, show 
the lowest BV/TV that was close to that observed for unseeded scaffolds. In all other groups, 
the BV/TV was comparable to that in the OM group, being highest for the EGM|cocktail+MSC 
group (Fig. 4).  
 
Figure 4. Ratio of bone material volume over tissue volume (BV/TV) of constructs after in vitro 
culture. n = 3; * indicate p < 0.05 and ** indicate p < 0.001  in comparison to unseeded group.  # 
indicate p < 0.05 among both groups. 
 
3.3. PROPERTIES OF CAPILLARY NETWORKS IN VIVO 
Macroscopic photographs taken with the stereomicroscope indicated in-growth of large, well-
developed blood vessels into each of the constructs (Fig. 5). In some groups, blood perfusion 
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through microvascular network structures was also observed. Only a few capillaries were seen 
in the OM group, as compared to a higher vascular density in the EGM group.  Groups 3 and 4, 
where vasculogenesis was induced prior to osteogenic differentiation, showed the development 
of the most robust capillary networks.   
 
Figure 5. Composition of engineered grafts. Top row: Gross images of constructs post-harvest 
showing the translucent capsule and the in-growth of blood vessels. Constructs are perfused to different 
extents in different experimental groups. The large blood vessels also seem to anastomose to 
engineered microvasculature resulting in blood flow through capillary-like networks. This is particularly 
evident in EGM|cocktail and EGM|cocktail+MSC groups. Scale bar = 500 µm. Second row: 
Constructs were stained with anti-human CD31. Capsular region filled with mouse cells are shown with 
asterisks (*). In EGM|cocktail and EGM|cocktail+MSC groups, lumen (stained with anti-human CD31) 
are larger and well-developed (black arrows) with red blood cells inside (stained with hematoxylin). In 
OM|cocktail group, there is little evidence of human-derived vascular tissue. Large vessel-like 
structures in the capsular region are not stained with anti-human CD31 mAb and are probably of mouse 
origin (yellow arrow heads). Scale bar = 50 µm. Rows 3 and 4: In vivo bone development. Goldner’s 
Masson trichrome staining of non-decalcified constructs indicate distinct levels of osteoid formation 
among groups (red stains). Third row: scale bar = 20 µm, Bottom row: scale bar = 500 µm. 
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Decalcified constructs were stained with anti-human CD31 to confirm that the vascular 
networks present prior to implantation remained viable and functional in vivo. Positively stained 
structures were found with cells inside, in all groups where vasculogenesis was induced prior to 
osteogenesis (Groups 3 and 4) suggesting that the perfused microvasculature might be of 
human origin (Fig. 5 and Fig. S4). Although there were positively stained cells in the 
OM|cocktail group, these vessels were not well developed and there was no evidence of 
perfusion. Non-decalcified grafts harvested from in vivo studies were stained with Goldner’s 
Masson Trichrome to visualize osteoids, which were observed to a higher extent in the OM and 
EGM|cocktail+MSC groups. Clearly, the least osteoid formation was observed in the EGM 
group. 
 
3.4. PROPOSED MODEL OF THE DEVELOPMENT OF VASCULARIZED BONE IN VITRO 
In initial hydrogel studies, we found that providing osteogenic medium to co-cultures of 
HUVECs and hMSCs was detrimental to vascular formation. As a result, subsequent studies 
induced robust vascular development through the application of EGM for two weeks. Early 
studies demonstrated that the capillary-like structures were formed by HUVECs within a couple 
days and were only stable in the presence of hMSCs. This suggests that the hMSCs may be 
playing a pericyte-like role in this system (Figure 6).  
 
 
 
Figure 6. Model of in vitro coordination of vascular and bone tissue development. In a co-culture 
of ECs and hMSCs (beige, spindle-shaped cells), angiogenic supplements provide cues to stimulate the 
formation of primitive vascular networks (red) by the ECs (dispersed ECs are not shown in the model). 
These, in turn, recruit hMSCs into a pericyte-like role (green) that enables the vascular network to 
remain stable when osteogenic cues are provided. These cues induce osteoblast formation (blue cells) 
and deposition of mineralized matrix (beige).  
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One prevailing view in the literature is that the process of perivascular cell migration and 
recruitment is mediated by PDGFR signaling [24-26]. Sequential addition of osteogenic factors 
to the EGM, and potential BMP expression by EC’s [27] facilitated de novo bone formation by 
undifferentiated hMSCs over a period of several weeks. The bone formation was augmented 
when osteo-induced MSCs were added to the bone scaffolds at the same time as the 
osteogenic supplements. Moreover, several studies have shown that BMP stimulate VEGF 
expression in osteoblasts, and VEGF up-regulate BMP-2 mRNA and protein expression in 
microvascular endothelial cells [27, 28].  
 
4. DISCUSSION 
The major goal of this study was to test the hypothesis that the sequential application of growth 
factors, to first induce the formation of stable vasculature and then initiate osteogenic 
differentiation, could provide a biologically-inspired in vitro model of bone vascularization. To 
this end, we systematically studied cultivation conditions that give rise to both functional 
vascular structures and robust osteogenesis using HUVEC-MSC co-cultures in conjunction 
with previously developed tissue engineering and bioreactor methods [19, 20, 29]. We propose 
that the system used in this study might provide a high-fidelity tissue engineering model of 
vascularized bone for mechanistic studies of heterotypic cell-cell interactions between 
endothelial cells and osteo-progenitors. In fact, a recent study showing that vascular 
endothelial cells may possess an intrinsic capability of transitioning to mesenchymal 
progenitors [30] opens tremendous possibilities for the role of endothelial cells in this model.   
In our model, the MSCs have two major roles: as pericytes stabilizing vascular networks and as 
osteogenic progenitors forming mineralized bone matrix. Several published studies show that 
bone marrow-derived MSCs adopt pericyte-like locations during in vitro co-culture with mature 
endothelial cells [15, 31, 32] or when co-delivered in vivo with mature endothelial cells [24, 33, 
34]. Our study supports these previous observations as the capillary-like structures formed by 
HUVECs were only stable in the presence of hMSCs (Fig. S1). 
The ability of MSCs to respond with spatial and temporal specificity to differentiation cues was 
key in gel studies where all cells were seeded at the beginning of culture and no cells could be 
introduced at later stages of culture (supplemental data). From these preliminary studies, 
several key outcomes were identified that determined the selection of experimental groups for 
the subsequent scaffold study: (i) a sequential-induction approach enabled vascular-osteogenic 
outcomes within the same culture space, with the need for endothelial growth factors to be 
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provided prior to osteogenic induction, and (ii) the role of BMPs as a vascular promoter was 
confirmed [35] even during in vitro culture. Mineralization of the tissue matrix was evident in the 
groups containing vascular networks, although to limited extent as cells were exposed to osteo-
inductive medium for only two weeks.  Thus, a longer osteo-induction period was adopted 
during scaffold studies.   
Trabecular bone scaffolds also provided great versatility of the in vitro co-culture system and 
enabled the evaluation of concurrent supplementation of growth factors and fresh MSCs 
responding to these growth factors. We also investigated the hypothesis of MSCs losing their 
ability to respond to osteogenic factors during the two-week exposure to vascular supplements, 
by comparing Group 4 (EGM|cocktail+MSC, in which osteo-induced MSCs were added along 
with cocktail medium) with the Group 3 (EGM|cocktail, in which the same MSCs present at the 
beginning of culture were exposed to cocktail medium). Data suggests that fresh MSCs 
enhance bone formation, as verified by increased bone volume fraction (Fig. 4), osteoid 
deposition (Fig. 5), and spatial proximity of bone proteins to vascular networks (Fig. 3). 
However the addition of additional MSCs is not critical, as bone formation also occurred in 
Group 3 (EGM|cocktail).  This suggests that MSCs may act initially as pericytes [15, 31, 32], 
but maintain the ability to undergo osteogenesis, which is arguably consistent with the prior 
evidence that osteoblasts take up pericytic locations in vivo [3].  
By adding HUVECs at the latter stages of culture, it was possible to evaluate osteogenesis that 
has been induced in the scaffolds prior to providing vascular cells and growth factors, an 
approach similar to that taken by Tsigkou et al [15]. This approach to improve vascularized 
bone tissue development (OM|cocktail group) was moderately successful: we observed 
reasonable osteogenic development as evidenced by deposition of bone protein, osteoid 
formation and the BV/TV ratio. However, two-week exposure to vascular growth factors was 
not sufficient to develop robust vascular structures, as evidenced by the sizes of vessel lumens 
that were smaller than those observed in Groups 3 and 4. In these two groups, not only lumen 
were evident after in vitro cultivation, they also anastomosed well during in vivo implantation, 
which is consistent with the earlier reports that well-developed vascular networks are 
necessary for functional anastomosis [36-39], although recent studies suggest that is also 
possible to obtain functional network formation without extensive in vitro cultivation [8, 15]. 
These studies open several under-explored areas of investigation.  For example, the DNA 
content was considerably higher in the OM group relative to the EGM group, suggesting that 
HUVECs may have survived better as a result of BMP2 supplementation in osteogenic media 
(Fig. 4).  
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In future studies, it might be relevant to distinguish whether HUVECs and MSCs are equally 
stimulated in this group and to decipher the role of cell proliferation in tissue development. 
Also, despite promising results, our studies suggest that alternative cocktails (e.g. EGM|OM or 
increased vascular growth factor concentration in OM|cocktail group) could be tested to 
synergistically improve mineralization with vascular network formation. Likewise, further studies 
are needed to optimize the temporal stages of culture, as the two-week period of vascular 
induction was selected based on the robust network structures observed for fibrin gel studies.  
Overall, by providing temporal variation of the culture environment, we were able to 
demonstrate the ability to derive vascular networks and induce bona fide osteogenic 
differentiation within single tissue grafts during in vitro cultivation. Notably, functional vascular 
networks and viable osteoid formation were detected post-implantation. The most successful 
approach involved induction of vasculogenesis prior to osteogenesis, with the addition of osteo-
induced MSC further improving tissue outcomes. Finally, while the focus of our study was to 
evaluate ‘functional’ outcomes such as vessel formation and matrix mineralization, significantly 
more work is needed to elucidate the underlying mechanisms that regulate heterotypic 
interactions and understand the interactive roles of multiple growth factors. 
In summary, it has long been accepted that vascularization is essential for the advancement of 
tissue-engineered bone grafts to clinical application [40]. Due to the close interaction between 
MSCs and HUVECs in co-culture systems, it may be possible to utilize the proposed tissue 
engineering model as a controllable experimental tool to elucidate other molecular mechanisms 
regulating the heterotypic cell-cell interactions. Such studies could have relevance for gaining 
further insights into developmental processes [41] and cellular interactions under conditions of 
disease.  
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Supporting Information  
 
 
Figure S1: Gel cultivation. A: HUVECs only at 3 weeks in EGM-2. Co-culture of HUVECs with MSCs 
(1:1) enables formation of stable micro-vasculature networks at 3 weeks in EGM-2 (B) that last up to 12 
weeks (C) during in vitro culture. D: von Willebrand Factor (vWF) staining of lumen. 
 
 
Figure S2: Gel screening studies.  HUVECs (pre-stained with Di-I) and MSCs were encapsulated in 
fibrin hydrogels (1:1 ratio) and cultured in small wells for 4 weeks to determine cellular responses to 
different medium conditions. Confocal images were used to evaluate vascular network formation and 
provide a read-out on HUVEC viability (cellular debris). Scale bar= 50 µm. Bottom row: von Kossa 
staining of mineral deposition within the gel regions.  Mineral is shown as black/dark brown stains within 
the gels. 
 
 
Figure S3: H&E staining of constructs at day 1. Cells are uniformly distributed throughout the 
scaffold upon seeding. Cells are located predominantly on the wall surfaces of scaffolds but grow into 
pore spaces subsequently. 
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Figure S4: EGM|cocktail+MSC group stained with anti-human CD31 mAb. Human origin lumen, with 
red blood cells inside (stained with hematoxylin) are pointed with yellow arrows.  
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Major conclusions 
Tissue engineering has proven its potential on providing valuable solutions to overcome the 
clinical need for regeneration and replacement of diseased tissues.  
In the orthopaedic field, joint ailments are one of the major drawbacks causing physical 
disability, limited activity, pain and reduced quality of life. In addition, joint ailments affect 
population of all ages, at a global scale, and are usually lifetime enduring. 
Among the distinct pathologies affecting joints, osteochondral lesions – where articular 
cartilage and underlying bone are damaged - present particular challenges to be overcome: 
- Osteochondral tissue is composed by a layer of hydrated soft cartilagineous tissue, 
composed of one cell type in a dense matrix; and the bone compartment, a dynamic, 
stiff and complex tissue, composed of a highly organized structure, several cell types, 
which demand an impregnated vascular network for survival. 
- The hierarchical structure, composition and mechanical properties specific of this 
tissue require the design of particular tools and strategies, by combining living cells, 
biomaterial scaffolds as templates, biochemical cues and bioreactors, this later 
providing precise environmental control and physical stimuli which mimic their unique 
physiologic biomechanical context.   
 
Aimed at improving current knowledge on in vitro engineering of cartilage and bone tissues, 
this thesis gathers a set of experimental approaches focused on the use of adipose tissue 
derived stem cells as single cell source to engineer both cartilaginous and osteogenic 
components, including the vasculogenic compartment of bone. To this end, we have 
additionally explored biomechanical cues, such as hydrostatic pressure stimulation for cartilage 
and flow perfusion for bone, and biochemical cues, such as chondrogenic, osteogenic and 
endothelial growth factors, alone or in combination, to better engineer cartilaginous and 
osteogenic tissues. 
 
Adipose stem cells of human origin (hASC) were used in this thesis as single cell source for the 
development of both tissues. The potential of these adult mesenchymal stem cells was 
extensively explored, due to their unique characteristics that makes them attractive for the 
purpose of osteochondral tissue engineering:  
1. Adipose tissue harvesting and processing procedures, leading to stem cell isolation, 
are simple and expedite, which are advantageous aspects towards clinical application; 
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2. hASC differentiation capacity into the chondrogenic and osteogenic lineages was 
confirmed, and their potential use for vasculogenesis was further suggested and 
supported; 
3. Not only differentiation capacity was confirmed, but also robust and viable 3D tissues 
were developed by hASC culturing;  
4. Biomechanical stimulation of hASC-scaffold constructs demonstrated that hASC detect 
physical forces of distinct nature (hydrostatic pressure and shear stress), magnitude 
and frequency, by responding diversely in terms of gene expression and matrix 
deposition. 
 
On what concerns the improvement of in vitro engineered cartilage tissue, two custom-made 
bioreactor systems were developed, being capable of generating and applying, in a controlled 
manner, hydrostatic pressure (HP) as biomechanical stimuli - at high and low magnitudes - to 
3D tissue engineering constructs. These devices hold key characteristics such as: 
1. Capacity of long term culturing (several weeks) of 3D constructs of distinct size and 
shape, in standard biohazard hood and CO2 incubator, in compliance with good cell 
culturing practices; 
2. Tunable loading parameters, namely HP magnitude (0-0.4 MPa for low HP bioreactor 
and 1.5-10 MPa for high HP bioreactor), and frequency (0-1 Hz). Specific device 
design leads to minimal need for operator manipulation.  
In this particular study, hASC were encapsulated in gellan gum hydrogels (ASC-GG), a 
biomaterial previously developed by our research group, which has proven adequate 
properties, such as biomechanical performance and structural versatility. More than 
hypothesizing the ability of hASC to sense and respond to pulsatile HP mechanical stimulation 
at 0.4 MPa, by increasing chondrogenic differentiation and improving cartilage tissue 
development, we have questioned the influence of physiologic levels of HP (5 MPa) on the 
magnitude of these outcomes. Both hypotheses were proven:  
1. hASC sense and respond to pulsatile hydrostatic pressure stimulation at low (0.4 MPa) 
and physiologic (5 MPa) pressure ranges;  
2. Physiologic HP amplitudes promoted a higher and better tissue matrix distribution, 
which resembles native articular cartilage.  
This approach may be proposed as an alternative strategy to current chondrocyte-based 
therapies for the repair of focal cartilage lesions. It benefits from a cell source that is abundant 
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and rapidly accessible, provides very high yields per volume of tissue, and may therefore 
minimize or even avoid lengthy cell expansion periods.  
 
Maintaining hASCs as cell source, potential templates for bone tissue engineering were further 
investigated. Different types of silk-based scaffolds were fabricated varying in soluble reagent 
(aqueous vs. hexafluoro-2-propanol (HFIP)), pore size (250-400µm vs. 400-600µm) and 
porous structure:  
1. aqueous, spherical-pore structure, small pores (250-500 µm);  
2. aqueous, spherical-pore structure, large pores (500-1000 µm);  
3. aqueous, lamellar structure,  
4. HFIP-derived, medium pore sizes (400-600 µm), and  
After 7 weeks of static culturing with osteogenic cues, HFIP-derived silk fibroin scaffolds, which 
exhibited higher stiffness as compared to aqueous-based silk fibroin scaffolds, appeared to 
provide a better platform for bone formation, in terms of deposition of matrix proteins (OPN, 
BSP, Col I), mineralization and mechanical properties of engineered constructs. The bone 
formation was equally distributed throughout the scaffold showing homogenous osteogenic 
activity of hASCs.  
 
Despite the encouraging results achieved using static culturing, we aimed to further augment 
bone tissue formation by hASC osteogenic differentiation using this porous silk scaffold, by 
applying a sequence of steady (400 µm/s) and pulsatile flows (ranging from 400 µm/s to 1200 
µm/s, at 0.5 Hz), associated with fluctuating shear stresses (0.045 – 0.134 dyn/cm2). We 
aimed to understand the importance of osteogenic pre-differentiation of hASC for the 
achievement of this goal – 1 or 2 weeks of pre-differentiation culturing was performed under 
steady perfusion. Our aim was accomplished, as all pulsatile flow regimes improved bone 
tissue development over steady flow - the prevalent regime adopted by literature. Cell 
response to pulsatile fluid flow was progressively enhanced with the increase of steady flow 
culturing time, being maximum for 2 weeks of culture. These findings are consistent with the 
notion that osteogenic hASC gradually develops mechanisms to detect and respond to 
changes in shear stress. 
 
The same cell-scaffold system was further used to engineer vascularized bone, under static 
conditions, by managing spatio-temporal cues. Three strategies were evaluated:  
1. induction of osteogenesis prior to vasculogenesis,  
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2. induction of vasculogenesis prior to osteogenesis, or  
3. simultaneous induction of osteogenesis and vasculogenesis.  
After 5 weeks of culture, bone development was evidenced by the deposition of bone matrix 
proteins, alkaline phosphatase activity and calcium deposition, along with the formation of 
vascular networks evidenced by endothelial cell surface markers, such as CD31 and von 
Willebrand factor, and morphometric analysis. The most robust development of the two tissue 
compartments was achieved by sequential induction of osteogenesis followed by the induction 
of vasculogenesis. Taken together, the collected data strongly supports the utility of hASC as a 
potential single cell source for the formation of vascularized bone tissue.  
In parallel, an original in vitro model was also developed, where HUVECs and hMSC were co-
cultured in order to grow vascularized bone under temporal variation of the culture 
environment. We were able to derive vascular networks and induce bona fide osteogenic 
differentiation within single tissue grafts in vitro. Functional vascular networks and viable 
osteoid formation were detected post-implantation in Severe Combined Immunodeficiency 
(SCID) mice. The most successful approach was achieved with induction of vasculogenesis 
prior to osteogenesis, for which the addition of osteo-induced MSC further improved tissue 
outcomes. Due to the close interaction between MSCs and HUVECs in co-culture systems, the 
proposed tissue engineering model may be useful as a controllable experimental tool to 
elucidate other molecular mechanisms regulating heterotypic cell-cell interactions.  
 
As conclusion of this thesis, new approaches are proposed to engineer fully developed and 
functional cartilage and vascularized bone tissue that can be used individually or in 
combination to restore and/or regenerate osteochondral lesions: Experimental data 
demonstrates that hASC cultured in gellan gum hydrogels under physiological hydrostatic 
pressure loading differentiate into the chondrogenic lineage and secrete dense cartilaginous 
extracellular matrix, while, if cultured in a silk fibroin-based porous scaffold with adequate 
mechanical properties, under shear stress forces, hASC differentiate into the osteogenic 
lineage, producing a calcified robust bone-like tissue. Moreover, when the appropriate spatial 
and temporal nourishment of growth factors where provided to hASC, both osteogenic and 
vascular compartments of bone tissue were identified, which add strength to the proposal of 
using hASC as single cell source to fully engineer osteochondral tissues. 
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Future perspectives 
Although results obtained prove successful use of human adipose stem cells for osteochondral 
tissue engineering, research in three additional directions are considered fundamental to 
consolidate the merits of such approach, namely: 
1) Exploitation of fluid perfusion as a biomechanical stimulation route of hASC endothelial 
differentiation in order to optimize blood vessel formation; 
2) Research regarding concurrent development of both bone and vessel compartments 
using hASC, in terms of timing and nature of biochemical and mechanical stimulation; 
3) Combination of both cartilaginous and osteogenic compartments into an integral, 
viable and functional osteochondral graft for further in vivo evaluation in animal models 
where relevant osteochondral pathologies are truly replicated so that: 
a. Surgical procedures and rehabilitation procedures can be jointly developed 
and tested; 
b. Long-term tissue integration can be properly evaluated. 
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